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XABSTRACT
In this thesis, the development and early regression of the human hyaloid 
vascular system including the main hyaloid artery (HA), vasa hyaloidea propria 
(VHP), tunica vasculosa lentis (TVL) and pupillary membrane (PM) have been 
examined. Morphology, cellular constituents and immuno-phenotypes were studied 
and the possible mechanisms involving regression were discussed. The related 
components and tissues, including hyalocytes and the primary vitreous, and their 
functions in hyaloid development and regression were also investigated.
Chapter 1 provides a literature review in development of human eye and 
ocular vasculature. Chapter 2 describes details of general technique, and specific 
methodological details are provided in each subsequent chapters. In Chapter 3, light 
microscopic studies of hyaloid development and regression using immunostaining 
and cresyl violet staining of whole mounts of hyaloid tissues indicated that the 
structure of the hyaloid vascular system comprised the HA, VHP, TVL and the 
PM. Ultrastructurally, the branches of the PM and TVL consisted of a continuous 
layer of non-fenestrated endothelial cells joined by intervening junctional 
complexes. Vessel and non-vessel associated hyalocytes and occasional fibroblasts 
were also present. The studies of time course of hyaloid development and 
regression demonstrated that the hyaloid system was well established by 10 weeks' 
gestation (WG) and started to show evidences of regression at 11 WG. Signs of 
vascular involution included thinning and narrowing of the VHP, thinning, 
stretching and a loss of anastomoses of the interconnecting vessels of the TVL and 
PM. The PM regression became increasingly evident after 18 WG, with vessels 
less convoluted and thinner in the central portion. These findings were consistent 
with the previous human studies but the time course of the hyaloid regression was 
observed to an earlier stage than that reported by other researchers.
Expression of leucocyte markers, antigenic features and cellular 
relationships of the normal human foetal hyaloid vasculature using 
immunohistochemistry and light microscopy in whole mounts have been reported
XI
in Chapter 4. The results showed that endothelial cells throughout the hyaloid 
system were immunoreactive to anti-von Willebrand factor (vWF) and anti-major 
histocompatibility complex classes-I (MHC-I). Pericytes and/or vascular smooth 
muscle cells were immunoreactive to anti-alpha-smooth muscle actin (SMA-a); 
anti-SMA-a labelled cells were distributed along large branches of the HA, VHP, 
TVL and the PM in two different morphological forms: dendritiform and 
circumferential form. No SM A-a immunoreactivity was detected on the cells 
located on small connecting capillaries. Juxtavascular and intervascular hyalocytes 
in HA, VHP, TVL, PM and non vessel-associated hyalocytes in the vitreous were 
immunoreactive to anti-MHC-I, MHC-II, CD45. Anti-glial fibrillary acidic protein 
(GFAP) reactivity was detected on Bergmeister's papilla but not on the hyaloid 
artery. Cells immunoreactive for anti-vimentin were seen in perivascular locations 
and vimentin immunoreactive filamentous processes were present throughout the 
hyaloid.
Calcitonin gene-related peptide (CGRP), a major neuropeptide, 
immunoreactivities were also expressed by normal human foetal hyaloid 
vasculature and hyalocytes in the hyaloid vessels and vitreous (Chapter 5). 
Substance P (SP) positive filaments were found in hyaloid vessels but not in 
vitreous, while anti-vasoactive intestinal peptide (VIP) showed weak co-localisation 
with anti-CGRP in hyalocytes and the hyaloid vessels. Anti-MHC-I, MHC-II, 
CD45, CGRP and VIP labelled hyalocytes in human foetal hyaloid vasculature and 
vitreous presented a morphological heterogeneity (Chapter 4 and 5).
The mechanisms of the hyaloid regression, the morphological features of 
cell death and apoptosis in the human foetal hyaloid system have been investigated 
using light and electron microscopy, DNA stains and terminal deoxyribonucleotidyl 
transferase mediated dUTP-biotin nick end-labelling (TUNEL) (Chapter 6). The 
results indicated that cell death and vessel involution have some features in common 
with the apoptotic involution. However, apart from the features of apoptosis, 
cytolysis also occurred during vascular regression (Chapter 6). Various stages of
XII
cell death and vascular involution associated with apposing hyalocytes, were also 
observed ultrastructurally within the hyaloid vasculature of specimens between 13 
and 20 weeks' gestation.
The role of hyalocytes and vitreous in hyaloid vascular regression and the 
effects of human foetal and adult vitreous and hyalocyte-derived factors on vascular 
endothelial cell growth were studied in vitro (Chapter 8). The results indicated that 
human adult vitreous, adult hyalocyte-conditioned medium (AHC) and foetal 
vitreous/hyaloid-conditioned medium (FHC) inhibited the proliferation and reduced 
the viability of human umbilical vein endothelial cells (HUVECs) in vitro, and the 
inhibitory effects were dose-dependent. The cytotoxic changes were evidenced by 
trypan blue exclusion viability test and cresyl violet staining, showing cell 
degeneration, fragmentation and vacuolation after treatment by high concentration 
of vitreous and FHC. The TUNEL technique also revealed evidence of apoptotic 
involution, with characteristic condensed nuclear chromatin and cytoplasmic 
apoptotic bodies post-treatment. In contrast with the effects of vitreous and 
hyalocyte conditioned medium, human foetal and adult retinal epithelial cell (RPE)- 
conditioned medium promoted HUVEC proliferation without influencing cell 
viability. This effect was consistent with the effect produced by exogenous vascular 
endothelial growth factor (VEGF) (Chapter 8). The observations suggest that 
human foetal vitreous/hyaloid-conditioned medium, adult hyalocyte-conditioned 
medium and vitreous contain anti-angiogenic factors which inhibit HUVEC growth 
and induce cell death; while human RPE conditioned medium contains mitogenic 
factors which may act in a similar way to VEGF to stimulate cell growth. These 
results, combined with previous studies (Chapter 4, 5, 6) yield important evidence 
about the functional roles of vitreous and hyalocytes in prenatal intraocular vascular 
regression. It also gives additional evidence about the functional roles of the RPE in
new vessel formation.
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CHAPTER 1. 
Introduction
Chapter 1. Introduction 2
I. DEVELOPMENT OF THE HUMAN EYE
The eye is derived from three primitive embryonic layers. The surface 
ectoderm, including its derivative, the neural crest, gives rise to the lens, the 
lacrimal gland and its drainage system, the epithelium of the cornea, conjunctiva, 
adnexal glands and the epidermis of the eyelids. The neural crest, which arises 
from the surface ectoderm in the region immediately adjacent to the folds of 
neural ectoderm, gives rise to the corneal keratocytes, the endothelium of the 
cornea and the trabecular meshwork, the stroma of the iris and choroid, the ciliary 
muscle, the fibroblasts of the sclera, the vitreous and the optic nerve meninges. It 
contributes to the formation of the orbital cartilage and bone, the orbital 
connective tissues and nerves, the extra ocular muscles and the subepidermal 
layers of the eyelids. The neural ectoderm gives rise to the primary optic vesicle 
and optic cup (the secondary optic vesicle), subsequently the retina and retinal 
pigment epithelium, the ciliary epithelium, the posterior epithelium, the sphincter 
and dilator muscle of the iris, and the optic nerve and glia. The mesoderm 
contributes only to the extraocular muscles and to the orbital and ocular vascular 
endothelium (Riordan-Eva, 1995). Figure 1.1 shows the optic vesicle and the three 
layers of embryonic tissue which are involved in human eye development.
Three main periods can be distinguished during prenatal development of 
the human eye: embryogenesis (optic vesicle stage) (Figure 1.1), organogenesis 
(optic cup stage) (Figure 1.2) and differentiation (Barishak, 1992). The primary 
optic vesicle develops into the optic cup by invagination (Figure 1.3). Prenatal 
development of the eye during different gestational ages are summarised in Table 
1. 1.
Embryology of specific structures
Lids and lacrimal apparatus
The lids develop from mesoderm except for the epidermis of the skin and 
the epithelium of the conjunctiva, which are derivatives of surface ectoderm
Fig. 1.1. Model of fore-brain and primary optic vesicle at 3
WG. a. cavity of fore-brain; b. surface ectoderm; c. neural ectoderm; d. 
cavity of primary optic vesicle; e. mesoderm-neural crest; /. mesoderm. 
(Reproduced from Mann, I.: The development of the human eye. New 
York: Grime & Stratton Inc. 1950)
Optic cup 
Lens vesicle
Fig. 1.2. Model of optic cup at 3-4 WG. (Reproduced from 
Mann, I.: The development of the human eye. New York: Grime & 
Stratton Inc. 1950).
(a) (b) (c) (d)
Fig. 1.3. Diagram of the process of invagination of the 
primary optic vesicle to form the optic cup. A. Cavity of 
primary optic vesicle. B. Cavity of the optic cup. (a)-(c) show vertical 
sections; (d) is a horizontal section. (From Mann, I.: The development 
of the human eye. New York: Grune & Stratton Inc. 1950).
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(Riordan-Eva, 1995). The lid buds are first seen at 6 weeks’ gestation (WG) 
growing in front of the eye, where they meet and fuse at 8 WG. The lashes and 
meibomian and other lid glands develop from the epidermis (Duke-Elder and 
Cook, 1963; Riordan-Eva, 1995).
The lacrimal and accessory glands develop from the conjunctival 
epithelium. The lacrimal drainage system derives from surface ectoderm. It is not 
until the age of three or four years that the lacrimal glands are fully functional 
(Riordan-Eva, 1995).
Sclera and extraocular muscles
The sclera and extraocular muscles are formed from condensations of 
mesenchyme encircling the optic cup and are first identifiable at 7 WG (Riordan- 
Eva, 1995). Differentiation of the sclera occurs in an antero-posterior process 
(Mann, 1950; Duke-Elder and Cook, 1963; Selleyer and Spitznas, 1988b). The 
condensation starts at the limbus, then posteriorly extends to the equator at the end 
of the 8th WG, reaching the posterior pole by the end of the 5th month of 
gestation (MG) (Duke-Elder and Cook, 1963; Selleyer and Spitznas, 1988b). 
Tenon's capsule appears near the insertions of the rectus muscles at 12 WG and 
has completed development at 5 MG (Riordan-Eva, 1995).
Anterior segment
The anterior segment of the globe is formed by the invasion of neural 
crest cells into the space between the surface ectoderm, which later develops into 
the corneal epithelium, and the lens vesicle, which has already separated from the 
surface ectoderm (Mann, 1950; Beauchamp and Knepper, 1984; Riordan-Eva, 
1995). The invasion of neural crest cells occurs in three stages: the first is 
responsible for formation of the corneal endothelium, the second for the formation 
of the corneal stroma, and the third for the formation of iris stroma. The anterior
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chamber angle is formed from a residual condensation of mesenchyme at the 
anterior rim of the optic cup (Riordan-Eva, 1995).
The corneal epithelium is first apparent at the 5th WG. Descemet's 
membrane is secreted by the flattened endothelial cells by 13 WG. The stroma 
slowly thickens and forms an anterior condensation that is recognisable at 16 WG 
as Bowman's layer. Mesenchymal cells of the posterior stroma also give rise to the 
endothelium and by 22 WG the appearance of the cornea is almost adult-like 
(Duke-Elder and Cook, 1963; Selleyer and Spitznas, 1988d).
The double row of posterior iris epithelium grows forward from the 
anterior rim of the optic cup during the 12th- 16th WG to lie posterior to the neural 
crest cells that form the iris stroma. By the 20th WG, the sphincter muscle of the 
pupil is developing from the anterior epithelial layer of the iris (from neural 
ectoderm) near the pupillary margin while the dilator muscle appears in the 
anterior epithelial layer near the ciliary body soon after 6 MG (Hogan et al., 1971; 
Riordan-Eva, 1995). The anterior chamber first appears at 7 WG and remains very 
shallow until birth. The trabecular meshwork develops from the loose vascular 
mesenchymal tissue after 9 to 10 WG.
Lens
Soon after the lens vesicle separates from the rim of the optic cup (6 WG), 
the cells of posterior wall of the lens vesicle elongate, encroach on the empty 
cavity and finally fill it (primary lens fibres) (7 WG); at the same time, a hyaline 
capsule is secreted by the lens cells (Barishak 1992; Riordan-Eva, 1995). By the 
8th WG, secondary lens fibres elongate from the equator and grow forward under 
the subcapsular epithelium. These fibres contribute to the formation of the lens 
sutures, which later on will constitute the foetal nucleus. The procedure is 
complete by the 7 month but growth and proliferation of secondary lens fibres 
continues at a decreasing rate throughout life, the lens therefore continuing to
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enlarge, causing compression of the fibres (Duke-Elder and Cook, 1963; Riordan- 
Eva, 1995).
Ciliary body and choroid
The ciliary epithelium is formed from the same anterior extension of the 
optic cup (neural ectoderm) that is responsible for the posterior iris epithelium. 
The ciliary muscle and blood vessels are derived from mesenchyme. During the 
4th MG, the pars plana and ciliary muscle appear, and by the 5th MG, the ciliary 
muscle is well developed (Barishak, 1992). Only the outer layer of epithelium 
becomes pigmented.
At 3-4 WG, a network of capillaries encircles the optic cup and develops 
into the choroid (Mann, 1950; Riordan-Eva, 1995). By the 12th WG, the 
intermediate and large venous channels of the choroid are developed and drain 
into the vortex vein (See below, Sellheyer and Spitznas, 1988a, c; Barishak, 1992; 
Riordan-Eva, 1995). The arteries of the choroid first become apparent during the 
6th MG (Sellheyer and Spitznas, 1988c).
Vitreous
Vitreous development includes three stages: primary vitreous (or 
hyaloidean vitreous, 3-6 WG), secondary vitreous (or definitive vitreous, 6-10 
WG) and tertiary vitreous (or zonule vitreous, 10 WG on) formation (Duke-Elder 
and Cook, 1963; Jaffe, 1969; Riordan-Eva, 1995; Cook etal., 1996).
At about 3 WG, mesenchymal cells and fibroblasts derived from 
mesenchyme at the rim of the optic cup or associated with the hyaloid vascular 
system, together with minor contributions from the embryonic lens and inner layer 
of the optic vesicle, form the primary vitreous (Riordan-Eva, 1995). When the 
lens vesicle detaches from the optic cup, the cavity formed begins to fill with 
primary vitreous (Jaffe, 1969). The hyaloid artery enters the primary vitreous, 
sending branches to the vitreous and supplying the vitreous aspect of the lens. By
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5-6 WG, when the hyaline capsule of the lens is formed and becomes separated 
from the primary vitreous, the lens probably no longer participates in the 
formation of the vitreous (Jaffe, 1969).
The secondary vitreous forms from 6 WG. The fibrils and hyalocytes of 
the secondary vitreous are thought to originate from the vascular primary vitreous. 
It has a finer texture although it is more dense than the primary vitreous. It is 
entirely avascular and is formed solely from the inner layer of the optic cup 
(neural ectoderm) (Jaffe, 1969). Anteriorly, the firm attachment of the secondary 
vitreous to the internal limiting membrane of the retina constitutes the early stages 
of formation of the vitreous base (Riordan-Eva, 1995). The hyaloid vessels within 
the primary vitreous grow until 12 WG, then atrophy (Mann, 1950; Jaffe, 1969; 
Riordan-Eva, 1995; Cook et ai, 1996). As the secondary vitreous is further 
elaborated, it compresses the vascularised primary vitreous into the centre of the 
globe. The primary vitreous is finally relegated to a cone-like structure adherent to 
the posterior lens (Jaffe, 1969; Riordan-Eva, 1995).
The tertiary vitreous stage starts form 10 WG. The bundle of Drualt forms 
during 12 to 16 WG (Mann, 1950; Jaffe, 1969; Cook et ai, 1996). This consists of 
vitreous fibrillar condensations extending from the future ciliary epithelium of the 
optic cup to the lens. The fibres of the bundle divide into an anterior group 
running immediately behind the iris and a posterior group running parallel to the 
anterior hyaloid membrane. The most anterior portion of the bundle atrophies, 
while the secondary vitreous remains connected to the ora and in apposition to the 
most posterior zonular fibres (Jaffe, 1969).
Retina
In the human retina, the outer layer of the optic cup remains as a single 
layer and develops into the retinal pigment epithelium. Pigmentation begins at the 
5th WG (Duke-Elder and Cook 1963; Riordan-Eva, 1995). At the same time, the 
external limiting membrane is evident (5 WG), while a thin basal lamina evident
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over the inner surface of the marginal layer plus contributions from the developing 
Müller cell processes combine to form the primitive internal limiting membrane 
(Cook et al, 1996). Secretion of the inner layer of Bruch's membrane occurs by 
the 6th WG. Cells of the inner layer of the optic cup undergo a complicated 
differentiation into the other nine layers of the retina - internal limiting membrane, 
nerve fibre layer, ganglion cell layer, inner plexiform layer, inner nuclear layer, 
outer plexiform layer, outer nuclear layer, external limiting membrane and 
photoreceptor layer (Mann, 1950; Hogan et al, 1971; Riordan-Eva, 1995). The 
inner plexiform layer separates the ganglion cell layer from the inner nuclear layer 
at 9 WG (Spira and Hollenberg, 1973). In the human retina, the outer nuclear 
layer, consists of photoreceptor somata, evident in the posterior retina by 10-12 
WG (Linberg and Fisher, 1990; Diaz-Araya and Provis, 1992). The outer 
plexiform layer also appears by 10 to 12 WG (Spira and Hollenberg, 1973; 
Linberg and Fisher, 1986). The ganglion cell layer is present centrally by 9 WG 
(Spira and Hollenberg, 1973) and well established and mature by 15 to 20 WG 
(van Driel et al, 1990; Barishak, 1992). Retinal cell differentiation occurs slowly 
throughout gestation.
Recent studies indicate that retinal neurogenesis occurs in a centro- 
peripheral sequence (Hollenberg and Spira, 1972, 1973; Barishak, 1992; Provis et 
a l, 1985, 1998), centred on the incipient fovea. The fovea develops by 
differentiation, cell migration (doming) and accumulation, thinning and elongation 
of foveal cones and lastly the formation of the depression (Hendrickson, 1992; 
Diaz-Araya and Provis, 1992; Pro vis et al, 1998). The foveal cones are amongst 
the first retinal cells generated and can be easily distinguished as a mosaic at the 
incipient fovea at 12 WG. Doming of the fovea surface starts at 17 WG, while the 
first evidence of the depression is apparent at 24 WG (Provis et. al, 1998). 
Quantitative studies of photoreceptor density at and surrounding the cone mosaic 
indicate that photoreceptors are displaced centripetally, commencing at around 12
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WG to reach their final adult morphology and density at about 4 years postnatal 
(Provis et al, 1998).
Optic nerve
The axons of the ganglion cells of the retina form the nerve fibre layer. 
The nerve fibres grow directly from the inner layer of optic cup into the stalk, 
which then becomes the optic nerve (8 WG) (Mann, 1950; Riordan-Eva, 1995; 
Cook et al., 1996). Mesenchymal elements enter the surrounding tissue to form 
the vascular septa of the nerve. Medullation extends from the brain peripherally 
down the optic nerve, and at birth has reached the lamina cribrosa. Medullation is 
completed by 3 months after birth (Riordan-Eva, 1995).
Blood vessels
Vessels containing nucleated red blood cells can be recognised easily in 
the mesoderm surrounding the optic vesicles at 2-3 WG (Mann, 1950). The details 
of the development of blood vessels of the human eye will be described below.
II. DEVELOPMENT AND REGRESSION OF THE HUMAN OCULAR 
VASCULATURE
By the 4th WG, two sets of vessels, which anastomose freely, are 
developing in the optic cup (Terry, 1942; Mann, 1950; Duke-Elder and Cook, 
1963). One set passes into the interior of the optic cup along the fissure, then 
enters the cup through the fissure at the 4-5th WG. This vessel is the future 
hyaloid artery. The other set grows upwards on either side of the margin of the 
cup and soon forms a complete vascular ring around the margin of the cup, and 
anastomoses with the first set. This vascular ring is the annular vessel (Terry, 
1942; Mann, 1950; Duke-Elder and Cook, 1963). Very soon after the 5th WG, the 
vascular arrangements can be clearly divided into the extra-ocular blood system 
and the intra-ocular system. The extra-ocular system, including the vessels of the
Chapter 1. Introduction 9
orbit and the primitive choroid, forms the rudiment of the definitive extra-ocular 
blood supply. The intra-ocular system, consisting of the hyaloid artery and its 
branches, supplies the developing intraocular tissues including lens, vitreous and 
adjacent tissues. This vessel system regresses, and a new and definitive intraocular 
blood system, the retinal vascular system, starts to grow from the trunk of the 
hyaloid artery (Mann, 1950). Figure 1.4 and Figure 1.5 show the two sets of 
vessels at the 4th WG and the 8th WG respectively.
Development of extraocular blood vessels -  orbital vessels and choroid
By 5-6 WG, a venous net, which is initially developed from the 
undifferentiated paraxial mesoderm encircling the optic vesicle, encloses the optic 
cup, receiving blood from the internal carotid artery; it forms the primitive 
choroid (Mann, 1950; Duke-Elder and Cook, 1963). This venous choroid is 
drained by four or more large branches into the supra-orbital and the infra-orbital 
plexus which open into the cavernous sinus (Mann 1950). The primitive venous 
choroid later becomes the choriocapillaris (Berens, 1936; Mann, 1950). By the 6th 
WG, the internal carotid gives off the arteria ophthalmica interna (ophthalmic 
artery), from which the long ciliary arteries are budded off and supply the choroid 
(7 WG). By the 7-8th WG, the long ciliary arteries have anastomosed around the 
rim of the cup to form the major circle of the iris (greater circle of the iris), and 
the superior and inferior orbital vessels (Berens, 1936; Duke-Elder and Cook, 
1963). By the 3rd MG, the short posterior ciliary arteries develop from the 
ophthalmic artery close to the origin of the long posterior arteries; they first appear 
as 5-6 small branches running forwards around the optic nerve but soon break up 
into 12-15 small twigs which perforate the sclera to reach the choroid and supply 
the choriocapillaris encircling the outer wall of the optic cup (Duke-Elder and 
Cook, 1963). By the 5th MG, all the layers of the choroid are visible and by the 
7th MG, the choroid is fully differentiated (Berens, 1936; Mann, 1950; Duke- 
Elder and Cook, 1963) (Figure 1.6 and 1.7).
Fig 1.4. Model of the developing blood vessels in the optic
cup at 4th WG. C. I. branches vascularising the margins of the optic 
cup; H. Hyaloid artery entering the foetal fissure; V. main vessel 
supplying eye (internal carotid artery). (Reproduced from Mann, I.: The 
development of the human eye. New York: Grune & Stratton Inc. 1950)
Fig. 1.5. Diagram of intra- and extra- ocular blood systems at
8 WG. a. annular vessel; h. choroidal vessel; c. hyaloid artery; d. vortex 
vein; e. pupillary membrane. (Reproduced from Mann, I.; The 
development of the human eye. New York: Grune & Stratton Inc. 1950)
Fig 1.6. Vascular development of the eye at 7 WG. I . C .  
internal carotid; O. arteria ophthalmica interna (ophthalmic artery); H. 
hyaloid artery; C.C. common ciliary artery; T.C. and N.C. temporal and 
nasal ciliary arteries; C.S. cavernous sinus; S.V. and I.V. superior and 
inferior ophthalmic veins; V.V. venae vorticosae (vortex veins) 
(Reproduced from Duke-Elder S, Cook C.: System of Ophthalmology. 
Vol III, Normal and Abnormal Development, Part 1 Embryology. 
London: Henry Kimpton. 1963)

Fig. 1.7. Anterior portion of the choroid and pupillary 
membrane at 7 to 8 WG. A. after the appearance of the long ciliary 
arteries (b,b) but before their anastomoses. The annular vessel is seen in 
blue in the centre. B. the same region after the anastomoses. The annular 
vessel is no longer distinct. (Reproduced from Mann, I.: The 
development of the human eye. New York: Grune & Stratton Inc. 1950)
A B
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The main vessels supplying or draining the optic cup extra-ocularly are 
summarised below:
i) Arteries. These appear first. They are derived from the internal carotid 
artery, which branches to form the arteria ophthalmica interna (ophthalmic 
artery). The interior branch from the main arteria ophthalmica interna enters the 
optic cup, referred to as the hyaloid artery and later gives rise to arteria centralis 
retinae. The external branch of the arteria ophthalmica interna vascularises the 
margins of the cup, referred to as the common ciliary artery. The common ciliary 
artery breaks up to form the nasal and temporal posterior and long ciliary arteries 
which circulate arteriosus iridis and choroid (Mann, 1950; Duke-Elder and Cook, 
1963).
ii) Veins. These vessels appear a little after the inception of the arteria 
ophthalmica interna and form a net on the outside of the cup (the primitive 
choroid, later, choriocapillaris). They drain via the venae vorticosae (later vortex 
veins) into the supro-orbital and infro-orhitalplexuses and then into the 
cavernous sinus. The superior and inferior ophthalmic veins are formed later by 
differentiation of some vessels of the plexuses, and remain in the adult (Mann, 
1950).
iii) Channels. These vessels (larger than capillaries) anastomosed in the 
region of the cup margin cannot be classified as either arteries or veins are named 
as channels. The earliest of the channel is the annular vessel (Mann, 1950).
Development and regression of foetal intraocular blood vessel -  Hyaloid system
The hyaloid artery (HA) is at first formed as the distal portion of the main 
trunk of the ophthalmica interna from the internal carotid. It enters the optic cup 
through the foetal fissure at about the 5th WG. In fact, from the cytological view, 
the artery does not "enter" the cup. It develops "piece by piece" on the spot by the 
differentiation of the mesenchymal cells to prevascular cells and endothelial cells 
of the vessel wall or to haemangioblasts and blood cells within the developing
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vessel (Balazs et al, 1980). The main trunk of the HA grows rapidly to reach the 
back of the lens and buds off to form the posterior tunica vasculosa lends (TVL) 
by 5-6 WG (Terry, 1942; Mann, 1950; Duke-Elder and Cook, 1963; Woollam, 
1972; Barishak, 1992). At this stage the annular vessel is complete and the 
branches of the posterior TVL continue to grow wrapping around the equator of 
the lens to form the lateral TVL, which also anastomoses with the annular vessel. 
The connections with the extra-ocular blood system are cut off one by one as the 
fissure closes during the 7th WG (Mann, 1950; Duke-Elder and Cook, 1963; 
Woollam, 1972; Barishak, 1992). At this time, the HA gives rise to several 
branches which completely fill the vitreous and anastomose freely with each other 
and with the branches of the posterior TVL. These vessels are known as the vasa 
hyaloidea propria (VHP) (Mann, 1950; Duke-Elder and Cook, 1963; Woollam, 
1972). By the 9th WG, the VHP reaches the height of development and 
anastomoses freely with the TVL.
There are different descriptions regarding the sequence of the formation of 
the VHP and the posterior TVL. Some studies suggest that the posterior TVL 
ramifies from the VHP (Berens, 1936; Mutlu and Leopold, 1964; Ko et al., 1985). 
In these reports the VHP has been considered to include three or more large 
branches at the back of the lens before they reach lens surface and ramify on the 
lens capsule. These vessels are classified by Mann and other authors as the main 
branches of the posterior TVL (Mann, 1950; Duke-Elder and Cook, 1963; 
Woollam, 1972; Barishak, 1992). In this thesis, all the vessels which are in the 
vitreous before they reach the posterior lens capsule are considered as VHP; only 
the vessels that wrap around the lens are classified as TVL.
The TVL includes posterior, lateral and anterior portions (Terry, 1942; 
Mann, 1950; Duke-Elder and Cook, 1963; Woollam, 1972; Barishak, 1992; Cook 
et al, 1996). The posterior TVL forms an irregular vascular network. It 
anastomoses with the VHP and grows anteriorly in a short, straight vessel form 
around the equator to form the lateral TVL. The lateral TVL anastomoses with
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annular vessel and drains blood into the annular vessel (6-7 WG). The anterior 
TVL, which is also called pupillary membrane (PM), is developed partly from the 
lateral TVL but mostly from buds of the annular vessel/long posterior ciliary 
artery (7 WG). The terminal branches interconnect with the arterial circles of the 
developing iris (Figure 1.7). By the 9th WG, the PM can be divided into two parts: 
the central portion, supplied by the long ciliary arteries, and the peripheral portion 
which anastomoses with the lateral TVL (Figure 1.8). (Terry, 1942; Mann, 1950). 
By the 6th-7th MG, the central portion of the PM starts to regress. The wall of the 
vessel loops shrink and blood flow ceases. By the 8th-9th MG, the central portion 
of the PM has disappeared completely, while the peripheral PM persists 
throughout life as part of the iris stroma (Mann, 1950; Hamming and Apple, 1980; 
Cook et al, 1996). The whole hyaloid vascular system is seen in Figure 1.8.
By the 12 WG, the hyaloid vasculature starts to regress (Mann, 1937, 
1950; Terry, 1942; Balazs et al, 1980; Barishak, 1992; Cook et al, 1996). 
Involution of the hyaloid is first evident in the VHP and subsequently the 
branches of the TVL and PM (Mann, 1937, 1950; Duke-Elder and Cook, 1963; 
Hamming and Apple, 1980; Ko et al, 1985). The regression of the VHP and TVL 
is normally completed by 34-36 WG (Berens, 1936; Mann, 1950; Duke-Elder and 
Cook, 1963; Barishak, 1992). The main trunk of the hyaloid regresses before the 
birth, but traces of its lental attachment sometimes can be seen in the adult 
(Berens, 1936; Duke-Elder and Cook, 1963).
Development of the retinal vasculature
At 14-16 WG, the portion of the hyaloid artery which passes through the 
optic disc develops a fusiform enlargement, the bulb (Berens, 1936; Mann, 1950; 
Duke-Elder and Cook, 1963; Hamming and Apple, 1980). This is surrounded by a 
small mass of neuroglial cells (Bergmeister's papilla) situated in the centre of the 
disc. The bulb gives rise to small branches, which first vascularise the disc and 
then spread into the substance of the retina as far as the outer plexiform layer.
aFig. 1.8. Hyaloid system at 9 WG. a. anterior tunica vasculosa 
lentis (pupillary membrane); b. lateral tunica vasculosa lentis; c. 
posterior tunica vasculosa lentis; d. outer set of vasa hyaloidea propria; 
e. inner set of vasa hyaloidea propria; /. main trunk of the hyaloid 
artery; g. optic nerve. (Reproduced from Mann, I.: The development of 
the human eye. New York: Grime & Stratton Inc. 1950)
Fig. 1.9. Diagram showing the bulb of the hyaloid artery and its 
branches on the disc to form the arteria centralis retinae. (From Mann, 
I.: The development of the human eye. New York: Grime & Stratton 
Inc. 1950)
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These are the branches of the arteria centralis retinae. They do not reach the ora 
serrata until 32 WG (Berens, 1936; Mann, 1950; Barishak, 1992). The tributaries 
of the vein develop at equal pace to form a second trunk running in the optic nerve 
beside the artery (Berens, 1936; Mann, 1950; Barishak, 1992). Some studies have 
suggested that deeper capillary plexuses of retina form only by extension from 
existing vessels (Gariano et al., 1994). Once the retinal vasculature is well 
developed, the hyaloid artery itself regresses. Figure 1.9 shows a diagram of the 
bulb and early vasculature of the developing retina. Studies of the expression of 
growth factors, particularly the vascular endothelial growth factor (VEGF), in the 
developing embryo suggest that VEGF plays a role in the normal development of 
retinal blood vessels (Breier et al., 1992; Jakeman et ai, 1993; Stone et al., 1995; 
Stone and Maslim 1997; Pierce et al., 1996, Provis et al., 1997a).
Developmental abnormities of the intra-ocular vasculature
The hyaloid vascular system is a most important element of the 
intraocular vasculature when considering developmental abnormities. Persistent 
hyaloid, persistent hyperplastic primary vitreous (PHPV) including persistent 
hyperplastic tunica vasculosa lentis (PHTVL) and persistent hyperplastic vasa 
hyaloidea pupilla (PHVHP), and persistent prepupillary membrane (PPM) are 
among the most common ocular pathologies in paediatric ophthalmology (Mann, 
1937; Reese, 1955; Spitznas et al., 1990). Ipsilateral cataract formation, glaucoma, 
retinal detachment, retinal/vitreous haemorrhage and retinal dysplasia are 
commonly associated with these abnormalities (Mann, 1934; Reese, 1955; 
Haddad etal, 1978; Kaste eta l, 1994).
Generally, there are three main stages or periods of development during 
which abnormalities occur. These are: the em bryogenetic p e r io d , the 
organogenetic period and thq foetal period (Mann, 1937). Factors which induce 
abnormalities in the embryogenetic period may exist in either the ovum or the 
sperm or both. They account for all familial and hereditary defects, even though
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these defects are not apparent at birth (Mann, 1937), such as cerebro-macular 
degeneration, albinism and coloboma. Defects initiated during the organogenetic 
period primarily affect structure and secondarily histological differentiation 
(Mann, 1937). Their origin may be embryogenetic, but environmental factors 
(chemical, osmotic, toxic, etc.) may play an important role in inducing the defects 
(Mann, 1937). Persistent hyaloid vascular system is an example of a defect in this 
period. Abnormalities arising during the foetal period are relatively few (Mann, 
1937).
i) Persistent hyaloid. Persistent hyaloid artery in whole or in part is one 
of the commonest developmental abnormalities occurring in the human eye 
(Duke-Elder and Cook, 1964). It presents as posterior remnants at the disc in 95% 
of premature infants and 3% of full-term infants when they are bom (Jones, 1963).
The cause of the persistence is not clear. There are no indications of 
genetic or hereditary implications. A common view is that they result from some 
factor(s) which causes a temporary "arrest" in the development of the embryo at 
the 6-7th MG (Mann, 1950; Duke-Elder and Cook, 1964). At this late stage, most 
of the ocular tissues have already differentiated and the persistent vascular 
remnants would be expected to occur without other abnormalities. The nature of 
the factor(s) which induce "arrest" are unknown, although it has been suggested 
that metabolic, toxic or a combination of more agents may be involved (Mann, 
1950; Duke-Elder and Cook, 1964).
The form and extent of the persistence show a wide range of variations 
(Mann, 1950; Duke-Elder and Cook, 1964). The complete persistence of the 
whole of the main trunk of the hyaloid artery filled with blood is rare. Sometimes 
it is only a fine thread or a substantial cord with various amounts of fibrous or 
glial tissue. Within this group, the main hyaloid trunk usually passes straight 
across the vitreous with one end attached to the optic disc and another attached to 
the posterior pole of the lens. It is often associated with the microphthalmia or 
other ocular dysplasia (Mann, 1937; Duke-Elder and Cook, 1964). In most
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situations, attachment is interrupted in the centre of the artery with only one end 
attached to the optic disc or to the posterior pole of the lens and the other end in 
the vitreous moving freely with rotations of the eye or appearing as a fibrous cord 
within Berger's space and the anterior aspect of Cloquet's canal (Mann, 1937; 
Duke-Elder and Cook, 1964; Spencer, 1996). In the majority of cases, the hyaloid 
continues to regress and disappears in most of the infants; only in a minority 
cases, remnants persist throughout adulthood.
Persistent hyaloid artery rarely has clinical significance or interferes with 
visual acuity (Mann, 1937; Reese, 1955). However, if hyperplasia or other 
complications occur, poor vision may result. The most common complication is 
cataract induced by fibrous or glial tissue proliferation in the posterior lens 
capsule (Duke-Elder and Cook, 1964).
ii) Persistent vasa hyaloidea propria. Simple persistence of the VHP is 
not common. Minute remnants of the vasa hyaloidea propria may occur floating in 
the vitreous, especially in the anterior region, where they may retain an 
association with the posterior capsule of the lens. These remnants can cause 
muscae volitantes of the vitreous. However, if they proliferate in the vitreous or 
on the posterior capsule of the lens, they will join to form the PHPV (see below) 
(Mann, 1950; Duke-Elder and Cook, 1964).
iii) Persistent hyperplastic primary vitreous /persistent hyperplastic 
tunica vasculosa lentis. Persistent hyperplastic primary vitreous is the term used 
to designate the condition of persistent TVL or persistent posterior foetal 
fibrovascular sheath of the lens (Reese, 1955; Manschot, 1958; Duke-Elder and 
Cook, 1964). In his Jackson Memorial lecture in 1955, Reese was the first to 
describe this abnormality in detail.
Persistent hyperplastic primary vitreous is part of a malformation 
involving the embryonic primary vitreous, ciliary processes, hyaloid vessels 
including the posterior TVL and part of the lens, and sometimes VHP. The 
posterior TVL undergoes considerable fibroblastic hyperplasia and occasionally
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the lateral and anterior TVL become involved so that the whole lens is surrounded 
by fibroblastic tissue. In this case, the vessels of the ciliary system may persist as 
well (Duke-Elder and Cook, 1964).
Persistent hyperplastic primary vitreous occurs in full-term normal infants 
with no apparent hereditary component (Haddad, et al, 1978; Kaste et al, 1993). 
The temporary arrest which occurs around the 3rd MG is believed to cause this 
persistence. One study has suggested that PHPV may be involved in a process of 
maturation that leads to accumulation of fibroblasts and the maturation of 
collagens of the vitreous (Spitznas et al, 1990). The tractus vitrealis and tractus 
retrolentalis which occur at the 5.5 to 6.5 mm stage (2-3 WG) are also associated 
with persistent hyaloid vasculature (Pau, 1996).
The clinical course of PHPV is various and progressive (Duke-Elder and 
Cook, 1964). Abnormal persistent primary vitreous, including persistence of VHP 
and posterior TVL, and concurrent hyperplasia of the embryonic connective 
tissue, produce the basic lesion (Reese, 1955; Spitznas et al., 1990; Kaste et al, 
1993). The extent and appearance of the abnormality vary with the degree of 
mesodermal hyperplasia surrounding the persistent primary vitreous, the extent of 
posterior migration of degenerative epithelial cells of the lens, and the presence or 
absence of retinal detachment and haemorrhage. The most common clinical sign 
presented is leukocoria (white pupil). Anterior, posterior and combined forms 
have been reported (Haddad et al., 1978; Kaste et al, 1993; Spencer, 1996).
Most cases of PHPV (90%) are unilateral (Duke-Elder and Cook, 1964; 
Haddad et al, 1978). In most unilateral cases, PHPV is found in a slightly 
microphthalmic eye and is not associated with other intraocular disorders. A small 
number of unilateral and most bilateral PHPV cases show additional ocular 
disorders, such as abnormalities of anterior chamber angle, colobomas, cataract, 
retinal detachment and retinal dysplasia (Haddad et al, 1978; Kaste et al, 1993; 
Spencer, 1996). Adipose tissue, cartilage and smooth muscle have been observed 
in the retrolental mass, in the lens and in the vitreous (Reese, 1955; Font et al,
Chapter 1. Introduction 17
1969; Spencer, 1996). Eyes with anterior PHPV usually result in a vision loss, 
mainly because of secondary glaucoma or phthisi bulbi (Spitznas et al, 1990). 
Leukocoria is infrequent in the posterior form but when it persists, retinal folds 
usually result in poor vision (Haddad et al., 1978; Spencer, 1996).
IV) Persistent pupillary membrane. Persistent pupillary membrane has 
been found in 95% of the newborns (Duke-Elder and Cook, 1964) and statistics 
show that it is common in infants who are younger than 1 year old, but much more 
rarely observed in old age. If, however, any remains beyond the end of the first 
year of the life it is likely to remain permanently (Duke-Elder and Cook, 1964).
If the PPM retains contact with the iris, it is characteristically attached to 
the lesser circle or sometimes more peripherally towards the ciliary margin 
(Mann, 1937; Duke-Elder and Cook, 1964; Cook et al., 1996). The form of PPM 
varies. The remnants are not necessarily the vessel itself, but can be connective 
tissues from the intervening membrane (Mann 1937). In spite of the various lorms 
of PPM, the rest of the eye is usually normal (Mann, 1937, Duke-Elder and Cook, 
1964; Riordan-Eva, 1995).
The causes of PPM are unclear and there is no evidence of heredity and 
genetic defect. The failure to disappear has been considered to result from 
abnormal general or local conditions acting from the 5th month onward (Mann, 
1937; Duke-Elder and Cook, 1964). The cases accompanied with microphthalmia 
may be considered as resulting from developmental 'arrests' of the whole eye 
during the period of vascular regression. There is no indication that PPM is 
usually accompanied by other persistent parts of hyaloid vessels, because the main 
trunk of the hyaloid, VHP and posterior of the TVL begins to disappear while the 
PM is at the height of development (Mann, 1937; Ko et al., 1985). Partial 
persistence of the PM is very common. The remnants do not impede the 
movement of the pupil nor interfere with vision, with rare exceptions where the 
membrane has been dense or complications in the cornea or lens exist (Duke-
Fig. 1.10. A clinical case of persistent hyaloid system. The
photograph shows one eye of a 28 week premature child with whole 
persistent hyaloid system including TVL and PM (arrow heads). (By 
courtesy of Professor F. A. Billson).
Chapter 1. Introduction 18
Elder and Cook, 1963). Figure 1.10 shows a 28 week premature child with whole 
persistent hyaloid system including TVL and PM.
III. HYALOCYTES - ORIGIN, MORPHOLOGY, DISTRIBUTION AND
FUNCTION
Origin of the hyalocyte
More than one and a half centuries ago, Hannover (1840) (reviewed by 
Grabner et al., 1980) first documented the cells in the vitreous body of the eye. It 
was not until 1959 that the hyalocyte was described as a term by Balazs (1959) 
(reviewed by Grabner et al., 1980) in order to define a homogeneous population 
of cells in the vitreous. The hyalocytes in the hyaloid vessel system (before 
arriving in the vitreous) have also been referred to as monocytes and amebocytes 
(Balazs et al, 1980), macrophages (Jack, 1972b,c; Sellheyer and Spitznas, 1987; 
Hess et al, 1991; Lang et al, 1994) and vitreal cells (Latker and Kuwabara, 
1981).
Regarding the origin of the hyalocyte, Grabner and co-workers (1980) and 
Balazs et al, (1980) reviewed several major theories. As early as 120 years ago, 
on the basis of hyalocyte morphology, distribution and amoeboid movement, 
Schwalbe (reviewed by Grabner et a l, 1980) in 1874 classified them as 
"Wandering cells " (i.e. lymphocytes or leukocytes). Henle (reviewed by Grabner 
et al, 1980) in 1841, Wolfrum (reviewed by Grabner et al, 1980) in 1909 and 
Seefelder (reviewed by Grabner et al, 1980) in 1910 thought that the source of 
hyalocytes could be neuroectodermal tissues because the neuroectoderm envelops 
the vitreous body. Virchow (reviewed by Balazs et al, 1980) in 1852 advocated 
that the hyalocytes are of the mesodermal origin . von Szilly (reviewed by Balazs 
et al, 1980) in 1904 believed that they are derived from both neuroectodermal 
and mesodermal tissue. Jokl (reviewed by Balazs et al, 1980) in 1927 
summarised and discussed the early literature and, based on his own studies, 
excluded the possibility that these cells were of ectodermal origin. More specific
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origins were also proposed, such as blood cells, fibroblasts, retinal cells, 
vasoformative cells (Balazs et al, 1980). Vrabec (reviewed by Grabner et al, 
1980) in 1969 suggested that hyalocytes derive from undifferentiated 
mesenchymal cells surrounding retinal vessels. On the basis of morphological 
observations, Lopez Enriquez (reviewed by Grabner et al, 1980) in 1931 believed 
these cells to be of microglial origin. After comparison with the retinal microglia, 
Wolter (1960, 1964) stated that vitreal hyalocytes may migrate from the retina. He 
proposed that the cells penetrate the internal limiting membrane of the retina and 
once in the vitreous space, the migrating cells acquire pseudopod-like processes 
and play a role in phagocytosis. Finally, he agreed that many of these cells were 
converted into giant cells (Gitter cells) and accumulate on the inner surface of the 
retina where they degenerate. The cellular remnants and the phagocytosed 
substances become soluble and may reach the retinal blood vessels by diffusion 
through the internal limiting membrane (Wolter, 1964; Jaffe, 1969). More 
recently, most researchers have agreed that hyalocytes have a close relationship 
with mononuclear phagocyte series (MPS) cells because some of the specific 
features of MPS cells can be found in hyalocytes (Hamburg, 1959; Jack, 1972a,b; 
Balazs et al, 1980; Grabner et al, 1980; Latker and Kuwabara 1981). Based on 
light and electron microscopic studies of the rat, Salu et al (1985) considered that 
hyalocytes were resting macrophages. As microglia are MPS cells and now 
widely accepted to be of mesodermal origin, the hyalocytes are considered to be 
of mesodermal origin (Grabner et al, 1980). In a summary, Balazs and co­
workers (1980) suggested that hyalocytes are derivatives of both undifferentiated 
mesenchymal cells of the eye primordium and the primitive reticular cells of the 
bone marrow (Balazs et al, 1980).
Morphology and distribution of the hyalocytes
Morphological studies of hyalocytes have been carried out on various 
species with phase-contrast microscopy, light and electron microscopy (EM) and
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cinephotomicrography (Hamburg, 1959; Balazs et al, 1964, 1980; Bloom and 
Balazs, 1965; Matsuo and Smelser, 1971; Grabner et al, 1980; Saga et al, 1984; 
Yamamoto and Fujimoto, 1984; Sellheyer and Spitznas, 1987; El-Hifnawi et al, 
1994). The morphology of the hyalocyte shows great variability. Under the light 
microscope, the cells have a compact ovoid or kidney-shape nucleus and 
pseudopodia (Balazs et al, 1964, 1980). The shapes of the pseudopodia range 
from lobulose to filamentous (Balazs et al, 1980). Hyalocytes can be 
distinguished from other cells by basophilic Periodic Acid Schiff-positive 
granules exhibiting light sensitive autofluorescence and take up of neutral red 
(Balazs et al, 1964, 1980). Lysosomal enzymes, specifically acid phosphatase, 
beta-glucuronidase and alkaline phosphatase (Freeman et al, 1968; Saga et al, 
1984) and esterase (Grabner et al, 1980) have been demonstrated in granules of 
hyalocytes. Ultrastructurally, hyalocytes in the vitreous show an irregular outline 
with fingerlike cytoplasmic processes and the nuclear membrane is irregular. The 
most specific feature is the highly electron-dense membrane-bound inclusion 
bodies. Some are seen to contain a granular material (Saga et al, 1984; 
Yamamoto and Fujimoto, 1984; Sellheyer and Spitznas, 1987; El-Hifnawi et al, 
1994).
Regarding their distribution, Balazs (1980) suggested that hyalocytes 
migrated from the hyaloid vasculature to the cortical layer of vitreous. According 
to his description, hyalocytes are first recognisable in the vascular vitreous at 10 
to 10.5 WG. They are restricted to the vicinity of the vessel walls to which they 
have been connected temporarily by pedicle-like cytoplasmic extensions. Later, 
they detach from the vessel walls and begin to migrate toward the periphery. At 
12 to 16 WG, these cells differentiate into immature foetal hyalocytes and show 
great variability in morphology. By 20 WG, hyalocytes are fully developed and 
have settled in the cortical layer of the vitreous (Balazs et al, 1980). The greatest 
number are found in the ciliary body and optic disc areas (Balazs et al, 1964).
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Relationship of hyalocyte function to the hyaloid vasculature
As a consequence of their MPS origin, hyalocytes have been suggested to 
have phagocytic properties (Wolter, 1960, 1964; Jaffe, 1969; Jack, 1972c; Balazs 
et al, 1980; Grabner et al, 1980; Latker and Kuwabara, 1981; Yamamoto and 
Fujimoto, 1984). Apart from simple phagocytosis, hyalocytes also function as 
immunoeffector cells involved in local inflammation as shown by adherence to 
glass and plastic surfaces, and the presence of IgG receptors and complement 
components on their surfaces (Grabner et al, 1980). In addition, hyalocytes may 
also play important roles in tissue remodelling and apoptosis (Lang and Bishop, 
1993, Lang et al,  1994; Lang, 1997), neovascularisation and formation of 
pathological vitreous membrane (Schneider et al,  1995), hyaloid vascular 
regression (Jack, 1972c, Latker and Kuwabara 1981; Yamamoto 1984; Lang et 
al, 1994) and cataract formation (Hess et al, 1991). In a clinical study using 
immunocytochemical staining of vitreal cells, Davis and co-workers (1992) 
showed vitreous cellular infiltrates with a high degree of HLA-DR expression. 
This positively supports the concept that hyalocytes are active participants in 
immunologically mediated processes perpetuating uveitis (Davis et al, 1992). 
Current evidence implies that hyalocytes function not only as simple macrophages 
in the hyaloid vasculature and vitreous, but also as a group of immune cells which 
participant development and regression of hyaloid vasculature, and maintain the 
stability of of vitreous (see Chapter 6).
IV. THE PURPOSE AND SIGNIFICANCE OF THE STUDY
The above literature review of the hyaloid vasculature, vitreous and 
hyalocytes has raised questions about a number of aspects of hyaloid 
development: Firstly, two sets of intraocular vasculatures are established during 
normal eye development - the hyaloid system and the retinal vasculature; as 
development of the retinal vasculature is completed, the hyaloid vasculature 
regresses entirely. Since the hyaloid vasculature is a transient system, does it have
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cellular components in common with a definitive ocular vasculature such as the 
retinal vasculature and what are the inter-relationships amongst these vascular 
elements? Do these vascular elements have specific phenotypes which differ from 
the retinal vasculature? Secondly, hyalocytes associated with hyaloid vessels or 
within the vitreous have been suggested to be from different origins (Balazs et al, 
1980), i.e. from mesenchymal cells and primitive reticular cells of bone marrow. 
This suggestion appears to be inconsistent with observations that they are a 
homogeneous population. Do hyalocytes in the foetal and adult vitreous retain the 
same characteristics? What are their functions in the vitreous and in the foetal 
hyaloid vasculature? Thirdly, the mechanisms of hyaloid vascular regression are 
still unknown. During normal development, many organs and tissues undergo 
involution and massive numbers of cells in these involuting tissues are eliminated 
by apoptosis. By what mechanisms does the hyaloid undergo regression, to what 
degree does this involve apoptosis? What factors influence apoptosis and mediate 
regression? Finally, the hyaloid vascular system is involved in several vascular 
eye diseases of development such as PHPV, PHTVL and retinopathy of 
prematurity (ROP), which are apparently related to failure to regress. Can studies 
of the hyaloid vasculature and models for the study of vascular angiogenesis and 
regression lead to insights that may improve therapeutic approaches to these 
diseases?
This study has addressed these questions in the following ways: by 
investigating the cellular constituents, inter-relationships and phenotypes of the 
human hyaloid vasculature using light and electron microscopy; by establishing 
tissue culture models of foetal and adult ocular tissues including retinal and 
choroidal vascular endothelial cells, retinal pigment epithelial (RPE) cells and 
hyalocytes; by examining angiogenesis and regression of the hyaloid vasculature 
during normal development using flat mounts and various tissue culture models; 
by investigating factors which may mediate hyaloid vascular angiogenesis and 
regression, and that influence vascular endothelial cell growth and/or death.
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TABLE 1.1. Development of human eye
Period/Stage Gestation Age 
(WG)
CRL*
(mm)
Development**
Embryogenesis 1-3 <3.2 A p p earan ce an d  m ig ra tio n  o f  the neural crest 
cells; fo rm atio n  o f  the p rim ary  fo re-b rain  
v esicles an d  o p tic  sulci
Organogenesis 4 3.2-3.4 C lo su re  o f  the n eu ra l canal: form ation  o f  
p rim ary  o p tic  v esicle  an d  o p tic  cup: 
d ev elo p m en t o f  th e len s p la te , re tin a  d isc and 
em b rv o n ic  fissure: h v alo id  arterv  enters 
optic cup
5 3.4-8 O ptic  cup  com pleted; ca p illa ries  an d  an n u lar 
vessels start to  crow : p rim ary  v itreous form ation; 
lens vesicle  fo rm a tio n  an d  detached; prim itiv e 
co rn eal ep ith eliu m  d iffe ren tia tio n
6 8-15 In cip ien t d iffe ren tia tio n  o f  sensory  retina; 
d ev elo p m en t o f  p rim a ry  lens fibres and 
p erio c u lar v ascu latu re: seco n d ary  v itreous 
fo rm atio n  an d  ap p e a ra n c e  o f  the firs t ey elid  fold
7 15-22 C lo su re o f  the em b rv o n ic  fissure; fo rm atio n  o f  
ou ter and  in n er n eu ro b la stic  la y er o f  retina; 
gan g lio n  cells  and  M iille r ce lls  start to  m igrate; 
corneal en d o th eliu m  a n d  stro m a and  iris strom a 
form ation; em b ry o n ic  lens nucleus, ex trao cu lar 
m u scles an d  sc lera  s ta rt to d ev elo p
8 22-30 R P E  d ifferen tia tio n ; ax o n s o f  gan g lio n  cells 
en ter optic  stalk; M iille r cell fib res and  
g lio b lasts appear; B erg m eister's  p ap illa  
form ation; d e v e lo p m e n t o f  seco n d ary  vitreous; 
p ro liferatio n  o f  se co n d a ry  lens fib res and 
sutures: p rim itiv e  c h o ro ic ap illa ris  and 
ex trao cu lar v essels  an d  lacrim al g lands develop; 
co rn eal ep ith eliu m , strom a, en d o th eliu m  ap p ear
*: Crown-rump length, Duke-Elder and Cook 1963. 
**: Barishak 1992.
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T A B L E  1.1. D ev e lo p m en t o ■ h u m a n  eye (con tin u ed )
Period/Stage Gestation Age 
(MG)
Length * 
(mm)
D evelopm ent**
Differentiation 
(Neo-foetal/ 
foetal period)
3 30-70 R apid  deve lopm en t o f  all tissues. P ho to recep to r 
d ifferen tia tion ; fo rm ation  o f  g lial lam ina sclera; 
decrease in axon num ber; secondary  v itreous 
com pleted ; D escem ef s m em brane form ation; 
defin itive  choro icap illa ris  fo rm ation ; ciliary  
ep ithe lium , lens, and  co n ju n c tiv a  are deve lop ing ; 
eyelid  fo lds fuse
4 70-110 Incip ien t m atu ration  o f  re tin a  and  appearance o f 
re tinal vascu la ture; hvalo id  vessels start to 
reg ress: op tic cup  and lam ina  crib ro sa  
form ation ; deve lopm en t o f op tic  nerve, ciliary  
m uscle , choro idal vascu la tu re , tertiary  v itreous 
and ang le  o f  an terio r cham ber; m atu ra tion  o f  the 
lens and  cornea; fu rther deve lopm en t o f  eyelid , 
ex traocu la r m uscles.
5 110-150 D ifferen tia tion  o f re tinal pho to recep to rs and 
vascu la ture: appearance o f  corneal B ow m an's 
m em brane and sph inc te r m uscle  o f  the iris; 
eyelids start to separate
6 150-200 C ontinued  pho to recep to r d iffe ren tia tion ; 
m atu ration  o f  eane lion  cells: fu rther 
deve lopm ent o f  retinal vascu la ture: 
w ell estab lished  o ra  serrata; 
d ila ta to r pupillae and  c ilia ry  processes appear
7 200-230 F urther d ifferen tia tion  o f  cones and rods; 
choro id  p igm en ta tion : pup illa rv  m em brane 
starts to rep ress in the cen tral I o o d : m acu lar 
starts to d ifferen tia te
8 230-265 D ifferen tia tion  slow s dow n; re tina  reaches 
periphery ; m acu la  con tinues to  thin; 
angle o f  A C and trabecu lum  develop  fu rther
9 265-300 M acula con tinues to  d ifferen tia te : hvalo id  
svstem  d isappears
Birth and after Birth 300-500 F ovea con tinues d iffe ren tia tion  until 45 m onths
25
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Previously used methods for investigating the hyaloid system included 
periodic and Schiff (PAS) and haematoxylin eosin staining (Mutlu and Leopold, 
1964; Ko et al, 1985), injection of Indian ink (Terry, 1942), serial sectioning 
(Terry, 1942; Braekevelt and Hollenberg, 1970; Boeve et al, 1988a), vascular 
corrosion casting followed by scanning EM (De Schaepdrijver et al., 1989; Strek 
et al., 1993) and transmission electron microscopy (TEM) (Jack, 1972a,b,c; 
Hamming et al., 1977). In this thesis, apart from traditional TEM, 
immunohistochemical labelling has been used to investigate the morphological 
features and cellular constituents of the human hyaloid vascular system. DNA 
staining and terminal deoxyribonucleotidyl transferase mediated dUTP-biotin nick 
end-labelling (TUNEL) have been used to study cell death and apoptosis in the 
regressing hyaloid vasculature. In addition, cell culture and cell proliferation 
assays were employed to examine the possible factors which influence hyaloid 
vascular development and regression at the cytobiological level.
Background and specificities of primary antibodies 
von Willebrand Factor (Factor VIII related antigen)
von Willebrand Factor (vWF) is a large multimeric glycoprotein essential 
for the normal arrest of bleeding after tissue injury (haemostasis). It was first 
described by Erik von Willebrand, in 1926, and was first detected 
immunologically and named as Factor VUI-related antigen by Zimmerman in 
1971 (Zimmerman et al., 1971). Today we know that Factor VIII antigen and 
vWF are two distinct molecules, vWF serving as the carrier for procoagulant 
Factor VIII in circulating blood, where they form Factor VIII/vWF complex 
(Ruggeri and Zimmerman 1987; Ruggeri and Ware 1993). Because vWF is 
synthesised and stored in endothelial cells and the subendothelial matrix of the 
vessel wall, it is commonly used as a specific marker for endothelial cells and 
vasculature (Sehested and Hou-Jensen, 1981; Jaffe et al, 1973, Hoyer et al, 
1973). It is also present in blood, in plasma, inside platelets and synthesised by
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megakaryocytes. vWF antibody specifically stains endothelial cells and 
megakaryocytes (DAKO specification sheet No 128). In this thesis vWF was used 
to label the hyaloid vasculature, retinal and choroidal vascular endothelial cells in 
flat mounts or in culture.
Smooth muscle actin-alpha
Pericytes react with antibodies to smooth muscle myosin, tropomyosin, 
smooth muscle actin-alpha and desmin (Nehls and Drenckhahn, 1991; Joyce etal, 
1985a, b). In contrast to antibodies against smooth muscle myosin and 
tropomyosin, which react with a variety of non-muscle cell types, anti-smooth 
muscle actin-alpha (SMA-a) is a specific antibody for smooth muscle and smooth 
muscle-related cells (Nehls and Drenckhahn, 1991; Gabbiani et al, 1984; Skalli et 
al., 1986, 1987). Therefore, it is commonly used as a marker to distinguish 
pericytes from endothelial cells or other cell types in culture or tissue sections 
(Herman and D'Amore, 1985; Skalli et al., 1986, 1989). DAKO SMA-a is an N- 
terminal decapeptide of alpha-smooth muscle actin, clone 1A4. It reacts with an 
alpha-smooth muscle isoform of actin but does not react with actin from 
fibroblasts, striated muscle or myocardium.
Glial fibrillary acidic protein
DAKO rabbit anti-cow glial fibrillary acidic protein (GFAP) reacts 
strongly with human glial fibrillary acid (GFA) and with GFA in other species. It 
stains astrocytes and some groups of ependymal cells (DAKO specification sheet 
No Z334). In the retina, it has been used to label astrocytes and their processes 
(Dreher etal, 1992).
Vimentin
DAKO vimentin V9 reacts with vimentin, the 57 kD intermediate filament 
protein present in cells of mesenchymal origin. The antibody labels a wide variety
Chapter 2. Materials and Methods 28
of cells including lymphoid cells, endothelial cells, fibroblasts and smooth muscle 
cells (DAKO specification sheet No M725). It has been used to label Muller cells 
in the retina (Dreher et al, 1992).
Leucocyte common antigen (CD45, Anti-HLe-1)
The human leucocyte common antigen, referred as clusters of 
differentiation 45 (CD45) or anti-HLe-1, is a family of five or more high 
molecular weight glycoproteins (Dalchau et al., 1980; Streuli et al., 1988). Anti- 
CD45 recognises human leucocyte antigen, molecular weight 180 to 220 kDa, that 
are members of the T200 family. It is present on all human leucocytes, including 
lymphocytes, monocytes, polymorphonuclear cells, eosinophils and basophils in 
peripheral blood, thymus, spleen, tonsil and on leucocyte progenitors in bone 
marrow (Becton Dickinson Specification Sheet, P47).
Human major histocompatibility complex class I and II antigens
The human major histocompatibility complex (MHC), HLA, is composed 
of a series of linked genes whose products are cell surface molecules and serum 
factors involved in immune responses (Radka et al., 1986). Molecules within the 
MHC were originally recognised through their ability to provoke vigorous 
rejection of grafts exchanged between different members of a species (Roitt 
1991).
MHC class I (MHC-I) molecules consist of a heavy peptide chain of 43 
kDa non-covalently linked to a smaller 11 kDa peptide called p2 - microglobulin. 
They are widely distributed on human nucleated cells with variable expression 
(Daar et al, 1984). DAKO HLA - ABC, W6/32, is directed against a 
monomorphic epitope on the 45 kDa polypeptide products of the HLA - A, - B 
and -C loci (Barnstable et al, 1978; DAKO Specification Sheet No M736).
MHC class II antigens (MHC-II) are gene products of the D region of 
HLA. They are expressed on the cell surface as glycoproteins consisting of two
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polypeptides, a heavy (alpha), and a light (beta) chain of molecular weight 34 kDa 
and 28 kDa respectively (Kaufman et al, 1984). The gene of MHC-II consists of 
at least four subregions: HLA - DP, - DQ, - DX, and - DR, containing a minimum 
of one alpha and one beta gene. DAKO HLA - DR, CR3/43, reacts with the beta- 
chain of all products of the gene subregions DP, DQ and DR. DAKO HLA - DR, 
CR3/43, has numerous applications in the identification of cells involved in 
initiating and maintaining immune reactions. It principally labels B cells, 
interdigitating reticulum cells, Langerhans cells (LC) and many macrophages. 
This antibody also allows analysis of the expression of HLA - DR on tissues in 
which the antigen is "switched on" in response to a variety of stimuli (DAKO 
specification sheet No M775).
Calcitonin gene-related peptide
Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide that 
arises from the alternative splicing of the RNA transcript of the calcitonin gene 
(Amara et al, 1982). It is widely distributed throughout central and peripheral 
nervous systems. Specific binding sites have been found in the ocular tissues of 
various species including human (Heino et al., 1995). In the present study, CGRP 
immunoreactivity was examined in the human hyaloid system and vitreous.
Vasoactive intestinal peptide
Vasoactive intestinal peptide (VIP) is a 28-amino acid polypeptide 
belonging to the secretin family of peptides (Longshore and Makman, 1981). It is 
widely distributed in the central and peripheral nervous systems as well as in the 
gastrointestinal tract. In the present study, VIP immunoreactivity was studied in 
human ocular tissues.
Substance P
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Substance P (SP) is a member of the tachykinin peptide family and 
consists of 11 amino acids. It is a potent vasodilator and has been found in 
perivascular nerve fibres within the walls of blood vessels in many systems 
(Owman et al, 1986). Investigations performed in our laboratory have revealed 
SP immunoreactivity in the human retina (James, 1993; Tadros, 1994). In the 
present study, SP immunoreactivity was tested in human foetal ocular tissues.
Endothelial cell specific glycoprotein (CD31)
DAKO mouse anti-human endothelial cell antibody is identical to the 
CD31 group of antibodies. It reacts with a 100 kDa glycoprotein in endothelial 
cells and a 130 kDa glycoprotein in platelets (Paruums et al., 1990). In the present 
study CD31 immunoreactivity was tested in human foetal and adult cultured 
endothelial cells and RPE cells.
Cytokeratin (CAM 5.2)
Cytokeratins are polypeptide chains which form structural proteins within 
the epithelial cell cytokeratin. Nineteen different molecular forms of cytokeratin 
have been identified in both normal and malignant epithelial cell lines (Makin et 
al, 1984). Because specific combinations of cytokeratin peptides are associated 
with different epithelial cells, these peptides are important markers for classifying 
and distinguishing normal and malignant cells of epithelial origin from non- 
epithelial origin (Becton Dickinson specification sheet No 92-0005). Becton 
Dickinson murine anti-human cytokeratin (CAM 5.2) corresponds to Moll's 
peptides #8 and #18 which are found in most epithelial cells. Therefore, it can be 
used for qualitative identification of normal and malignant cells of epithelial 
origin. In the present study, it was used for identifying human retinal pigment 
epithelium.
Vascular endothelial growth factor
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VEGF is a dimeric heparin-binding glycoprotein with a molecular weight 
of 46 kD and structural homology to platelet derived growth factor (PDGF). 
VEGF has strong mitogenic activity , with high specificity for endothelial cells 
(Ferrarra et ai, 1991, 1992). Four forms of VEGF have been identified by cDNA 
cloning from human HL60 Leukaemia cells or foetal liver, with amino acid 
lengths of 121, 165, 189 and 206 amino acids. Santa Cruz polyclonal VEGF (A- 
20) reacts with the 165, 189 and 121 amino acid splice variants of VEGF from 
human origin (Santa Cruz Biotechnology antibody specific sheet). It also can 
neutralise VEGF from human endothelial cells.
All primary antibodies used in this study are summarised in Table 2-1.
Specimens 
Foetal Eyes
Normal human foetal eyes were obtained following informed, maternal 
consent from hospitals in the Sydney metropolitan area after surgery for the 
termination of pregnancy. The study was approved by the Human Ethics 
Committee, University of Sydney, Australia. Tissues used in the present studies 
were from foetuses in the age range 10 to 20 WG. All specimens were obtained 
within 60 min of surgery. Eyes were opened at the ora serrata and the vitreous, 
lens and attached hyaloid vasculature were gently removed. The hyaloid 
vasculature including the HA, VHP, TVL on the lens and the PM with cornea 
were dissected away from the vitreous and processed for fixation.
The gestational ages of foetuses were determined by medical records and 
by the measurements of crown-rump length (CRL) using ultrasound examinations.
In some foetal eyes, specific cells or tissues including hyalocytes, lens 
with hyaloid vessels, choroidal endothelial cells and RPE cells were isolated and 
cultured (Chapter 7 and 8). Specimens used in the study are summarised in Table
2- 2 .
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Adult eyes
Human adult eyes with a post mortem delay less than 24 hours and an age 
range of 17 to 83 years old were obtained following informed consent for 
donation of corneal transplantation and for therapeutic, medical or scientific 
research, through the Lions New South Wales Eye Bank. All specimens with a 
known history of eye disease or other contraindications including cause of death 
were excluded from these studies.
Adult vitreous, choroid, RPE and retina were dissected from adjacent 
tissue and cells corresponding to those in foetal eyes including hyalocytes, 
choroidal vascular endothelial cells, RPE cells, retinal capillary endothelial cells 
and pericytes were isolated for culture; crude vitreous extraction was used in a 
HUVEC proliferation assay (Chapter 7 and 8. Table 2-2).
Fixation
Foetal tissues were fixed in either periodate-lysine-paraformaldehyde 
(PLP) solution containing 2% paraformaldehyde, 0.9% lysine and 0.1% periodate 
(pH 7.4) or in 2% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) 
(pH 7.4) for a minimum of 16 hours at 4°C. Seven specimens were fixed in PLP 
for up to 4 months.
Immunohistochemical techniques
All primary antibodies were diluted in 0.1 M Tris buffered saline (TBS) 
containing 0.4% saponin (pH 7.6) (TBS saponin) and 2% serum. Sheep or donkey 
serum was used in the peroxidase method while goat serum was used in the 
immunogold method.
For the peroxidase method, either biotinylated anti-mouse Ig whole 
antibody (Amersham, NSW, Australia), for anti-MHC-I, -II, CD45, SMA-a and 
vimentin, or biotinylated anti-rabbit Ig whole antibody (Amersham) for anti- 
GFAP, vWF, CGRP, VIP and SP were used as secondary antibodies. Conjugates
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were diluted 1:50 in TBS saponin containing either 2% normal sheep or donkey 
serum.
For the immunogold method, goat F (ah') 2 anti-mouse Ig G + IgM 
(BioCell Research Lab. Cardiff, UK) were used as secondary antibody for anti- 
MHC-I, -II, CD45, SMA-a and vimentin; goat F (ab') 2 anti-rabbit Ig G with lnm 
gold (BioCell Research Lab) were used as secondary antibody for anti-GFAP, 
vWF, CGRP, VIP and SP. The gold conjugates were diluted 1:100 in TBS saponin 
containing 2% normal goat serum (pH 7.6).
Avidin-biotin-peroxidase procedures
Flat mounts of hyaloid specimens were rinsed in 0.1 M TBS saponin (pH 
7.6) for 2 h at room temperature, then incubated in 3% H2O2 for 15 min to reduce
endogenous peroxidase activity. In some specimens of each group, this step was 
omitted so that endogenous peroxidase activity by peripheral blood cells could be 
detected. Tissues were rinsed in TBS saponin twice then incubated in TBS 
saponin containing either 10% either sheep or donkey serum for 18-24 h at 4°C to 
block non-specific binding prior to incubation for 48-72 h at 4°C in primary 
antibodies. Biotinylated secondary antibodies (anti-mouse or anti-rabbit Ig whole 
antibody) were diluted 1:50 in TBS saponin containing either 2% normal sheep or 
donkey serum. Specimens were incubated in the appropriate secondary antibody 
for a further 18-24 h at 4°C, then washed in TBS saponin for 6-24 h. Bound 
antibodies were detected using the avidin-biotin peroxidase labelling technique 
(Vectastain, Vector Laboratories, Burlingame, CA) then visualised using a nickel- 
enhanced, 3,3’-diaminobenzidine tetrahydrochloride solution (Adams, 1981; 
Diaz-Araya et al., 1995). TVLs were carefully dissected from the lenses; PMs 
were dissected from corneas. HA, VHPs, TVLs and PMs were placed onto 
gelatine coated slides, air dried, dehydrated in graded ethanol, cleared in xylene, 
mounted in DePex (BDH, Sydney, Australia) and coverslipped.
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Immunogold-silver procedures
Following incubation in primary antibody, specimens were rinsed in 
several changes of TBS saponin, then incubated overnight in the appropriate 
secondary antibody (Diaz-Araya et al., 1995). After further rinsing in TBS 
saponin, the tissue was fixed in 2.5% glutaraldehyde in 0 .1M sodium cacodylate 
buffer (pH 7.4) for 60 min at room temperature. Tissues were washed in purified 
water, incubated in silver enhancing solution (BioCell, UK) for 10 to 20 min, 
washed and mounted in glycerol (BDH) on glass slides.
Immunostaining controls
Primary antibodies were substituted with diluent or a non-immune 
isotype-mouse monoclonal IgG 1 negative control (1:50, DAKO) for control 
specimens. In some cases incubation in 3% H2O2 was omitted to observe the 
endogenous peroxidase activity of peripheral blood cells. All other procedures 
were identical to normal immunostaining. Control tissues showed no positive 
immunoreactivity for any of the antibodies used.
Histological staining - cresyl violet
After fixation, specimens were flat mounted on gelatine-coated slides and 
air dried, then stained with 0.5% cresyl violet for 30 seconds, rinsed and 
dehydrated in graded ethanol, cleared in xylene, mounted in DePex (BDH, 
Australia) and examined by light microscopy.
Cryostat sections
Freshly collected whole foetal eyes and dissected hyaloid vessels were 
fixed in PLP for 4 to 6 hours at 4 °C. The eyes and hyaloid tissues were 
transferred into 7% sucrose/PBS (pH 7.4) overnight at 4 °C, then into 15% 
sucrose/PBS (pH 7.4) for 4 hours at 4 °C. The eyes and dissected hyaloid tissues 
were embedded in Tissue-Tek, O. C. T. 4583 compound embedding medium
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(Miles Inc., Elkhart USA) and snap frozen in liquid nitrogen. Sagittal sections of 
10 pm thick were cut on a cryostat (Leitz, Leica, NSW, Australia). Sections were 
then immunolabelled or cresyl violet stained.
Transmission electron microscopy
2% paraformaldehyde fixed hyaloid specimens including HA, VHP, TVL 
and PM, in the age range 10 to 20 WG, were cut into small pieces, then post-fixed 
in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 hours, 
followed by 2% osmium tetroxide fixation for another 1-2 hours. Specimens were 
then stained en-bloc with 2% aqueous uranyl acetate, dehydrated in graded 
ethanol and acetone and embedded in epon-araldite resin at 60°C for 48 hours. 
Semithin sections (0.5-1 pm thick) were cut and stained with 0.1% toluidine blue 
for orientation and selection of the area to be trimmed. Ultrathin sections (100 nm) 
were cut with a diamond knife on an ultra microtome and mounted on 200 mesh 
grids then stained with a 4% aqueous uranyl acetate for 15 min and Reynolds lead 
citrate for 2 min. Sections were examined at 75 kV with an Hitachi 500 TEM 
(Chapter 3, 6 and 8).
Immuno-gold electron microscopy (Immuno-TEM)
Specimens were processed for normal immunogold-silver labelling. After 
Ag enhancement, gold toning was carried out: specimens were incubated with 
0.05% aurum chloride for 30 min, followed by 0.05% oxalic acid for 5 min and 
1% sodium thiosulphate for 1 hour. Specimens were washed in TBS for 10 min 
between each steps. The immunostained tissues were osmicated, dehydrated, 
embedded and processed for electron microscopy as described above. Results are 
reported in Chapter 4 and 5.
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TUNEL techniques:
Internucleosomal DNA fragmentation of apoptotic cells can be detected 
with the TUNEL technique (Gavrieli et al., 1992). In this study, a modified 
TUNEL technique was used.
Hyaloid specimens including HA, VHP, TVL and PM were fixed in 2% 
paraformaldehyde in 0.1 M PBS (pH 7.4) for up to 3 months at 4°C. Hyaloid 
vessels were dissected from adjacent tissues and washed in 0.1 M TBS (pH 7.6) 
for 1 h then post-fixed in 100% acetone for 10 min at -20°C. After washing in 
distilled water in room temperature, specimens were immersed in 70% ethanol for 
30-60 min then transferred to 3% H2O2 for 15 min. After several rinses in TBS 
saponin, specimens were incubated in TBS saponin containing 10% sheep serum 
overnight at 4°C to block non-specific binding. Specimens were then washed 
twice in TdT buffer (3mM trizma base, 14mM sodium cacodylate, 0.1 mM cobalt 
chloride) for 10 min. Tissue was incubated in a reaction mixture containing 0.3 
units/ml DNA deoxynucleotidylexo-transferase (TdT, Boehringer-Mannheim, 
Australia) and 0.4nmol/ml biotinylated dUTP (Boehringer-Mannheim, Australia) 
in TdT buffer for 2 h in a humid chamber at 37 °C. To stop the reaction, 
specimens were incubated with a stop bath containing 300mM/L NaCl, 30mM/L 
sodium citrate for 15 min, then blocked in 1% bovine serum albumin in PBS for 
15 min followed by two 5 min washes in PBS.
For light microscopy (peroxidase method), specimens were incubated in 
extra avidin-conjugated peroxidase, 1:500 in PBS (Sigma-Aldrich, Sydney, 
Australia), for 1 h and reacted with 3,3’diaminobenzidine (ABC Kits, Vector 
Laboratories, Burlingame). TVLs were dissected from the lenses carefully; PMs 
were dissected from corneas. HA, VHPs, TVLs and PMs were placed onto 
gelatine coated slides, air dried, dehydrated in graded ethanol, cleared in xylene 
and mounted in DePex.
For fluorescence microscopy, specimens were incubated in streptavidin- 
conjugated indocarbocyanine (Cy-3, Jackson Immuno Research Lab,
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Pennsylvania, USA), 1:1000 diluted in PBS, for 1 h followed by a 5 min wash in 
PBS and mounted in PBS/glycerol gelatine (Sigma-Aldrich).
DNA stains
Unfixed hyaloid specimens were flat mounted on gelatine-coated slides, 
stained for 60 seconds with a mixture of acridine orange and ethidium bromide 
(AO/EB), lOOmg/ml of each in PBS (Mishell et al, 1980), cover slipped and 
viewed by fluorescence microscopy (Chapter 6 and 8). Using this combined 
staining, the condensed chromatin of apoptotic cells in viable cells was identified 
with AO as bright green fluorescence and non-viable cells stained with EB as 
bright orange fluorescence or as bright red with the green filter.
Tissue culture
The following cells were cultured in specific culture media respectively: 
Human umbilical vein endothelial cells (HUVECs, ACTT CRL 1730, USA) were 
cultured in F12K nutrient growth medium (Sigma-Aldrich, NSW, Australia); 
human foetal and adult RPE isolated from foetal and adult retinae were cultured in 
Dulbecco's Modified Eagle Medium (DMEM) growth medium (Trace, NSW, 
Australia); human adult and foetal vascular endothelial cells isolated from 
choroidal and retinae were cultured in Isocove’s Dulbeccos Modification of 
Eagle’s Medium (Isocove’s DMEM) (Trance); human foetal and adult hyalocytes 
isolated from vitreous were cultured in F12K nutrient growth medium (Sigma- 
Aldrich).
The details of isolation and culture human ocular cell types will be 
described in the Chapter 7 and 8.
Statistics
One-way analysis of variance (ANOVA) and Student-t test were used 
(Chapter 8) for statistical analyses as appropriate. All values were expressed as
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mean and standard deviation (Mean ±  SD). P< 0.05 was considered statistically 
significant.
TABLE 2.1. Antibodies used in the thesis
A n tib o d y M a n u fa c tu r e r D ilu tio n S p e c if ic ity  &  D is tr ib u t io n
P r im a r y
P olyclona l rabb it an ti­
hum an von W illeb rand  
F acto r 
(an ti-vW F)
D A K O , A ustra lia 1:100 S tains endo thelia l ce lls and 
m egakaryocy tes
M o n o c lo n a l  m o u s e  
an ti­
hum an a lpha-sm oo th  
m uscle ac tin  
(an ti-S M A -a )
D A K O , A ustralia 1:75 R eacts w ith  sm ooth  m usc le  iso fo rm  
o f  actin ; stains vascu la r sm ooth  m uscle  
ce lls and parenchym es. A lso 
sta ins m yoep ithelia l cells and pericy tes .
P o lyclonal rabb it a n ti­
cow  glial fib rilla ry  
ac id ic  p ro tein  
(an ti-G FA P )
D A K O , A ustralia 1:1000 S tains astrocy tes an d  som e ependym al 
cells
M o n o c lo n a l  m o u s e  
an ti­
sw ine v im en tin  
(an ti-v im en tin )
D A K O , A ustra lia 1:100 S tains a  w ide varie ty  o f ce lls o f  
m esenchym al orig in , inc lud ing  
glial cells, M iiller ce lls , lym pho id  cells, 
endo thelia l cells, fib rob lasts and  
sm ooth  m uscle  ce lls
M o n o c lo n a l  m o u s e  
an ti­
hum an leucocy te  
com m on an tigen  
(an ti-C D 45)
B ecton D ick inson , 
A ustralia
1:50 R eacts w ith all hum an  leucocy tes, 
includ ing  lym phocytes, m onocy tes , 
po lym orphonuclear cells, eo s inoph ils , 
and  basophils in periphera l b lood , 
thym us, sp leen, tonsil and on 
leucocyte p rogen ito rs in bone m arrow
M o n o c lo n a l  m o u s e  
an ti­
hum an m ajo r 
h is tocom patib ility  
com plex  class I 
(an ti-M H C -I)
D A K O , A ustralia 1:50 R eacts w ith hum an nuclea ted  ce lls
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TABLE 2.1. Antibodies used in the thesis (continued)
A n tib o d y M a n u fa ctu rer D ilu tion S p ec ific ity  & D istr ib u tion
P rim ary
M o n o c lo n a l  m o u s e  
an ti­
hum an m ajo r 
h istocom patib ility  
com plex  class II 
(an ti-M H C -II)
D A K O , A ustralia 1:50 R eacts w ith  B cells, in terd ig ita ting  
re ticu lum  cells, L angerhan  cells 
and m any  m acrophages
P o lyclonal rabb it an ti­
hum an calc iton in  
g ene-re la ted  pep tide 
(an ti-C G R P)
Im m uno-
d iagnostics,
A ustra lia
1:500 R eacts w ith  C G R P  d istribu ted  
th roughou t the cen tral and  peripheral 
nervous system s
P o lyclonal rabb it an ti­
hum an vasoactive 
in testinal pep tide 
(an ti-V IP)
Sero tec , A ustra lia 1:500 R eacts w ith  V IP  d istribu ted  in the 
cen tra l and periphera l nervous system s 
as w ell as in the gastro in testinal tract
P o lyclonal rabb it an ti­
hum an substance P 
(anti-SP)
A uspep , A ustralia 1:500 P resen ts in C N S, perivascu lar nerve 
fib res and the w all o f  b lood vessels in 
m any  system
M o n o c lo n a l  m o u s e  
an ti­
hum an endo thelia l cell, 
C D  31 
(an ti-C D 31)
D A K O , A ustra lia 1:50 R eacts w ith  a  fo rm alin -resis tan t 
ep itope  o f  CD 31 in endothelial ce lls 
in norm al tissues
M o n o c lo n a l  m u r in e  
anti
-hum an cy tokeratin  
(C A M  5.2)
(an ti-C A M )
B ecton  D ick inson , 
A ustra lia
p red ilu ted Q ualita tive  iden tifica tion  o f norm al 
ce lls and m alignan t ce lls o f ep ithelia l 
o rig in
P olyclonal rabb it an ti­
hum an vascu la r 
endothelia l cell grow th  
factor
(an ti-V E G F)
L ab  Supply  
A ustra lia  
N SW , A ustra lia
1:500 N eu tra lize  V E G F  from  hum an 
endo thelia l ce lls
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TABLE 2.1. Antibodies used in the thesis (continued)
A n tib o d y M a n u fa c tu r e r D ilu tio n S p e c if ic ity  & D is tr ib u t io n
S econ d ary
B io tiny la ted  sheep 
an ti-m ouse  Ig 
w hole an tibody
A m ersham , 
N SW , A ustra lia
1:50 U sed  to d etec t m ouse 
im m unog lobu lin s  in av id in-b io tin  
p erox idase  labelling
B io tiny la ted  donkey  
an ti-rab b it Ig 
w hole an tibody
A m ersham , 
N SW , A ustra lia
1:50 U sed  to d etec t rabb it 
im m unog lobu lin s in  av id in-b io tin  
perox idase  labelling
goat F  (ab ') 2 an ti­
m ouse Ig G  + IgM
B ioC ell R esearch  
L ab., U K
1:100 T o  v isua lise  m ouse 
im m u nog lobu lin s  in im m unogold  
labelling
goat F  (ab ') 2 a n ti­
rabb it Ig G ln m  gold
B ioC ell R esearch  
L ab ., U K
1:100 T o  v isua lise  rabb it 
im m unog lobu lin s  in im m unogold  
labelling
C ontrol
M ouse m onoclonal 
Ig G l nega tive  contro l
D A K O , A ustra lia 1:50 D irected  tow ards A sperg illus n iger 
g lucose  ox idase, an enzym e w hich is 
n e ith er p resen t nor inducible 
in m am m alian  tissues
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TABLE 2.2. Human specimens
T issu es A ges n In vestiga tion  m eth od s C h ap ter
F oeta l (W G )
Hyaloid 
(HA, VHP, 
TVL, PM)
10-20 217 Histological staining: cresyl violet 
Immunolabelling: 
vWF, SMA-oc, CD45, MHC-I, 
MHC -II, vimentin, GFAP, CGRP, 
SP, VIP
TUNEL techniques/DNA stains 
TEM
Tissue/cell culture
3, 6 ,8
3, 4, 5, 6, 7, 8
6 ,8 
3, 5 ,6  
7 ,8
Vitreous/
Hyalocyte
10-20 109 Histological staining: cresyl violet 
Immunolabelling: 
vWF, SMA-oc, CD45, MHC-I, 
MHC -II, vimentin, GFAP, CGRP, 
SP, VIP
TUNEL techniques/DNA stains 
TEM
Tissue/cell culture
3 .6 .8
3, 4, 5, 6, 7, 8
6 .8
3, 5 ,6  
7 ,8
Choroidal
capillaries
16-20 9 Tissue/cell culture 7 ,8
RPE 14-20 5 Tissue/cell culture 7 ,8
A d u lt (Y ears)
Retinal
capillaries
17-83 13 Tissue/cell culture 7 ,8
Choroidal
capillaries
17-83 12 Tissue/cell culture 7 ,8
Vitreous/
Hyalocyte
17-83 21 Tissue/cell culture 7 ,8
RPE 17-83 7 Tissue/cell culture 7 ,8
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Morphological studies of the hyaloid vasculature and hyalocytes
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Introduction
The hyaloid vascular system of the eye is a transient network of intraocular 
vessels present during eye development. It is comprises the main HA, the VHP 
and the TVL and the PM (Mann, 1950; Duke-Elder and Cook, 1963). The 
anatomy and development of the hyaloid system have been described in detail in 
Chapter 1. Briefly, the HA arises from the dorsal ophthalmic artery during the 
third WG and enters the developing eye though the embryonic fissure at 4 to 5 
WG. The VHP is a system of small capillary branches that extend from the main 
trunk of the HA throughout the vitreous towards the lens. These vessels ramify in 
the primary vitreous and anastomose with each other and with the TVL. The TVL 
consists of the terminal branches of the hyaloid artery including the posterior, 
lateral and anterior portions which surround the lens and anastomose with the 
annular vessels via lateral and anterior TVL (PM). The PM (anterior TVL) is 
mostly formed by budding from the annular vessels, which grow inwardly to 
vascularise the mesoderm anterior to the lens (Mann, 1950). It also partly 
develops from the lateral TVL. The hyaloid vascular system is rich in 
anastomoses with the ciliary artery and choriocapillaris (Mann, 1950; Duke-Elder 
and Cook, 1963; Strek et al, 1993). Hyaloid vessels nourish the growing lens and 
adjacent mesoderm during early development and subsequently atrophy. In the 
human, the process of regression is completed around 35 WG (Mann, 1950; Duke- 
Elder and Cook, 1963; Birnholz and Farrell, 1988). Abnormalities of regression of 
the hyaloid vascular system are associated with ocular pathologies including 
persistent hyaloid artery, PHPV or PHTVL, and PPM (Mann, 1937; Reese, 1955; 
Duke-Elder and Cook, 1964; Haddad, et al, 1978; Boeve et al, 1988b, 1990; 
Spitznas et al, 1990; Kaste et al, 1993).
A number of histological descriptions of both normal and maldeveloped 
human hyaloid vasculature have been published previously (Easterbrook and 
Sloan 1978; Bischoff et al, 1983; Ko et al, 1985; Spitznas et al, 1990; Strek et 
al, 1993). However, the use of immunolabelling techniques to investigate the
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structure of the human hyaloid vascular system has not been previously reported. 
In this chapter, structural studies of the development and regression of the human 
foetal hyaloid system in the age range 10 to 20 WG have been carried out using 
histological staining and immunolabelling combined with light and electron 
microscopy. The vitreous and hyalocytes were also investigated.
The origin, morphology, distribution and functions of hyalocytes were 
reviewed in the general introduction. This chapter will investigate the structural 
relationships between hyalocytes, the hyaloid vasculature and the constitution of 
the vitreous.
Materials and methods
Histological and immunohistochemical technique
Normal human foetal eyes in the age range of 10 to 20 WG (n=30) were 
processed with cresyl violet staining (n=16) or MHC-I immunohistochemical 
labelling (n=14). Either whole mounted tissues (n=22) or cryostat sections (n=8) 
were used. Avidin-biotin peroxidase and immunogold procedures were used to 
visualise the MHC-I expression. All procedures were carried out as detailed in 
Chapter 2.
Transmission electron microscopy
Six hyaloid specimens initially fixed in 2% paraformaldehyde were post- 
fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 
hours, followed by 2% osmium tetroxide incubation. They were then dehydrated 
in graded ethanols and acetone, stained en-hloc in 1% aqueous uranyl acetate and 
embedded in epon-araldite resin at 60 °C. Ultrathin sections were examined at 
100 kV using Hitachi H500 transmission electron microscope.
Chapter 3. Morphology of the Hyaloid and Hyalocytes 45
Results
Vascular structure of the hyaloid
The present study indicated that the entire structure of the hyaloid vascular 
system, including the posterior and anterior components, was immunoreactive to 
MHC-I antibody. The posterior system included the HA, VHP and TVL (Figure 3- 
1A); the anterior system is comprised of the PM which occupied the region in 
which the iris and pupil subsequently develop and was circumscribed by the iris 
and ciliary body (Figure 3-IB).
The HA emerged from the centre of the optic disc and after entering the 
vitreous, the main trunk of the HA gave off five to ten collateral branches - the 
VHPs. These branches were arranged in a linear fashion in the primary vitreous 
and ran to the posterior pole of the lens. In the primary vitreous, ramified VHPs 
anastomosed with each other and with TVLs (Figure 3-1 A).
The TVL was composed of the terminal branches of the hyaloid, including 
the posterior, lateral and anterior portions. The posterior TVL derived from the 
diverging branches of the VHPs, and was present as a tortuous dense network of 
anastomosing vessels, covering the posterior surface of the lens (Figure 3-1 A). 
The lateral part of the TVL was derived from the branches given off from the 
periphery of posterior TVL. These short, straight vessels ran parallel to each other, 
without any anastomosis (Figure 3-1 A). They covered the lens equator and 
contributed to the vessels of the anterior surface of the lens (PM), either directly, 
or in loops. The lateral TVL also extended branches to connect choriocapillaris 
and annular vessel.
The anterior part of the TVL, also referred to as the PM, was formed by 
small shunts of the annular vessel, which vascularise the anterior surface of the 
lens (Figure 3-IB). The vessels in the PM formed arcades in the central area and 
anastomosed with the lateral part of the TVL through short recurrent branches 
(Figure 3-IB).
Fig. 3.1. Photomicrographs of normal human hyaloid 
vascular system labelled with anti-MHC-I (peroxidase 
method, 19 WG). A. Main hyaloid artery (HA) joins several 
branches of the vasa hyaloidea propria (arrow heads) which are 
continuous with a network of fine vessels comprising the tunica 
vasculosa lends (*). Small arrows indicate areas of vascular thinning. 
B. The pupillary membrane (PM) occupies the region in which the iris 
and pupil subsequently develop and is circumscribed by the ciliary 
body (CB). Scale bars = 500 pm.
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The HA, VHP, TVL and PM were also seen in cryostat sections, using 
anti-MHC-I labelling or cresyl violet staining (Figure 3-2).
Time course of vascular regression
The hyaloid system, including the branches of the VHPs and the dense 
network of the TVL and PM, has been found well established by 10 WG, 
attaining maximal development by 12 to 13 WG. However, in spite of the ongoing 
development of the hyaloid system, signs of vascular involution were apparent as 
early as 11 WG. By 13 to 15 WG, immediately after the attainment of maximal 
development, the hyaloid system showed clear evidence of regression, including 
thinning and narrowing in diameter of the VHPs (Figure. 3-1 A); thinning and 
stretching of the interconnecting vessels of the TVL (Figure 3-3A), a decrease in 
tortuosity and a loss of anastomoses in the PM (Figure 3-3B, C). During 13 to 15 
WG, PM vessels were much thicker in diameter than the vessels seen at 18 WG or 
after (Figure 3-4). In the PM, regression of vessels became increasingly evident 
after 16 WG. The vessels were less convoluted and thinner in the central portion 
although no visible vessel 'openings' (Vessel loops regress in the central part of 
the PM to form the avascular pupillary area, Ko et al, 1985) were observed 
during the first half of gestation (Figure 3-4). The partial loss of cells in the vessel 
walls produced a 'string of pearls' appearance with alternating cell clusters and 
acellular regions (Figure 3-3C). When cellular elements were completely lost, 
thread-like vascular strands were observed (Figure 3-3A, B). Involution of the 
hyaloid was first evident in the VHP and subsequently the branches of the TVL 
and PM. Apoptotic and cytolytic cell death was also apparent (Figure 3-3D) (see 
Chapter 6). Further investigations of the mechanisms of hyaloid vessel regression 
will be described in Chapter 6 and 8.
Fig. 3.2. Cryostat and resin semithin sections. A. The main 
hyaloid artery (HA) emerges from the centre of the optic disc (OD) (19 
WG, cryostat, cresyl violet staining). Scale bar = 500 |Ltm. B. Resin 
semithin cross sections of the vasa hyaloidea propria at 13 WG, 
stained with 0.1% toluidine blue. Red blood cells (RBC) are evident 
within the vessel lumen (arrows). Scale bar = 10 pm. C. Cryostat 
section shows that the posterior and lateral tunica vasculosa lends 
(TVL) (arrow heads) are located around the lens. Arrows indicate lens 
epithelium. The lateral-anterior portion of the TVL is located in between 
the ciliary processes (CP) and lens (L). (15 WG, MHC-I labelling plus 
cresyl violet staining). Scale bar = 100 pm. D. Cryostat section of the 
pupillary membrane (PM) (arrow heads) in anterior chamber (AC). At 
the limbus (arrow), the PM is close to the cornea (C). (19 WG, MHC-I 
labelling plus cresyl violet staining). Scale bar = 100 pm.

Fig. 3.3. Evidence of vascular regression and cell death in 
whole mounts of the hyaloid. A. In this 14 WG specimen, 
thinning, stretching and partial cell loss in the interconnecting vessels of 
the tunic vasculosa lends can be seen (arrows); areas of the vessel 
showing "thread-like" changes are indicated by arrow head (cresyl 
violet staining). B. By 18 WG, interconnecting vessels PM are 
regressing; part of a thread-like remnant (arrow) is seen and several 
hyalocytes are left in the position previously occupied by the vessel 
(arrow heads) (peroxidase anti-MHC-I labelling). C. Thinning of the 
pupillary membrane, showing "string of pearls" appearance is also 
apparent (arrow heads) (18 WG, peroxidase anti-MHC-I labelling). D. 
Apoptotic cells (arrow heads) can be observed in the pupillary 
membrane area (16 WG, resin semithin section, stained with 0.1% 
toluidine blue). Arrow indicates a small vessel. A-C scale bars = 50 
fim, scale bar in D = 25 (im.

Fig. 3.4. Comparison of the pupillary membrane at 
different ages. Flat mounted pupillary membrane enclosed by iris 
(Ir), labelled with anti-von Willebrand factor (A) and MHC-I (B), 
using the peroxidase method. Note that at 14 WG (A), vessels are 
thicker in diameter than the vessels seen at 17 WG (B) at the same 
magnification. Scale bars = 100 fim.
*!%
 tr
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Morphological structure and distribution of hyalocytes in the foetal hyaloid 
vascular system and vitreous
By means of cresyl violet staining and anti-MHC-I, -II, CD-45 and CGRP 
immunostaining (see Chapter 4 and 5), three morphological distinct populations 
of hyalocytes were found throughout the developing foetal hyaloid vascular 
system and vitreous during 10 to 20 WG. The first population (type I) of immuno- 
positive cells had a round or oblong-shaped somata, with 2 to 5 primary dendrites, 
many with varicosities (Figure 3-5). The second population (type II) showed 
densely stained somata with 3 to 5 short primary processes and stellate 
morphology. The third population (type III) had a rounded densely stained somata 
often with a few fine, hair-like processes or without any processes (Figure 3-5). 
These three populations co-existed throughout the whole vascular system and 
each population of cells had vessel and non-vessel associated subpopulations. 
Vessel-associated hyalocytes, containing closely and loosely vessel-associated 
subpopulation, were in close proximity to the hyaloid vasculature (Figure 3-5). 
Some "closely vessel-associated" hyalocytes (hereinafter referred to as 
juxtavascular hyalocytes) were found attached to the vessel wall, but were not a 
constituent of the vessel wall, and were of morphological type III (Figure 3-5). 
"Loosely vessel-associated" hyalocytes (hereinafter referred to as intervascular 
hyalocytes) included all three types of morphological form described above. Non 
vessel-associated hyalocytes were in the foetal vitreous and were mainly 
distributed in three layers. In the central area of the vitreous (deep layer), small 
rounded hyalocytes (type III) were located in the vicinity of the hyaloid vessels. In 
the superficial layer (cortical layer) dendritiform cells were present (type I). These 
cells had large somata and ramified, long processes. The medium size, short- 
process cells (type II) were found between the above two layers (Figure 3-6). In 
the areas of ciliary body and ciliary process, a dense population of dendritiform 
hyalocytes were present.
Fig. 3.5. Flatmounted specimen of the human hyaloid 
vasculature labelled with anti-MHC-I or -II (peroxidase 
method), showing three types of closely and loosely 
vessel-associated hyalocytes in the hyaloid vascular 
system. Rounded cells (arrow heads); short-process cells (small 
arrows) and dendritiform cells (large arrows) can be seen in a 19 WG, 
anti-MHC-I labelled pupillary membrane (A) and in a 14 WG, anti- 
MHC-II labelled tunica vasculosa lends (B). Scale bars = 20 pm.
I
Fig. 3.6 Through focus sections of three layers of 
hyalocytes in a whole mount of the foetal vitreous after 
staining with cresyl violet (16 WG). Labelled positive cells 
include rounded cells (arrow heads) in the deep layer (A), short- 
process cells (small arrows) in the middle layer (B), and dendritiform 
cells (large arrows) in the superficial layer (C). Scale bars = 20 pm.
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Electron microscopical observation
The branches of the PM and TVL consisted of a continuous single layer of 
non-fenestrated endothelial cells joined by intervening junctional complexes 
containing zonulae adherens, macula adherens and possible zonulae occludens 
(Figure 3-7A, B, C). Figure 3-7A and B showed the cross sections of the vessel 
walls of the TVL and VHP. The endothelial cell nuclei were ovoid or elongated in 
shape and had a relatively regular contour. An incomplete layer of pericytes was 
located external to the endothelial cells with irregular shaped nuclei and dense 
nuclear chromatin (Figure 3-7A, B). The whole vascular complex was surrounded 
by a loose collagenous matrix, referred to as the basement membrane, which was 
in some locations continuous with the vitreous (Figure 3-7B). Different 
populations of vessel-associated hyalocytes and occasional fibroblasts were 
present in the collagenous matrix (Figure 3-7A, D). A small distinct population of 
vessel-associated hyalocytes was observed by EM in the hyaloid system. These 
cells have relatively abundant cytoplasm with numerous granules in one end of the 
cytoplasm and monolobed nucleus with peripherally accentuated chromatin, and 
relatively smooth surface. Their morphology was consistent with the 
juxtavascular (type III) hyalocytes observed in hyaloid flat mounts. These cells 
were located outside the vascular basement membrane but closely apposed to the 
vascular endothelial cells or pericytes (Figure 3-7E). The hyalocytes in the 
vitreous were isolated from each other with various morphologies and many of 
them had an irregular outline with finger-like cytoplasmic protrusions (Figure 3- 
7A, D). Some hyalocytes contained various numbers and sizes of vacuoles and 
dense membrane-bound pyknotic bodies (Figure 3-7A, D). Fibroblasts had small 
dense nuclei and typically contained rich rough-surfaced endoplasmic reticulum in 
their cytoplasm; a variety of vacuoles was also found in the cytoplasm (Figure 3- 
7F). The fibroblasts were normally found in the vitreous or adjacent to the vessels. 
They were present individually without direct contact with the vessel walls 
(Figure 3-7A, F). Morphologically, no cells resembling astrocytes or Müller cells
Fig. 3.7. TEM samples of foetal hyaloid at 13 WG. A .
Cross section of the TVL shows vascular elements including 
endothelial cell profiles (EC), junctional complexes (arrows), pericytes 
(p), a hyalocyte (H) and a fibroblast (F). A red blood cell (rbc) is seen 
within the lumen (L) of the vessel. A loose collagenous matrix (C) 
surrounds the vascular complex. Scale bar = 2 pm. B. Cross section of 
a VHP vessel. The vessel wall consists of endothelial cells (EC) jointed 
by junctional complex (arrows). A pericytes (p) is located outside of the 
endothelial cell layer; vitreous collagen (V) is continuous with the 
basement membrane of the vessel. Scale bar = 5 pm. C. A higher 
magnification electron micrograph shows a junctional complex between 
the endothelial cells including zonulae adherents, macula adherents and 
possible zonulae occludents  (arrow). Scale bar = 1 pm . D. A 
intervascular hyalocyte (H) is seen between two vessels. The cell 
shows bilobed nucleus and is characterised by long cytoplasmic cell 
processes (arrows) and electron-dense membrane-bound inclusion 
bodies (arrow head). Scale bar = 2 pm. E. An electron micrograph 
shows an example of distinct population of juxtavascular hyalocytes 
(H). The cell has relatively smooth cell surface and appears with a 
single lobed nucleus with characteristic granules (arrow heads) in one 
end of cytoplasm. It is separated from the vasculature, endothelial cells 
(EC) and pericyte (p), by a collagen membrane (arrows). Scale bar = 2 
pm. F. Micrograph shows example of a fibroblast (F) in between the 
vessels. Note the rich rough-surfaced endoplasmic reticulum (arrow 
head) in their cytoplasm; numerous small granules and some vacuoles 
are also present in the cytoplasm (arrows). No direct contact is seen 
between the fibroblasts and hyaloid vessels. Scale bar = 1 pm.
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were found in the hyaloid system at the ultrastructural level. Subcellular 
organelles were found in the cytoplasm of endothelial cells and pericytes, 
including ribosomes, mitochondria, rough-surfaced endoplasmic reticulum and an 
occasional Golgi apparatus.
Various stages of apoptotic and cytolytic involution were observed in the 
hyaloid between 13 and 19 WG, including condensed nuclear chromatin, 
condensed cytoplasm, cytoplasmic pyknotic bodies and individual cell death. (For 
details see Chapter 6).
Discussion 
Labelling techniques
Previous morphological studies of the hyaloid vascular system have largely 
been undertaken in animals and have utilised resin injection methods (Strek et al, 
1993), EM (Sellheyer and Spitznas, 1987), periodic acid-Schiff (PAS) and 
haematoxylin-eosin staining (Balazs etal, 1980; Ko 1985).
MHC-I antigens are widely distributed in human nucleated cells with 
variable intensities (Daar et al, 1984). In the present study, this antibody labelled 
the whole hyaloid vascular system and its cellular elements. Compared to vWF 
labelling (see Chapter 4), which labels the vasculature and vascular endothelial 
cells only, MHC-I labels not only vascular endothelial cells but also vessel and 
non-vessel associated hyalocytes (details of hyalocyte labelling will be discussed 
in Chapter 4). MHC-I labelling, therefore, provides more reliable staining for 
studying vascular structures and their cellular components. In addition, cresyl 
violet was used to stain fixed whole hyaloid vessels which allowed not only 
morphological study of the overall vasculature but also individual cells and their 
nuclei.
Four distinct cellular constituents of the hyaloid system were identified by 
TEM: vascular endothelial cells, pericytes, hyalocytes and fibroblasts. 
Additionally, fibrillar and basement membrane collagens were observed
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surrounding the vessels, consistent with previous findings (Ko et al, 1985; Mutlu 
and Leopold, 1964; Matsuo and Smelser, 1971; Jack, 1972a,b; Bloom, et al, 
1980; Sellheyer and Spitznas, 1987). Fenestrae have been reported by several 
authors in various species (Jack, 1972a; Sellheyer and Spitznas, 1987; El-Hifnawi, 
1994). Sellheyer (1987) indicated that fenestrae were only observed before 9.9 
WG in human embryos. In the present study, fenestration was not observed in the 
normal hyaloid vasculature during 10 to 20 WG, consistent with Sellheyer's 
observation. The junctional complexes between endothelial cells were observed, 
which together with an absence of fenestrae, suggest that the hyaloid is a non- 
permeable vasculature (Hamming et al., 1977). Ultrastructural studies found no 
evidence of macroglia or a glia limitans in the hyaloid vasculature and implied 
that the non-permeable status (barrier) of the hyaloid system is determined by 
constituents other than macroglia.
Development and regression of the hyaloid
Previous human studies have suggested that vascular regression 
commenced after 12 WG (Mann, 1950, Balazs et al, 1980) with the first vessel 
element to undergo regression being the VHP, followed by the TVL, the PM and 
lastly the main hyaloid trunk, culminating in the entire involution of the hyaloid 
by 35-36 WG (Mann, 1950; Duke-Elder and Cook, 1963; Birnholz and Farrell, 
1988). In the present study, the hyaloid system appeared well established by 10 
WG and started to regress as early as 11 WG. By 13 to 15 WG vessel regression 
was clearly evident. The involution of the hyaloid was first evident in the VHP 
and subsequently the branches of the TVL and PM consistent with previous 
studies.
Previous studies found that the development of the PM reached its 
maximum at 24 WG, after which it began to thin with stretching in the central 
portion (pupillary part) of the vessel (Ko et al, 1985). In contrast with previous 
observations, the present study has found that the PM started to show regression
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from 14 WG. During 14 to 16 WG, PM vessels were much thicker in diameter 
than the vessels at 18 WG or after. The regression of vessels was more evident 
after 16 WG with vessels less convoluted and thinner in the central portion but no 
visible vessel 'openings’ (Ko et al., 1985) were observed between 10 to 20 WG in 
human eyes. Further investigations of the mechanisms of vascular regression, 
including the role of apoptosis and cytolytic cell death of endothelial cells, 
hyalocytes and pericytes in hyaloid vessels will be detailed in Chapter 6 and 8.
Heterogeneity of hyalocytes
Previous studies have suggested that foetal hyalocytes undergo a migration 
from the hyaloid vessel wall to the cortical layer of the vitreous (Balazs et al., 
1964, 1980). In the present study, three types of hyalocytes have been found using 
cresyl violet staining and MHC-I labelling. In the hyaloid vasculature, these three 
types of cells co-exist throughout the whole vascular system and are further 
subdivided into vessel and non-vessel associated subgroups. In the foetal vitreous, 
these three cell types have a tendency to distribute in different layers. It is 
uncertain whether these three layers of cells represent different developmental 
stages of hyalocytes which are undergoing migration from the vessels to cortical 
vitreous. At the ultrastructural level, a small population of juxtavascular 
hyalocytes were morphologically distinct from large intervascular hyalocytes. 
They were small to medium in size with round or slightly elongated shapes, 
equivalent to the population type III hyalocytes observed at the light microscopic 
level. These cells have a relatively smooth cell surface and monolobed nucleus 
with characteristic granules in the cytoplasm, which morphologically resemble 
large granular lymphocytes. However, large, intervascular hyalocytes had 
morphological features in common with macrophages, such as a bilobed nucleus, 
long finger-like processes with characteristic cytoplasmic granules, suggesting 
they may be from the MPS lineage. Their function and relationships to the hyaloid 
vasculature will be further discussed in Chapters 4 and 6.
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Fibroblasts were occasionally found in the vitreous and between the 
vasculature at the EM level. It is possible to distinguish them from the hyalocyte 
by their typical rough-surfaced endoplasmic reticulum and numerous small 
granules by TEM. However, at the light microscopic level, fibroblasts were also 
labelled by anti-MHC-I since MHC-I labels most nucleated cells, it is difficult to 
distinguish fibroblasts from hyalocytes by MHC-I labelling. Although they are 
morphologically similar to the short-process hyalocytes at the light microscopic 
level, they are of mesenchymal origin and do not differentiate into hyalocytes 
(Balazs et al., 1980). Further studies are needed to distinguish these two 
populations at the light microscopic level.
Present findings suggest that, at least, there is a heterogeneous phenotypic 
population of immunoreactive hyalocytes in the developing hyaloid vasculature 
and vitreous. In fact, the hyalocytes exist not only in the cortical layer of the foetal 
vitreous, but are also present in the deeper layers of the foetal vitreous at ages
from 10 to 20 WG.
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Introduction
The development of the hyaloid vasculature has been described previously 
in a number of species (Agarwal et al, 1964; Jack, 1972a, b; Hamming, et al, 
1977; Bloom et al, 1980; Boeve et al, 1989; De Schaepdrijver et al, 1989; El- 
Hifnawi et al, 1994), including human (Mann, 1950; Balazs et al, 1980; Ko et 
al, 1985; Sellheyer and Spitznas 1987; Strek, et al, 1993). However, the cellular 
inter-relationships and phenotypic characteristics of the hyaloid system have not 
been documented. In Chapter 3, a detailed description of the general 
morphological structure of the human hyaloid vascular system in the age range 10 
to 20 WG was provided, using MHC-I immunolabelling, cresyl violet histological 
staining and EM study. In this chapter, the expression of leucocyte markers, 
antigenic features and cellular relationships of the normal human foetal hyaloid 
vasculature are investigated at the light microscopic level. Definition of the 
cellular relationships and phenotype of the human hyaloid vascular system may 
improve our understanding of vascular involution and pathologies related to 
persistence of the hyaloid.
Materials and methods
Human foetal hyaloid vascular specimens (n=90), age range of 10 to 20 
WG, were processed using peroxidase (n=47) and immunogold (n=43) 
histochemistry techniques. Immunolabelled antibodies against vWF, SMA-a, 
GFAP, vimentin, MHC-I and MHC-II, and CD45 were used to identify the 
cellular constituents of the hyaloid vasculature in flat mount including the main 
HA, the VHP, the TVL and the PM. In addition, 7 specimens were processed as 
negative controls. All procedures have been detailed in Chapter 2. Specimens 
were classified into 3 age groups: 10 -13 WG, 14-16 WG and 17-20 WG. The 
primary antibodies used in the studies described in this Chapter are listed in Table
4.1 and 4.2.
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Results
Immunolabelling of cellular elements of the hyaloid
Anti-vWF
The hyaloid vasculature generally showed strong immunoreactivity with 
anti-vWF; expression was evident on individual endothelial cells in the HA, VHP, 
TVL and PM (Figure 4-1 A, B). Vessel walls were composed of vWF positive 
cells which were elongated and arranged along the longitudinal axis of the vessels 
(Figure 4-1 A). In the small capillaries, only a single layer of vWF positive 
endothelium was apparent in the vessel wall (Figure 4-1 A). Additionally, a 
consistent feature of the vascular reactivity to anti-vWF staining was an increased 
staining intensity of the large vessels compared to that seen in small vessels and 
branches of the hyaloid vasculature (Figure 4- IB).
Anti-SMA-a
Anti-SMA-a intensely labelled perivascular cells which are 
morphologically similar to the vascular pericytes in the large branches of the HA, 
VHP, TVL and PM (Figure 4-2), but SMA-a immunoreactivity was not present 
on small connecting vessels of the hyaloid (Figure 4-2C). Positive cells were 
located outside the endothelial layer. There were two types of SMA-a positive 
cells identified in the hyaloid system: dendritiform and circumferential form 
(Figure 4-2). Most of these positive cells were dendritiform with short-processes 
(Figure 4-2A). Slender processes of circumferential SMA-a positive cells 
wrapped around the vessels were apparent only in large branches of the main VHP 
and HA, including the initial segment of the HA at the optic disc (Figure 4-2B, D).
Anti-vimentin
Vimentin was expressed by perivascular cells and their processes in the 
HA, VHP, TVL and PM; intervascular hyalocytes were also apparently labelled 
(Figure 4-3). On the vessel wall of the VHP, TVL and PM, vimentin-positive cells
Fig. 4.1. Anti-vWF peroxidase labelled hyaloid vessels and
endothelial cells. A. Endothelial cells (EC) of the TVL are labelled 
with anti-vWF (14 WG). Scale bar = 20 pm. B. The vessels of 
pupillary membrane labelled with anti-vWF antibody showed an 
increased staining intensity in the larger vessels (arrows) (17 WG). 
Scale bar = 100 pm.
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Fig. 4.2. Photomicrograph of the hyaloid vasculature, 
showing a-SMA positive cells in two morphological forms: 
dendritiform and circumferential. A. Dendritiform peroxidase 
labelled a-SMA positive cells are seen in large branches of the VHP 
(15 WG). Scale bar = 10 pm. B. Circumferential processes of 
immuno-gold labelled a-SMA positive cells are apparent in the VHP 
(17 WG). Scale bar = 50 pm. C. Dendritiform peroxidase labelled a- 
SMA positive cells (arrows) are evident in small vessels of the TVL, 
but are not observed in interconnecting vessels (C) (19 WG). Scale bar 
= 100 pm. D. A view of the main hyaloid artery immuno-gold labelled 
with anti-a-SMA, as it emerges from the optic disc (OD), note the 
intraretinal branch vessel (arrow head) (20 WG). Scale bar = 20 pm.
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had a similar morphology to perivascular hyalocytes and vascular pericytes 
(Figure 4-3). Vimentin positive cells were typically dendritiform in the TVL and 
PM (Figure 4-3A). Unlike the slender processes of circumferential SMA-a 
positive cells, the processes of vimentin positive cells in the HA wrapped around 
the vessels randomly (Figure 4-3B), differing morphologically from the 
circumferential processes of SMA-a positive pericytes observed in HA and VHP. 
Vimentin immunoreactivity was present in all vessels including connecting 
vessels and vessels showing evidence of regression (Figure 4-3A).
Anti-MHC and CD45 antigens
Anti-MHC-I, -II and CD45 labelled perivascular dendritic cells (DC) in the 
HA, VHP, TVL and PM are shown in Figures 4-4 and 4-5. Large numbers of anti- 
MHC-I, II and CD45 positive hyalocytes were present throughout the whole 
hyaloid vascular system and vitreous, including the intercapillary spaces (Figure 
4-4, 4-5). In addition to the labelling hyalocytes, MHC-I also labels vascular 
endothelial cells and vessel walls (see Chapter 3). Consistent with the findings 
described in Chapter 3, MHC-I immunoreactive cells were of three morphological 
types (Figure 4-4B). With MHC-II and CD45 labelling, three types of hyalocytes, 
with similar morphology to MHC-I immunoreactive positive cells, were also 
identified in the hyaloid system and vitreous (Figure 4-5). These three types of 
cells co-existed throughout the whole vascular system and, had juxtavascular and 
intervascular subgroups (Figure 4-4). Large numbers of hyalocytes in the vitreous 
were also found to be positively labelled with MHC-I, -II and CD45 antibodies 
(Figure 4-5D) and were distributed in the same three layers described in Chapter 3 
for MHC-I labelled hyalocytes (Chapter 3).
Fig. 4.3. Perivascular cells peroxidase labelled by anti- 
vimentin antibody. A. Anti-vimentin positive cell somata and 
processes are evident in this PM specimen (arrows), including 
interconnecting vessels (C) (17 WG). Intervascular hyalocytes are also 
seen anti-vimentin positive (arrow heads). Scale bar = 20 pm. B. Anti- 
vimentin labelled perivascular processes can be seen in HA and VHP. 
Note the processes are randomly distributed on the vessels (18 WG). 
Scale bar = 20 pm.

Fig. 4.4. Three types of MHC-I positive hyalocytes in the 
hyaloid vasculature. A. A TVL preparation illustrates a variety of 
vessel-associated forms of hyalocyte labelled with anti-MHC-I 
(immunogold method): type I - dendritiform cells (large arrows); type II 
- short-process cells (small arrows); type III - rounded cells (arrow 
heads) (14 WG). Scale bar = 100 ^tm. B. TVL-associated hyalocytes 
labelled with anti-MHC-I (peroxidase method), showing type I 
(arrows) and type III (arrow head) hyalocytes. Note the vessel wall is 
also well stained by the antibody. Juxtavascular and intervascular 
hyalocytes co-exist (19 WG). Scale bar = 20 |im.

Fig. 4.5. Flatmounted specimens of the human hyaloid 
vasculature labelled with anti-MHC-II and CD45 antibodies 
(peroxidase method). A. PM-associated dendritiform (type I) 
(arrows) and rounded (type III) (arrow heads) hyalocytes labelled with 
MHC class II (19 WG). Scale bar = 50 pm. B. Dendritiform (type I) 
(arrows) and rounded (type III) (arrow heads) anti-CD45 positive 
hyalocytes are seen in association with the TVL (19 WG). Scale bar = 
20 pm. C. At a higher magnification, CD45 positive dendritiform 
hyalocytes are seen in the TVL (18 WG). Scale bar = 20 pm. D. CD45 
labelled hyalocytes in the vitreous (18 WG), showing all three types. 
Scale bar = 20 pm.

Fig. 4.6. Photomicrographs of GFAP labelled cells in the 
hyaloid (immunogold method). A. Bergmeister's papilla (arrow 
head) and main hyaloid artery (arrow) emerge from optic disc (OD) (20 
WG). Scale bar = 100 pm. B. Higher magnification view of 
Bergmeister's papilla is shown emerging from the optic disc (OD) and 
is invested by GFAP positive filamentous cell processes (arrow heads) 
which appear to be continuous with retinal astrocytes (arrows) (20 
WG). Scale bar = 20 mm.

Fig. 4.7. Control Experim ents (peroxidase m ethod). A.
Primary antibody was substituted with mouse monoclonal IgG 1 
negative control. No immunoreactivity was observed in this 16 WG 
TVL. Scale bar = 50 pm. B. Both 3% H2 O2 pre-incubation and 
primary antibody incubation were excluded. Only red blood cells 
(arrows) were reactive with substrate. No immunoreactivity was 
observed in vessel walls (11 WG of PM). Scale bar = 25 pm.
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Anti-GFAP
Anti-GFAP labelling was diffuse in the HA, VHP, TVL and PM. However, 
in Bergmeister's papilla, intensely reactive filamentous cell processes, closely 
resembling retinal astrocytes, were detected (Figure 4-6). No clearly GFAP 
positive cells or processes were detected throughout the hyaloid vessels in the 
ages studied (10 to 20 WG).
Controls
In all cases where the primary antibody was substituted with diluent or 
mouse monoclonal IgG 1 negative control, no immunoreactivity was observed 
(Figure 4-7). For the peroxidase method, in the specimens where hydrogen 
peroxide incubation was also omitted, only intravascular red blood cells could be 
identified (Figure 4-7B). No immunoreactivity from other cells or vessels was 
displayed.
Age group comparisons of antigenic expression
Comparison of different age groups revealed no difference in antigenic 
expression between 10 to 20 WG for all immuno-markers used.
Discussion
Cellular constituents and their relationships
The expression of leucocyte markers, antigenic features and cellular 
relationships have been described in detail in this chapter. Using a panel of the 
specific antigenic markers, the phenotypes of vascular endothelial cells, pericytes 
and vessel-associated hyalocytes were identified in the hyaloid vasculature. The 
absence of macroglia in the hyaloid vasculature was also reported.
The capillaries of the hyaloid consist of a single layer of endothelial cells, 
which are specifically labelled by anti-vWF, consistent with 
immunohistochemical studies of other vascular endothelial cells (Hoyer, et al,
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1973; Gariano et al., 1996). Vascular immunologic reactivity to anti-vWF 
increased in intensity in the large vessels compared to the small vessels and 
branches of the hyaloid vasculature. This change may be due to the different 
thickness of the vessel walls or/and due to antigenic heterogeneity of vascular 
endothelium between large vessels and capillaries (Page etal., 1992).
Vascular pericytes are a major element of the hyaloid vasculature. 
Pericytes are thought to have functions which include control of endothelial cell 
proliferation and differentiation and regulation of capillary blood flow (Hirschi 
and D'Amore, 1996). Pericytes contain both smooth muscle and non-smooth 
muscle isoforms of actin and myosin (Herman and D'Amore, 1985; Nehls and 
Drenckhahn, 1991). In situ, pericytes from "true" capillaries have been reported to 
express mainly non-smooth muscle actin and myosin antigens, whereas pericytes 
from pre- or post-capillary venules contain mainly smooth muscle isoforms 
including tropomyosin and desmin (Nehls and Drenckhahn, 1991; Joyce et al., 
1984, 1985a,b). Anti-SMA-a is a specific antibody for smooth muscle cells and 
pericytes of the vasculature and has been commonly used as a marker to 
distinguish pericytes from endothelial cells or other cell types in vitro (Herman 
and D'Amore, 1985; Skalli et al., 1989) or in situ (Nehls and Drenckhahn, 1991; 
Galmiche et a l, 1993). However, in bovine retinal and rat mesentery 
microvascular tissues, mid-capillary pericytes do not express SMA-a, although 
the pericytes of pre- and post-capillaries do display reactivity (Nehls and 
Drenckhahn, 1991). In the present study, pericytes on connecting vessels of the 
hyaloid did not express detectable level of SMA-a immunoreactivity, although 
they were present, as shown by light and electron microscopy. In addition, two 
forms of SMA-a positive cells were found in HA and large branches of VHP, but 
in the small vessels of the TVL and PM, only dendritiform SMA-a positive cells 
could be identified. A similar finding was obtained in the human foetal and adult 
neural retina (Provis et al, 1997a). In the main HA and large branches of VHP, 
SMA-a positive cells may represent not only pericytes, but also some smooth
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muscle cells, the dendritiform SMA-a positive cells in the small vessels of TVL 
and the PM would appear to be the representative of true pericytes since there 
were no smooth muscle cells in these vessels, as confirmed by TEM. The 
functional difference between these two types of SMA-a positive cells in the 
hyaloid system is unclear, however, the present findings suggest heterogeneity of 
microvascular pericytes in the hyaloid. The findings also agree with the 
suggestion that SMA-a is not a universal marker for pericytes (Nehls and 
Drenckhahn, 1991; Shepro and Morel, 1993). Some studies have suggested that 
monoclonal antibody 3G5 is a specific marker for vascular pericytes (Powers et 
al, 1984; Nayak et al, 1988). However, this monoclonal antibody has yet to be 
tested against a selection of different pericytes so that the marker's specificity for 
retinal or ocular pericytes is not established (Shepro and Morel, 1993). Further, 
3G5 also appears on smooth muscle cells; the antibody is not continually 
expressed and is detected mainly in smooth muscle cells that are biosynthetically 
active, such as cells in the S-phase of the mitotic cycle (Shepro and Morel, 1993), 
therefore, it has not been used in the present study. A specific marker is needed to 
distinguish true capillary pericytes from vascular smooth muscle cells. The 
absence of SMA-a immunoreactivity in pericytes of true capillaries or connecting 
vessels may not indicate an entire lack of SMA-a, rather the cells may express 
insufficient levels of SMA-a antigen to be detected (Hirschi and D'Amore, 1996). 
At the present stage, the best criterion in vivo is their anatomical location within 
the microvessel basement membrane, while in vitro pericytes are identified by 
morphological and growth characteristics (Shepro and Morel, 1993).
Previous studies have described the relationship between macroglia, 
neovascularisation and barrier formation in normal and pathological retinae 
(Stone and Dreher, 1987; Janzer and Raff, 1987; Penfold et al, 1990b; Provis et 
al, 1991; Dreher et al, 1992; Madigan et al, 1994). Macroglia in the retina has 
been considered as one of the components of the BRB. In normal mature retinae, 
GFAP is recognised as a primary marker for astroglial intermediate filaments and
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vimentin as a primary marker for Mtiller cell intermediate filaments (Bjorklund et 
al., 1985a; Okada et al., 1990; Dreher et al, 1992; Madigan et al., 1994). Unlike 
the developing retina, the normal hyaloid vasculature has no vascular glial 
limitans although a glial sheath surrounding the first portion of the main hyaloid 
artery (Bergmeister's papilla) has been reported in primates (Hamming et al., 
1977). The expression of intermediate filament proteins in the normal hyaloid 
vasculature of the human has not been described previously although some GFAP 
positive cells have been found extending for a short distance from the optic disc 
along the proximal part of the hyaloid artery in the cat (Ling and Stone, 1988). In 
the present study of the human hyaloid, GFAP positive filamentous cells were 
shown to be confined to Bergmeister's papilla and were not observed throughout 
the hyaloid vessels. There was no evidence of macroglia or a glial limitans in the 
hyaloid vasculature in the developing human eye in the present study. The evident 
termination of Bergmeister's papilla beyond the retina is consistent with both the 
ultrastructural and antigenic findings reported in this study. It would appear that 
although the hyaloid vasculature is a transient structure, it develops and regresses 
as a relatively impermeable system. The apparent absence of macroglial elements 
suggests that cells types other than Müller cells and astrocytes may have the 
capacity to influence the permeability in the hyaloid vasculature.
The current study found vimentin immunoreactivity in perivascular cells 
and processes in all vessels of the hyaloid vasculature including connecting 
vessels. The origin of vimentin positive processes remains to be established, such 
processes may be derived from immature pericytes and/or hyalocytes expressing 
vimentin antigen during embryonic vasculogenesis.
In studies of embryonic development of the hyaloid system, it has been 
suggested that both endothelial cells and pericytes differentiate from the 
mesenchymal cells (Ko et al., 1985; Jack, 1972a; Balazs et al., 1980) that can 
express vimentin (Azumi and Battifora, 1987). DAKO-Vimentin V9 labels a wide 
variety of cells of mesenchymal origin including vascular smooth muscle cells
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(DAKO specification sheet No M725). During the first half of gestation, pericytes 
are not fully differentiated. These immature pericytes may contain intermediate 
filament protein that may be labelled by anti-vimentin antibody.
The present study also found that non-vessel associated hyalocytes and 
intervascular hyalocytes are vimentin positive. Therefore, there is a possibility 
that these vimentin positive perivascular cells are hyalocytes or a mixed 
population of perivascular cells. Further studies are needed to identify the origin 
of these cells.
Immune cells
The term hyalocyte was introduced by Balazs and co-workers (1964) to 
describe a population of cells in the vitreous. Subsequently, hyalocytes were noted 
to display characteristics in common with macrophages and were considered to be 
closely related to MPS cells (Jack, 1972b; Lang and Bishop, 1993; Schneider et 
al., 1995). Several theories related to the derivation of hyalocytes have been 
considered including neuroectodermal, macrophage, microglial and mesenchymal 
origins (Grabner et al, 1980). In human brain MHC-I, -II and CD-45 antigens are 
expressed by MPS cells, DC, LC and microglia (Franklin et al., 1986; Lowe et al, 
1989). In addition, populations of resident DC and macrophages have been 
reported in rat iris, ciliary body and choroid (McMenamin et al, 1992; Forrester 
et al, 1994), in human foetal retina (Penfold et al, 1990a), foetal cornea (Diaz- 
Araya et al, 1995) and adult retina (Penfold et al, 1993). In the present study, the 
hyalocytes in human foetal hyaloid system and vitreous between 10 and 20 WG, 
showed features in common with the MPS cells, such as the constitutive 
expressions of MHC -I, MHC-II and CD45 antigens which are normally found in 
the retinal microglia and macrophages (Penfold et al, 1991, 1993; Diaz-Araya et 
al, 1995).
Related to their MPS lineage, hyalocytes are presumed to function as 
phagocytes in the removal of debris from the vitreous (Grabner et al, 1980;
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Yamamoto and Fujimoto, 1984) and may also play important roles in tissue 
remodelling (Lang et ai, 1994) and vascular regression (Jack, 1972a, Yamamoto 
et al., 1984). In the present study, three types of morphologically distinct 
populations of MHC-I, -II and CD45 positive hyalocytes were seen throughout 
the developing hyaloid vasculature and vitreous. Whilst MHC-II expression was 
confined to hyalocytes, MHC-I was expressed by hyalocytes and endothelial cells 
of hyaloid vessels including the HA, VHP, TVL and PM. This finding suggests 
that hyalocytes associated with normal foetal hyaloid vasculature and vitreous 
form a heterogeneous population of leucocyte lineage cells and the hyalocytes 
function not only as simple macrophages present in the hyaloid vasculature and 
vitreous, but may also represent as a network of immune accessory cells or 
antigen-presenting cells which are intrinsic to the hyaloid vasculature, capable of 
producing cytokines and other cytolytic mediators. A further subpopulation of 
juxtavascular type III hyalocytes, morphologically resembling large granular 
leucocyte and constantly expressing MHC-I, MHC-II and CD45, was identified. 
These cells may function to mediate cytotoxity and may be subsequently 
responsible for the hyaloid vascular regression (for details see Chapter 6).
Chapter 4. Immunohistochemical Studies of the Hyaloid 63
TABLE 4.1. Specimens and primary antibodies used in peroxidase 
immunostaining
Age
(weeks'
gestation)
vWF
1:100
a-SMA
1:75
MHC-I
1:50
MHC-II
1:50
CD45
1:50
GFAP
1:1000
vimentin
1:50
control
10- 13 2 4 2 1 1 1 1 1
14- 16 3 2 1 1 1 4 4 1
17 - 20 3 2 1 2 2 4 2 1
Total number 
n=47 8 8 4 4 4 9 7 3
Numbers indicate all specimens, including HA, VHP, TVL and PM, used in the 
experiments. All primary antibodies were raised in mice except vWF & GFAP 
which were raised in rabbit.
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TABLE 4.2. Specimens and primary antibodies used in silver 
enhanced gold immunostaining
Age
(weeks'
gestation)
vWF
1:100
a-SM A
1:75
MHC-I
1:50
MHC-II
1:50
CD45
1:50
GFAP
1:1000
vimentin
1:50
control
10- 13 2 1 1 1 3 2 1 1
14- 16 2 1 4 1 1 1 1 1
17- 20 3 3 3 2 1 3 2 2
Total number
n=43 7 5 8 4 5 6 4 4
Numbers indicate all specimens, including HA, VHP, TVL and PM, 
used in the experiments.
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Introduction
A variety of neuropeptides has been detected in ocular tissues including 
CGRP, SP and VIP (Uusitalo et al, 1989; James, 1993; Heino et al, 1995). 
Recent studies have shown that neuropeptides have immune functions in addition 
to their traditional vaso-activities (Heino et al, 1995; Schratzberger et al, 1997). 
CGRP, VIP and SP have been suggested to influence the functions of immune 
cells including macrophages, microglia and lymphocytes (Calvo et al, 1994; 
Heino et al, 1995; Schratzberger et al, 1997). However, the expression of these 
neuropeptides in the human hyaloid vascular system and hyalocytes has not been 
reported. The studies in this Chapter have investigated the profiles of neuropeptide 
expression in flat mounts of the hyaloid vasculature, including the HA, VHP, TVL 
and PM, and the vitreous using antibodies against CGRP, VIP and SP in order to 
further explore the relationships of these neuropeptides to hyalocytes, the vitreous 
and vascular regression.
Materials and methods 
Immunohistochemical labelling
Normal human foetal eyes (n=24) aged from 10 to 20 WG, were used in 
these experiments. Specimens were fixed in 2% paraformaldehyde in 0.1 M PBS 
(pH 7.4) at 4 °C. Both peroxidase and immunogold methods were used in the 
experiments. The details of the methods for the immunolabelling have been 
described in Chapter 2. Specimens and primary antibodies used in this Chapter are 
summarised in Table 5.1.
Immuno-Transmission electron microscopy (Immuno-TEM)
TEM combined with an immunogold labelling technique was used to 
investigate the ultrastructure of immunoreactive tissue and cells labelled by anti- 
CGRP in another three specimens. Briefly, after anti-CGRP immunogold 
labelling, specimens were incubated with 0.05% aurum chloride for 30 min,
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followed by 0.05% oxalic acid (5 min) and 1% sdium thiosulphate (1 hour). 
Immunostained pieces of the specimens were then osmicated, dehydrated, 
embedded and processed for EM using standard procedures (Chapter 2).
Results
Vessel associated hyalocytes, including juxtavascular and intervascular 
subgroups, and vascular endothelial cells labelled intensely with anti-CGRP 
throughout the hyaloid system (Figure 5-1 A). Hyalocytes in the foetal vitreous 
were also CGRP positive (Figure 5-IB). CGRP reactive hyalocytes in the hyaloid 
vessels and vitreous were a morphologically heterogeneous population which 
again included large dendritiform, medium short-process and small rounded three 
types as described in Chapters 3 and 4 (Figure 5-1 A, B). These three types of 
CGRP reactive hyalocytes were distributed in the vitreous predominantly in three 
layers - from the cortical layer of the vitreous to the hyaloid vasculature, they were 
dendritiform cells (type I), short-process cells (type II) and small rounded cells 
(type III) (Figure 5-2). These findings were consistent with the studies of 
hyalocytes stained by cresyl violet (Chapter 3, Figure 3-6) and immunolabelled by 
MHC-I, -II and CD45 (Chapter 4, Figure 4-4, Figure 4-5).
VIP reactivity was found co-localised with CGRP in the hyalocytes. There 
was a weaker reaction from VIP compared with CGRP labelling (Figure 5-3). 
Vascular endothelial cells were not immunoreactive to anti-VIP (Figure 5-3A). 
Anti-VIP positive hyalocytes showed the same three morphological types 
throughout the hyaloid and vitreous (Figure 5-3A, B).
Beaded anti-SP reactive cell processes were found only in the PM however 
the reaction failed to detect cell bodies in the hyaloid vasculature. The hyalocytes 
of the PM were weakly labelled with SP (Figure 5-4A). No immunoreactivity was 
observed in control specimens where the primary antibody was omitted (Figure 5- 
4B).
Fig. 5.1. Anti-CGRP immuno-peroxidase labelling. A. Anti- 
CGRP labelled hyalocytes are observed associated with the PM. Both 
rounded (arrow heads) and dendritiform (arrows) types are seen. 
Endothelial cells (EC) of the PM are also labelled (18 WG). B. CGRP 
reactive hyalocytes in the cortical vitreous, showing mainly 
dendritiform (arrows) and occasionally rounded types (arrow head). 
Scale bars = 20 pm.

Fig. 5.2. Through focus sections of three layers of 
hyalocytes in a whole mount of the foetal vitreous after 
labelling with CGRP. Labelled positive cells include rounded cells 
in the deep layer (A) (18 WG); short-process cells in the middle layer 
(B) (18 WG) and dendritiform cells in the superficial layer (C) (16 
WG). A dendritiform hyalocyte in the cortical layer is shown at high 
magnification (D) (16 WG). A-B: immunogold labelling; C-D: 
peroxidase labelling. Scale bars = 20 fim.

Fig. 5.3. Anti-VIP immuno-peroxidase labelling. A. Both 
dendritiform (arrows) and rounded (arrow heads) hyalocytes are seen 
in this 16 WG PM. The staining is weak in comparison with CGRP 
labelling. Vascular endothelial cells are anti-VIP negative. B. Weakly 
labelled anti-VIP hyalocytes in the vitreous are mostly of dendritiform 
morphology (16 WG). Scale bars = 25 pm.

Fig. 5.4. Substance P immuno-gold labelling. A. Beaded SP 
positive cell processes (arrows) are seen in the PM, but endothelial cells 
are not labelled. Hyalocytes (arrow heads) are weakly labelled. B. 
Control specimen, 3% H2 O2 pre-incubation was omitted and primary 
antibody was substituted with diluent. No immunoreactivity is found 
although red blood cells (arrow heads) are shown peroxidase positive 
(19 WG). Scale bars = 20 |im.

m
Fig. 5.5. Electron micrograph of a CGRP immunoreactive 
hyalocyte in the vitreous. The hyalocyte is surrounded by collagen 
fibrils of the vitreous (V). Distinct labelling is displayed in cytoplasmic 
granules (arrow heads) (14 WG). Note the granules resemble mast cell 
granules. Scale bar = 1 |am.
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At the ultrastructural level, anti-CGRP immunolabelling was present in 
cytoplasmic granules of the hyalocytes distributed along hyaloid vessels and 
within the vitreous (Figure 5-5). The morphologies of the anti-CGRP 
immunoreactive cells were heterogeneous, as already observed by light 
microscopy; some hyalocytes in the vitreous had large granules detected by the 
EM, resembling mast cell granules (Figure 5-5).
Discussion
CGRP has been previously found in ciliary muscle, ciliary processes, 
corneal epithelium, iris, choroid and the retinae of the guinea pig, monkey, pig, cat 
and human (Bjorklund et al, 1985b; Uusitalo et al., 1989; James 1993; Heino et 
al, 1995). These studies suggested that CGRP might have functions related to the 
regulation of blood flow, ciliary muscle tone and outflow facility, and 
regeneration of the corneal epithelium . VIP immunoreactivity has been identified 
in rat iris and ciliary body, choroid and the retinae of the monkey and human 
(Lammerding-Koppel et al., 1991; Tadros, 1994). It has been suggested that VIP 
may act as an important transmitter or modulator in these ocular tissues 
(Lammerding-Koppel et al., 1991; Tadros, 1994). SP immunoreactivity has also 
been found in the retinae of rat, cat and human (James, 1993; Tadros, 1994, Provis 
et al, 1997b) where it is thought to regulate the activity of CGRP, since it is often 
co-localised with CGRP. The functions of CGRP, VIP positive cells and SP 
positive processes observed in the hyaloid system remain to be investigated.
In recent years, a variety of neuropeptides has been shown to play a role in 
regulating immune responses in addition to the traditional activity on the 
vasculature. Human epidermal dendritic cells and human retinal paravascular 
microglia have been found to express CGRP (James, 1993; Hosoi et al., 1993). 
CGRP has been shown to suppress human and mouse epidermal Langerhans cell 
function (immunoinhibitor) (Hosoi et al., 1993; Asahina et al., 1995) and to 
stimulate proliferation of lymphocytes and monocytes (Schratzberger et al., 1997).
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Human peripheral monocytes/macrophages have been shown to produce 
inflammatory cytokines such as interleukin 1 (IL-1) and tumour necrosis factor-a 
(TNF-a), in response to SP stimulation. It has been suggested that SP might act as 
animmunostimulator (Martin et al., 1993) and chemoattractant (Schratzberger et 
ai, 1997) during inflammation. In the human retina, microglia-like structures have 
been found to be immunoreactive to VIP (Tadros, 1994). Furthermore, mouse 
peritoneal macrophages, human peripheral blood lymphocytes, human monocytes, 
rat lymphoid cells and rat peritoneal macrophages were also shown to express VIP 
receptors (Calvo et al., 1994). VIP has been demonstrated to activate adenylate 
cyclase in human lymphocyte membranes and to stimulate cAMP production in 
peripheral blood lymphocytes. Thus VIP has been shown to play a role in 
immunoregulation (Calvo et al., 1994) as well as stimulation of lymphocyte 
proliferation (Schratzberger et al., 1997).
The current study has shown that hyalocytes in the human foetal hyaloid 
vasculature and vitreous express CGRP and VIP. SP immunoreactivity was also 
found in the vessel wall of the PM and hyalocytes. The observation of a 
heterogeneous hyalocyte population shown by CGRP and VIP labelling is 
consistent with the results from previous cresyl violet staining, MHC-I, MHC-II 
and CD45 labelling of the hyaloid vasculature and vitreous. (Chapters 3 and 4)
Mast cells have previously been reported to contain neuropeptides 
(Riederer et al., 1995; Cheng-Chew and Leung 1996; Ottosson and Edvinsson, 
1997). CGRP immunoreactivity has been detected in human mast cells located in 
the nasal mucosa (Riederer et ai, 1995) and mast cells in dermal tissue of the dog 
were found to be immunolabelled by VIP antiserum (Cheng-Chew et al., 1996). 
The descriptions presented in this chapter further illustrate the heterogeneity of 
vitreal hyalocytes including the apparent presence of a population of mast cells 
(Figure 5-5).
Combined with their morphological features, the present study has 
provided further evidence that hyalocytes of the hyaloid vascular system and
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vitreous have a close association with cells of the MPS and are of leucocyte 
lineage. The possible relationships of CGRP, SP and VIP expression to the growth 
and regression of the hyaloid vasculature requires further investigation. However, 
neuropeptides have previously been shown to modulate both vascular and 
immunological activity, and it can be reasonably speculated that they might 
therefore influence the activities of both vascular and immune cells of the hyaloid 
system and consequently act as a group of immunological neuromodulators 
related to the regression of the hyaloid vasculature and the immunological status 
of the vitreous.
Chapter 5. Neuropeptide Expression in the Hyaloid and Vitreous 71
TABLE 5.1. Specimens and primary antibodies used for 
neuropeptide labelling
Primary antibody Number of specimens Total
Immunogold labelling Peroxidase labelling
CGRP 3 4 7
VIP 3 4 7
SP 2 3 5
Control 2 3 5
Total 10 14 24
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Introduction
Regression of the hyaloid vascular system has been extensively 
investigated (Jack, 1972c; Birnholz and Farrell, 1988; El-Hifnawi et al, 1994) but 
the mechanisms involved in involution of the hyaloid system, particularly in 
human tissue, have not been fully described. Some studies have suggested that 
MPS cells associated with the vasculature and throughout the vitreous may be 
involved in the involution of vascular endothelial cells and pericytes and 
subsequent vascular regression (Latker et al, 1981; Lang and Bishop, 1993; Lang 
etal., 1994).
During normal development of vertebrate embryos, many tissues and 
organs undergo regression and remodelling (Glucksman, 1951; Saunders, 1966; 
Ucker, 1991) including the involution of the embryonic tail (Tata, 1966), death of 
retinal ganglion cells and their axons (Provis and Penfold 1988) and death of 
retinal photoreceptors (Young, 1984; Penfold and Provis, 1986; Maslim et al., 
1995). A significant proportion of cells die autonomously (Ellis et al, 1991) and 
are eliminated by neighbouring cells (Cowan et al., 1984; Penfold and Provis, 
1986) consistent with apoptotic cell death (Kerr et al, 1972). A number of studies 
indicate that apoptosis is involved in eye diseases including cataract formation 
(Morgenbesser et al, 1994; Li et al, 1994, 1995), retinoblastoma (Buchi et al, 
1994; Nork et al, 1997; Madigan and Penfold, 1997), retinal ischaemia and 
diabetic retinopathy (Nickells and Zack, 1996; Xu et al, 1997).
The morphological features of apoptosis include the condensation and 
shrinkage of the cellular nucleus and cytoplasm, followed by fragmentation of the 
cell and formation of apoptotic bodies, with subsequent phagocytosis by 
surrounding cells (Kerr et al, 1972; Wyllie, 1986). Biochemically, the DNA of 
apoptotic cells is cleaved into internucleosomal segments (multiples of 
approximately 185 bp) that produce a ladder pattern when resolved by agarose gel 
electrophoresis (Wyllie et al, 1984; Compton, 1992). The introduction of TUNEL 
(Gavrieli et al, 1992) technique has facilitated the detection of small numbers of
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apoptotic cells in situ. Compared with the necrosis, apoptosis occurs rapidly and 
only scattered cells die at one time, inflammation is characteristically absent and 
no scar forms (Kerr et al., 1972).
In the present study the morphological features of vascular regression and 
cell death in flat mounts of the human foetal hyaloid system have been 
investigated using light and electron microscopy, DNA stains and TUNEL 
labelling. The mechanisms of hyaloid vascular regression and the involvement of 
vascular endothelial cells, pericytes and hyalocytes in this regression were also 
studied.
Materials and methods 
Specimens
Human foetal eyes (n=55) in the age range of 10 to 20 WG were used. 
Specimens were classified into 3 age groups: 10-13 WG, 14-16 WG and 17-20 
WG (Table 6-1) to identify the time course of vascular regression and cell death.
Light microscopy: cresyl violet staining and MHC-I immunolabelling
Hyaloid specimens dissected from 10 foetal eyes (post mortem delay < 60 
minutes), fixed in 2% paraformaldehyde for up to 2 months, were stained with 
0.5% cresyl violet. Details of the procedures have been described in Chapter 2. 
Apoptotic cells were identified by the intense purple staining of the condensed 
nuclear material characteristically seen in individual cells undergoing apoptotic 
involution.
MHC-I immunolabelling was applied to investigate vessel structures (see
Chapter 3).
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TUNEL labelling
A modified TUNEL technique (Gavrieli et a l , 1992) was used to study a 
further 24 hyaloid whole mounts. The labelling was visualised with either 
peroxidase or fluorescence microscopy (see Chapter 2 for the details).
TUNEL controls
a) . DNase positive control: After incubation with 3% H2O2 , specimens 
(n=4) were incubated in exogenous DNase (lmg/ml in TdT buffer, pH 7.2) for 20 
min as positive controls. At the end of incubation, the specimens were rinsed and 
processed by the standard TUNEL procedure (see Chapter 2).
b) . Enzyme specificity control: TdT was omitted from the reaction solution 
in 4 specimens to confirm the specificity of the enzyme labelling. All other 
procedures were identical to standard TUNEL labelling.
DNA stains
Nine unfixed hyaloid specimens were flat mounted on gelatine coated 
slides and stained with lOOmg/ml AO and l()()mg/ml EB mixture in PBS (pH 7.2) 
(Mishell et al, 1980) and viewed by fluorescence microscopy (see Chapter 2).
Transmission electron microscopy
Four additional specimens were processed for TEM, using standard 
methods (see Chapter 2).
Results
Cell death and vessel regression in the hyaloid 
Light microscopy
The features and time course of hyaloid vascular regression during 10 to 
20 WG development have been described in Chapter 3. Briefly, after 13 WG, the 
hyaloid system showed clear evidence of regression, including a) thinning and
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narrowing in diameter of the VHPs (Chapter 3, Figure 3-1); b) thinning and 
stretching of the interconnecting vessels of the TVL (Figure 6-1 A); and c) a 
decrease in tortuosity as well as a loss of anastomoses in the PM (Chapter 3, 
Figure 3-3, Figure 3-4). The partial loss of cells in the vessel wall leads to the 
'string of pearls' appearance of cell clusters alternating with acellular regions 
(Figure 6-IB, Figure 3-3C). When cellular elements were completely lost, thread­
like vascular strands were observed (Figure 6-1C, Figure 3-3B).
During vascular regression, vascular cell death was observed, with the 
majority of dying cells within the TVL, VHP and PM, and fewer in the HA. 
Vascular regression and cell death were most often seen after 13 WG. With cresyl 
violet staining, individual dying cells were observed in the hyaloid vasculature 
with typically shrunken, highly condensed pyknotic and fragmented nuclear 
chromatin that stained intensely in dense purple masses (Figure 6-2), which are 
considered features of apoptosis. Some small capillary segments and 
interconnecting vessels displayed evidence of thinning in the whole length of the 
vessel between junctions; apoptotic vascular cells containing condensed nuclei 
and fragments were visible within these segments (Figure 6-3).
TUNEL labelling confirmed these observations. Individual TUNEL 
positive cells were observed with pyknotic bodies (Figure. 6-4A, B; 6-5 A, B), 
sometimes along entire regressing vessel segments (Figure 6-5C). In TUNEL 
negative controls (TdT omitted), no evidence of TUNEL positive labelling was 
apparent (Figure 6-6A). In the exogenous DNase-treated positive controls, all cells 
displayed TUNEL positive nuclei (Figure 6-6B).
Cells with DNA fragments were also identified using combined AO/EB 
staining (Figure 6-7). AO intercalates into any cellular DNA and fluoresces green; 
it also binds to RNA which fluoresces red-orange. Thus a stained cell will have a 
green nucleus surrounded by red-orange cytoplasm. The RNA is scattered through 
the cytoplasm and appears as red-orange dots. As such, AO staining does not 
differentiate between viable and non-viable cells; however, EB can only be taken
Fig. 6.1. Cresyl violet and anti-MHC-I stained specimens.
A. A 14 WG cresyl violet stained TVL shows thinning of the 
interconnecting vessels (arrow). Two vascular cells are undergoing 
apoptosis (arrow heads). Scale bar = 20 pm. B. Micrograph from an 
18 WG PM labelled by anti-MHC-I (peroxidase method), shows 
thinning of an interconnecting vessel with "string of pearls" appearance 
(arrow). Scale bar = 50 pm. C. Thread-like vascular strands (arrow 
heads) are demonstrated in this 19 WG, MHC-I peroxidase labelled 
PM. Scale bar = 20 pm.

Fig. 6.2. Apoptosis in TVL (14 WG). A. Two endothelial cells 
with highly condensed, fragmented nuclear chromatin (arrows) are 
apparent in the TVL by cresyl violet staining. Hyalocytes (arrow heads) 
are associated with the vessel and adjacent to the apoptotic cells. B. 
Fragmentation (arrow) of an endothelial cell is seen in this 14 WG 
TVL. Two vessel associated hyalocytes are close to the fragmented cell. 
Scale bars = 20 pm.

Fig. 6.3. Apoptotic cell death in vessel segments (cresyl 
violet staining). A. A PM vessel segment (14 WG) is showing 
evidence of regression. The vessel segment between the junctions 
(large arrows) has thinned. An apoptotic vascular cell (small arrow) is 
observed within this vessel with an accompanying hyalocyte (small 
arrow head). Disappearance of vascular cells in the middle of the 
segment leads to vessel breakdown (large arrow head). B. A TVL 
segment undergoing involution (17 WG). Apoptotic vascular cells 
containing condensed nuclei were visible within the segment (arrows). 
Several hyalocytes (arrow heads) are adjacent to the apoptotic cells 
along the regressing vessel segment. Scale bars = 20 pm.

Fig. 6. 4. TUNEL labelling of hyaloid vessels (peroxidase 
method). A. A vascular associated TUNEL positive cell containing 
intensely labelled pyknotic bodies is seen in this 14 WG TVL (arrow). 
Scale bar = 20 pm. B. Individual TUNEL positive cells are seen 
associated with a vessel in this 17 WG PM (arrow heads). A TUNEL 
positive hyalocyte is seen in between the vessels (arrow). Scale bar = 
20 pm. C. TUNEL control. TdT was omitted and no positive labelling 
can be observed. Scale bar = 50 pm.

Fig. 6.5. TUNEL labelling of hyaloid vessels (fluorescent 
Cy3 method). TUNEL positive cells containing pyknotic bodies are 
apparent in this 14 WG TVL (arrows) in the same field and at the same 
magnification using blue filter (A) and green filter (B) respectively. 
Scale bars = 20 pm. C. TUNEL-positive cells (arrows) were labelled 
in red (under green filter), and arranged along the regressing vessel. 
Scale bar = 100 pm. (18 WG).
i
W  H
©
Fig. 6.6. Controls for TUNEL labelling (fluorescent Cy3 
method, 17 WG). A. No evidence of TUNEL labelling is observed 
in the TVL when TdT was omitted (negative control). B. TUNEL 
labelled TVL in a positive control. Pre-treatment with exogenous 
DNase produces nuclear labelling in all cells. Scale bars = 50 \ x m .

Fig. 6.7. Illumination of combined AO/EB staining of PM
(12 WG). Micrographs A and B are of the same field and at the same 
magnification with a blue filter (A) and a green filter (B). At an early 
stage of cell death, viable condensed or fragmented cells (direct 
microscopical observation) are stained bright green by AO (arrows) 
(A), while the same cells are negative for EB staining (arrows) (B). 
At a later stage of cell death, non-viable apoptotic cells are stained in 
bright orange by EB overwhelming AO (arrow heads) (A), and stained 
bright red by EB with a green filter (arrow heads) (B). Scale bar = 25
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up by non-viable cells which have lost their membrane integrity. EB intercalates 
into DNA and makes it appear orange, but binds to RNA weakly. Thus a non- 
viable cell will have bright orange chromatin (the EB overwhelms the AO) and its 
cytoplasm, if it has any contents remaining, will appear dark red. With a blue 
filter, viable cells appear green and non-viable cells appear orange; while with a 
green filter, only non-viable cells are visible, appearing red. Using this combined 
staining, the condensed chromatin of viable apoptotic cells was identified by AO 
fluorescence green and non-viable cells were identified by EB fluorescence bright 
orange or in bright red with a green filter.
In the present study, it was found that at an early stage of apoptosis, 
condensed or fragmented nuclei were stained by AO, while EB staining was 
negative (Figure 6-7). This indicates that during early apoptosis cells were still 
alive. In advanced stages of cell death, cells became permeable to EB and the non- 
viable cells were stained fluorescence bright orange (EB overwhelms AO) or 
bright red fluorescence viewed with a green filter (Figure 6-7). There was no 
evidence of massive necrosis at the light microscope level in this study.
Electron microscopy:
The ultrastructure of the normal hyaloid vasculature has been described in 
Chapter 3 (see Figure 3-7). Briefly, the normal hyaloid vessels consist of a 
continuous layer of non-fenestrated endothelial cells joined by junctional 
complexes with an incomplete layer of pericytes located external to the 
endothelial cells (Figure 6-8A). Vessels were surrounded by a loose collagenous 
matrix continuous with the vitreous (Figure 6-8A). Vessel-associated hyalocytes, 
either juxtavascular or intervascular (Figure 6-8B, C) and occasional fibroblasts 
were present inside and/or outside the collagenous matrix (Chapter 3, Figure. 3-7).
A variety of ultrastructural features consistent with cellular involution, 
including apoptosis and cytolysis, were observed within the hyaloid vasculature of 
specimens between 13 and 20 WG. Endothelial cells of established patent vessels
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throughout the hyaloid system showed various stages of cell death, including 
condensation of the cytoplasm and nucleus, cytolysis, vacuolation and dissolution 
(Figure 6-9, 6-10, 6-11).
In initial stages of vessel involution, only individual endothelial cells were 
involved (Figure 6-9A). Many vacuoles were seen in the cytoplasm and 
neighbouring pericytes were condensed. The junctional complexes between the 
involuting cell and neighbouring endothelial cells were usually intact. Moderate 
condensation and shrinkage of the cytoplasm and nucleus were found in some 
endothelial cells undergoing early cell death (Figure 6-9B). At this stage, some 
mitochondria can still be recognised in the condensed cytoplasm (Figure 6-9B). 
Small gaps in the vessel wall were occasionally seen in the involuting vasculature 
(Figure 6-9A, B). Pyknotic bodies were observed associated with the vascular 
complexes (Figure 6-10A). Some hyalocytes in the vitreous were also seen 
phagocytosing cell debris (Figure 6-10B). Most features of early nuclear and 
cytoplasmic changes as well as cell phagocytosis were consistent with apoptotic 
involution. It is noteworthy that involuting endothelial cells were frequently 
juxtaposed to hyalocytes which, in some cases, appeared to be in close contact 
with the plasma membrane of endothelial cells (Figure 6-9B).
In the later stages of vascular regression, pyknotic bodies associated with 
regressing vessels were sometimes visible (Figure 6-10A, 6-11). Many vascular 
cells including endothelial cells and pericytes were degenerating and cytoplasmic 
vacuolation was predominantly apparent (Figure 6-11). Gaps of varying size were 
observed along the vessels, with a clearly discontinuous vessel wall (Figure 6-9, 
6-11). The collagenous basement membrane surrounding the involuting vessel 
was relatively intact (Figure 6-11).
Fig. 6.8. Ultrastructure of normal hyaloid elements (13
WG). A. An EM cross section of the TVL shows vascular elements 
including endothelial cells (EC), junctional complexes (arrow), 
pericytes (P) and a hyalocyte (H). Red blood cells (rbc) are seen within 
the lumen (L) of the vessel. A loose collagenous matrix (C) surrounds 
the vascular complex. Scale bar = 5 p.m. B. A closely vessel-associated 
hyalocyte (H), with a single lobed nucleus (mononuclear type) and 
relatively smooth cell surface, is located outside the basement 
membrane (*). Scale bar = 2 p,m. C. A loosely vessel-associated 
hyalocyte (H), with bilobed nucleus (macrophage type) and long 
cytoplasmic cell processes (arrow heads), is seen adjacent to a vessel.

Fig. 6.9. Early stage of hyaloid vascular involution. A.
This electron micrograph shows a single endothelial cell undergoing 
cytolytic cell death in the vessel (large arrow head). Many vacuoles are 
seen in the cytoplasm (arrow heads) and neighbouring pericytes are 
condensed (outline arrows). A small gap (small arrow) exists in 
between two pericyte profiles which are adjacent to the involuting 
endothelial cell. The junctional complexes (large arrows) between the 
involuting cell and neighbouring endothelial cells (EC) are still intact. 
Two hyalocytes (H) are close to the involuting endothelial cell. Red 
blood cells (rbc) are seen in the lumen (L). Basement membrane (*) is 
also intact and whole vessel is surrounded by a collagen matrix (C) (13 
WG). B. This electron micrograph shows an involuting TVL vessel. A 
condensed endothelial cell (*) has lost contact with a neighbouring 
endothelial cell, leaving gaps in the vessel wall (small arrows). A 
juxtavascular hyalocyte (mononuclear type) (H) is adjacent to the 
condensed endothelial cell and probably making contact with it (outline 
arrow). Vacuoles are apparent in the cytoplasm of the condensed 
endothelial cell (arrow heads). A shrunken endothelial cell is also seen 
in the vessel (large arrow head). Red blood cells (rbc) are present 
within the lumen (L). Scale bars = 2 (Ltm.

Fig. 6.10. Various aspects of vascular regression. A. In this 
electron micrograph, a pyknotic body is observed associated with the 
vascular com plex. B. A hyalocyte in the vitreous is shown 
phagocytosing cell debris. C. A normal white blood cell, several red 
blood cells and a platelet are seen in the lumen of a vessel; note that the 
vascular cells appear normal. Ages: A and B: 16 WG, C: 13 WG. EC: 
endothelial cell; P: pericyte; H: hyalocyte; L: lumen; arrow: junctional 
complex; PB: pyknotic body; V: vitreous; rbc: red blood cells; W: 
white blood cells; *: platelet. Scale bars = 2 pm.
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Fig. 6.11. Ultrastructure of hyaloid vascular involution at 
a late stage (13 WG). The vascular endothelial cells (EC) appear to 
be degenerating, showing condensation of the nuclei (large arrows) and 
vacuolation of cytoplasm (small arrow heads). Juxtavascular hyalocytes 
(mononuclear type) (H) are seen adjacent to the involuting endothelial 
cells and appear to degenerate themselves. Pericytes are no longer 
present. Destruction of cells has made many gaps between endothelial 
cells (small arrows) in the vessel wall. Pyknotic bodies (large arrow 
heads), perhaps apoptotic residue, are seen associated with the vessel 
and inside the lumen (L). The collagenous basement membrane 
surrounding the involuting vessel is relatively intact. Scale bar = 2 pm.

Fig. 6.12. Light micrograph of cellular elements involved 
in vascular regression. A. In this 14 WG TVL, three apoptotic 
endothelial cells (arrows) are seen within a vessel segment. Hyalocytes 
(arrow heads) are visible adjacent to these apoptotic cells (cresyl violet 
staining). B. A light micrograph of TUNEL (peroxidase method) 
labelled 14 WG TVL showing both juxtavascular (arrows) and 
intervascular (arrow heads) TUNEL-positive hyalocytes. Scale bars = 
50 pm.
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Cell types involved in cell death and vascular regression
Vascular endothelial cells containing pyknotic bodies were observed with 
light microscopy using cresyl violet staining (Figure 6-12A) and TUNEL labelling 
(Figure 6-12B); or with fluorescence microscopy using AO/EB staining. Both 
juxtavascular and intervascular hyalocytes in the hyaloid vessels and non vessel- 
associated hyalocytes in the vitreous were involved (Figure 6-12A, B). Some 
hyalocytes were seen proximal to apoptotic vascular capillary cells (Figure 6-2A, 
B; 6-3A, B; 6-12A, B). At the EM level, pericytes and endothelial cells 
degenerated at the same time (Figure 6-9A), although within an individual vessel, 
pericytes were sometimes no longer seen prior to endothelial cell degeneration 
(Figure 6-11). Electron microscopy revealed evidence of endothelial cell, pericyte 
and hyalocyte involvement in apoptotic and cytolytic cell death and phagocytosis 
during hyaloid vascular regression (Figure 6-9A, B; 6-10A, B; 6-11). White blood 
cells and platelets were observed within ultrastructurally normal vessels (Figure 6- 
10C).
Discussion
Determination of cell death and vascular regression in the human foetal 
hyaloid
Although morphological descriptions of hyaloid vessel regression have 
been published for a number of species including human during the last century 
(Parsons, 1902; Terry, 1942; Multi and Leopold, 1964; Jack 1972c; Hamming et 
al, 1977; Bloom et al, 1980; Latker et al, 1981; Sellheyer and Spitznas, 1987; 
De Schaepdrijver et al, 1989; Boeve et al., 1989; El-Hifnawi et al., 1994), the 
mechanisms involved in involution of this vasculature have not been determined. 
The process of hyaloid vessel involution is considered to be initially driven by 
genetic processes, and some extra stimuli possibly influence the progress. In early 
studies of hyaloid regression, some features consistent with apoptotic cell death, 
including the condensation of endothelial cell and pericyte nuclei, shrinkage of the
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cytoplasm and homogeneous dense contents have been described by several 
researchers in different species (Latker et al., 1981; Bloom et al., 1980; Sellheyer 
and Spitznas, 1987). The term "apoptosis" was first applied to hyaloid regression 
in the report of PM regression in Sprague-Dawley rats (Lang et al., 1994).
Determination of whether cells die by apoptosis as opposed to necrosis is 
best made on the basis of the distinct structural changes in the chromatin, which 
occur prior to the lysis of the cell membrane. These morphological changes can be 
assessed by light and electron microscopy. Although internucleosomal DNA 
laddering, detected by agarose gel electrophoresis, is now considered one of the 
hallmarks of apoptosis, the technique is relatively insensitive since a large number 
of cells must be simultaneously undergoing apoptosis in order to generate enough 
material for detecting and it cannot be quantified (Nickells and Zack, 1996). The 
method is thus difficult to apply in the present study because of the small numbers 
of cells undergoing apoptosis in the hyaloid. In situ TUNEL labelling has been 
suggested to be sufficiently sensitive to detect apoptosis of a single cells, however, 
this method is sometimes unable to distinguish between internucleosomal DNA 
fragmentation and random DNA degeneration which occurs during necrotic cell 
death (Nickells and Zack, 1996). Furthermore, an in vitro study of cell apoptosis 
indicated that major DNA fragmentation is a late event in apoptosis and happens 
in phases of both apoptosis and necrosis, so that TUNEL labelling is sometimes 
non-specific (Collins et al., 1997). Thus morphological criteria obtained from the 
light and electron microscopy, combined with TUNEL labelling or other DNA 
fragmentation detection techniques provide the best basis for identification of 
apoptosis (Verhaegen, 1998).
In the present study a number of methods, including cresyl violet 
histological staining, mixed DNA-binding fluorescent dyes (AO/EB) staining and 
TUNEL labelling combined with light and electron microscopy, have been used to 
assess morphological changes of cell death in situ. The results indicate that, at the 
light microscope level, many features of cell death during hyaloid vascular
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regression are consistent with apoptosis; there is no evidence of massive necrosis 
with light microscopic study. However, the morphology of dying cells and 
vascular involution with EM study indicates features of both apoptosis and 
cytolysis. The cytolytic changes were not detected at the light microscopic level 
by TUNEL labelling, in agreement with other studies (Collins et al, 1997). The 
results also suggest that caution should be taken in the interpretation of in situ 
detection of DNA fragmentation and that morphological studies, especially EM 
studies, are necessary for the confirmation of apoptotic involution.
Patterns of cell death and the involvement of cellular constituents in hyaloid 
vascular regression
The present studies indicate that during development of the human foetal 
eye, cell death occurs within the hyaloid vessel system correlated with vascular 
regression. The pattern of the cell death was associated with two major sequential 
phases. At first, individual vascular cells undergo cell death by apoptosis and/or 
cytolysis (initial phase). Then apoptosis and cytolysis were found in consecutive 
vascular cells along individual vessel segments, suggesting a localised 
synchronisation of involution of vascular cells, so that vessels may regress one 
segment at a time from junction to junction (secondary phase). This was observed 
in rodents as well (Lang et al, 1994).
The features of cell death detected by cresyl violet staining, AO/EB 
staining and TUNEL labelling in the hyaloid vasculature are generally consistent 
with the features of apoptosis (Kerr et al, 1972; Majno and Joris, 1995). Although 
macrophages (hyalocytes) are apparent in the sites of vascular regression, the 
active inflammatory reaction is characteristically absent. Table 6.2 summarises the 
main differences between general apoptosis, necrosis and specific cell death 
occurred in hyaloid vascular regression. The low incidence of apoptotic bodies or 
phagocytosis of pyknotic bodies by neighbouring cells detected in the hyaloid 
involution suggests that the mode of cell death mediating hyaloid vascular
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regression may involve both apoptotic and cytolytic aspects, especially during the 
secondary phase of degeneration. It is also noteworthy that the elimination of a 
cell by apoptosis is a rapid phenomenon and the transit time from the very onset 
of cell shrinkage through to phagocytosis of the apoptotic bodies can be under 30 
minutes (Verhaegen, 1998). Thus a significant number of cells can be eliminated 
in a short time period without leaving a visual trace and this may decrease the 
chance for the detection of apoptosis in a tissue sample (Collins et al., 1997; 
Verhaegen 1998).
Cellular components involved in apoptosis and vascular regression in the 
hyaloid include vascular endothelial cells, pericytes and hyalocytes. From the 
present results, cell death was more often seen in vascular endothelial cells, 
Neighbouring pericytes showing signs of cell death are sometimes observed with 
EM. At the light microscope level, it is difficult to distinguish dying pericytes and 
endothelial cells as they located close to each other. At the EM level, pericytes 
were sometimes absent prior to endothelial cells. This finding suggests that 
pericytes may be more sensitive to the factors triggering cell death or apoptosis 
and undergo involution more rapidly than endothelial cells.
Hyalocytes (sometimes referred to as amoebocytes, vitreal cells or 
macrophages) are considered to be closely related to MPS cells in lineage (Balazs 
etal., 1980; Latker et al,, 1981 Lang et al, 1993, 1994; Zhu et al, 1997, 1998b). 
Previous histological studies have shown that hyalocytes play a role during 
hyaloid vascular regression (Matsuo and Smelser, 1971; Jack, 1972c; Hamming et 
al„ 1977; Bloom etal,, 1980; Latker et al., m \ ;  Lang etal., 1993, 1994, 1997; 
Zhu et al., 1996b). A recent report showed that the hyaloid vasculature and 
pupillary membrane persist in a population of mice whose macrophages have been 
disrupted or ablated (Lang et al., 1993), implying that hyalocytes are required in 
vascular regression. It has been found in this study that hyalocytes are usually 
apposed to dying vascular cells and subsequently undergo apoptosis or cytolysis 
themselves, becoming TUNEL positive.
Chapter 6. Cell Death and Hyaloid Regression 83
Human hyalocytes in the hyaloid system and vitreous have been found, 
from the studies in this thesis, to consist of heterogenous populations (Chapters 3, 
4, 5). They are classified, by morphology, as dendritiform (type I), short- 
processed (type II) or rounded (type III); and by location, as juxtavascular or 
intervascular hyalocytes or non vessel-associated hyalocytes (Chapters 3, 4, 5). A 
distinct population of juxtavascular hyalocytes, with single lobed nuclei and 
cytoplasmic granules, is present in the hyaloid vessel system, particularly 
associated with regressing vessels, sometimes directly contacting the vascular 
cells. These cells have previously been misclassified as fibroblasts (Matsuo and 
Smelser, 1971) and more often as pericytes (Spitznas et ai, 1990; Lang et al., 
1994). This subpopulation is morphologically similar to large granular 
lymphocytes and presumably can act to initiate apoptosis or cell death during 
vascular regression. Apart from juxtavascular hyalocytes, another subpopulation 
of hyalocytes is present in the intervascular spaces (intervascular hyalocytes) or 
in the vitreous. These cells usually displayed bilobed nuclei with characteristic 
long cytoplasmic processes and membrane-bound electron-dense material, and 
morphologically and functionally resemble macrophages. These cells were found 
engulfing cell debris associated with vessel regression.
The mediators of cell death and vascular regression in the hyaloid vessels 
remain unknown. Apoptosis is potentially one of the primary pathways for cell 
death and vessel regression in the hyaloid vasculature. A variety of extracellular 
stimuli including hormones, cytokines, killer cells, and different chemical and 
physical agents should be considered (Majno and Joris, 1995). Hyalocytes have 
been demonstrated to produce and process transforming growth factor-P (TGF-P) 
(Lutty et ai, 1993) which has been shown to trigger apoptosis in liver (Lin and 
Chou, 1992) and inhibit vascular endothelial cell proliferation (Lutty et ai, 1993). 
TGF-P has also been reported to induce abnormal changes in lens epithelial cells, 
including margination of chromatin and cytoplasmic condensation of blebbing 
cells and cell loss (Liu et al, 1994). Other cytokines including TNF-oc and
Chapter 6. Cell Death and Hyaloid Regression 84
granulocyte-macrophage colony stimulating factor (GM-CSF), reported to be 
produced by natural killer cells (Ostensen et al, 1987; Timonen, 1997), can also 
induce apoptosis (Robaye et al, 1991; Aliprantis et al, 1996; Timonen, 1997). 
GM-CSF has been reported to be expressed by ocular macrophages (hyalocytes) 
in transgenic mice which subsequently induces hyaloid vascular regression 
(Cuthbertson and Lang, 1989). TNF-a, released by macrophages, induces DNA 
fragmentation by stimulating endonuclease activity (Larrick and Wright, 1990). It 
is also shown a direct toxicity on vascular endothelial cells and induced apoptosis 
on endothelial cell (Robaye et al, 1991). Juxtavascular hyalocytes, resembling 
large granular lymphocytes, similarly may produce cytokines which can initiate 
cell death and subsequent hyaloid regression. Further experiments are required to 
study the lineage of these cells.
In contrast to factors which stimulate apoptosis, there are many "survival 
factors" which are considered to protect cells from apoptosis. Survival factors 
have been identified in vitro and in vivo, which can inhibit death in many cell 
types (Raff, 1992). Growth factors, which are generally characterised as 
stimulators of cell proliferation, have recently been implicated as inhibitors of cell 
death and as survival factors. They include fibroblast growth factor (FGF), PDGF 
(Collins et al, 1994) and VEGF (Alon et al, 1995; Olson et al, 1997). FGF has 
been suggested to suppress apoptosis in the mouse lens (Chow et al, 1995). Lack 
of these growth factors may lead to the induction of apoptosis.
When there is a mechanical block to blood flow, apoptosis of vascular 
endothelial cells within the involved capillaries may occur (Azmi and O'Shae, 
1984). Meeson and co-workers (1996) have reported that apoptotic vascular 
endothelial cells projecting into the lumen of capillaries cause a restriction of 
blood flow and that as the blood flow in a capillary segment is diminished, the 
proportion of cells undergoing apoptosis increases; therefore synchronous 
vascular endothelial cell death may be a consequence of plasma stasis (Meeson et 
al, 1996). The present study has shown vessel thinning, narrowing and eventual
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breakdown during hyaloid regression. Although occlusion by macrophages 
(hyalocytes) of the capillary lumen, found by Jack (1972c) and other researchers 
(Matsuo and Smelser, 1971; Hamming 1977), could not be satisfactorily 
confirmed in the current studies, cell debris and apoptotic residues were found 
accumulated in regressing vessels, particularly in vessels at late stages of 
regression. Red blood cells were rarely found in these late stage involuting 
vessels, indicating the diminution of blood flow and the collapse or partial 
collapse of the vessel. This may contribute to the deprivation of essential plasma- 
derived survival factors to vascular cells and consequently induce segmental 
regression.
Recently in vitro cell proliferation studies have shown that both human 
vitreous extracts and hyalocyte-conditioned medium can inhibit endothelial cell 
growth and induce apoptosis (Zhu et al., 1997, 1998b, see chapter 8), whereas 
human RPE-conditioned medium can promote endothelial cell growth without 
influencing their viability (see Chapter 8). This suggests that local inhibitory 
factors from the vitreous and hyalocytes may also play a pivotal role in inducing 
cell death and consequently hyaloid vascular regression.
A possible sequence of hyaloid vasculature regression
Together with previous observations of hyaloid regression, the present 
study provides new insights into the mechanisms involved in regression of the 
human hyaloid vasculature. A possible sequence of events involved in regression 
is proposed.
1. Internal and external factors initiate individual apoptotic involution of 
vascular cells along vessel segments in the early stage. Such factors include 
juxtavascular hyalocytes, acting as killer cells either by direct contact or via 
release of cytotoxic agents, and local growth factors. The latter may increase the 
level of vascular inhibitory factors such as TGF-P and TNF-a, and/or diminish the 
level of vascular growth factors such as FGF, PDGF and VEGF.
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2. Loss of vascular cells results in vessel thinning and partial blockage of 
the vessel segment, which induces blood flow stasis within these vessel segments.
3. Following stasis of blood flow, two things may happen. First, there may 
be a further loss of plasma-derived growth factors, including albumin (Zoeliner et 
al., 1996) which have been recognised as critical for vascular endothelial cell 
survival. Second, there may be a release of enzyme and/or toxin and cell debris 
from lytic cells. These events may induce a secondary phase of synchronous cell 
death in the vessel segment and consequently gradual loss of whole vessel 
segments, as proposed by Lang (1994, 1997).
4. Finally, pyknotic bodies and vascular debris are phagocytosed and 
eliminated by neighbouring cells including intervascular hyalocytes (macrophage 
type) and vessel regression is completed.
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TABLE 6.1. Specimens used to investigate cell death and vessel 
regression
Age
(WG)
Cresyl violet 
staining
AO/EB
staining
TUNEL labelling EM
peroxidase Cy3 control
10- 13 3 2 3 2 1 1
14- 16 3 2 4 4 3 1
17 - 20 4 5 5 6 4 2
Total
n=55 10 9 12 12 8 4
Numbers indicate all specimens, including HA, VHP, TVL and PM, 
used in the experiments.
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TABLE 6.2. Comparison of the features of apoptosis, necrosis and 
cell death present in hyaloid regression
C h a ra c te ris tic A p o p to sis N ecro sis C ell d eath  in h y alo id  reg ressio n
S tim u li P h y sio lo g ical P ath o lo g ica l P h y sio lo g ical
O cc u rren c e In d iv id u al cells M a ssiv e  ce lls In d iv id u al ce lls  and
W h o le  v essel seg m en ts
D N A  fra g m en ta tio n In tem u cle o so m a l R an d o m In tem u cle o so m a l
P ath o lo g y A p o p to tic  bodies S w e llin g /ly sis A p o p to tic  b o d ie s and  lysis;
N o  sw ellin g
P h ag o cy to sis By resid e n t cells By in fla m m ato ry By re sid e n t ce lls
cells L o w  in c id en c e
L ysis N o Y es Y es
In flam m atio n N o Y es N o
S car fo rm a tio n N o Y es N o
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Neovascularisation is a significant factor of a number of retinal and 
choroidal diseases, including proliferative diabetic retinopathy, ROP and age- 
related macular degeneration (ARMD). Angiogenesis and vascular regression are 
reciprocal processes which occur spontaneously during neovascularisation and 
normal eye development. Laboratory investigations of the factors influencing the 
growth of new vessels in vivo have been impeded by the lack of a reproducible 
human or animal model. An alternative approach is to use in vitro techniques such 
as cell or tissue culture of ocular microvasculature and other cellular elements to 
define the factors which control vascular growth and regression. In this chapter, 
the methods for the isolation and culture of human foetal and adult choroidal 
microvascular endothelial cells (CMEC), human adult retinal microvascular 
endothelial cells (RMEC) and human foetal and adult RPE cells will be described. 
The establishment of these cultured cell models will help understanding of the 
cellular mechanisms for controlling angiogenesis and vascular regression.
I. ISOLATION AND CULTURE OF HUMAN FOETAL AND ADULT 
CHOROIDAL AND RETINAL VASCULAR ENDOTHELIAL CELLS 
Introduction
Despite much research over the last twenty years, the isolation and culture 
of microvascular endothelial cells remains a major challenge. Most attempts at 
culturing endothelial cells from capillaries have met with limited success. The 
harsh enzyme treatment and severe mechanical manipulations used to isolate the 
capillary endothelial cells have resulted in both poor viability and low yield.
The most commonly isolated human endothelial cells are those from the 
umbilical vein. However, it has been suggested that the vasculature is 
heterogeneous, with differences not only between endothelium derived from large 
as opposed to small blood vessels (Kumar et al., 1987; Fujimoto and Singer, 
1988) but also organ and species specificity (Rymaszewski et al, 1992; Page et 
al, 1992; Lelkes, 1993; Scott and Bicknell 1993).
Chapter 7. Isolation and Culture of Human Ocular Cells 91
The choroid plays an important role in homeostasis of the eye and 
functions to dissipate heat and nourish the RPE cells and outer retina (Guyer et al, 
1994). The choroidal endothelium also plays a critical role in subretinal 
neovascularisation, since in subretinal neovascularisation, newly formed vessels 
arise from the CMECs and grow into the subretinal space (Sakamoto et al, 1995). 
Although methods for the culture of bovine (Morse and Sidikaro, 1990; Liu and 
Li, 1993) choroidal endothelial cells and for formation of vessel-like tubes using 
human choroidal endothelium (Sakamoto et al, 1995) have been reported, it is 
difficult to obtain a pure CMEC culture because the CMECs are deeply embedded 
in the choroidal tissue and are surrounded by various other cell types that often 
contaminate the culture.
Culture of RMECs has previously been demonstrated from rabbit 
(Tripathi et al, 1973), kitten (Frank et al, 1979), calf (Buzney and Massicotte, 
1979; Wong et al, 1987; Capetandes and Gerritsen, 1990), cow (Gitlin and 
D'Amore, 1983) and human (Tripathi and Tripathi, 1980; Su and Gillies 1992). 
The culture of human RMEC has been proven more difficult and existing 
techniques employed to culture bovine retinal capillary endothelial cells are not 
good enough for the culture of human RMEC.
Dynabeads are superparamagnetic polystyrene beads with a surface 
suitable for coating with antibodies, peptides, proteins or glycoproteins. There are 
four general groups of cell separation products: primary coated Dynabeads (pre­
coated with primary monoclonal antibodies), secondary coated Dynabeads (pre­
coated with secondary antibodies), streptavidin Dynabeads (pre-coated with 
streptavidin) and uncoated and activated Dynabeads. They allow the gentle 
isolation of cells within a short period of time, thus favouring good cell viability 
after separation. Dynabeads have predominantly been used coupled to monoclonal 
antibodies to isolate mononuclear lymphocytes including T and B cells (Lea et al, 
1986), to separate neuroblastoma cells from other neurones (Kemshead et al, 
1986) and to bind to hepatocytes and malignant cells (Danielsen et al, 1986).
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Ulex Europaeus I (UEA-I) lectin has been previously used as a marker to detect 
endothelial cells in tissue sections and tissue culture (Holthofer et al., 1982; 
Walker 1985). It binds selectively to human endothelial cells, via an endothelial 
cell surface glycoprotein that contains an a-L-fucosyl group (Hormia et al, 1983). 
UEA-I lectin coated Dynabeads have been used to isolate human endothelial cells 
derived from the microvasculature of neonatal foreskin, and osteoarthritic and 
rheumatoid arthritic synovium (Jackson et al., 1990; Abbot et al., 1992) and 
human lung (Hewett and Murray, 1993). In this chapter, a method for the isolation 
of human CMECs and RMECs, by covalently coupling UEA-I lectin (Holthofer et 
al., 1982) to magnetic polydispersible polymer particles (Dynabeads), will be 
described. This method is simple, reproducible and allows the isolation of pure 
populations of CMEC or RMEC within three hours of obtaining a human 
cadaveric eye.
Materials and methods
Preparation of UEA I coated Dynabeads
Dynabeads M-450 Tosylactivated (Dynal, VIC, Australia) containing 
0.02% sodium azide were initially washed in 0.1% PBS (pH 7.4) three times as 
sodium azide is cytotoxic. A magnetic particle concentrator (MPC-1) (Dynal) was 
used to collect the beads in the washing procedure. UEA-I lectin (Sigma-Aldrich, 
NSW, Australia) was then covalently bound to the Dynabeads.
Equal volumes of UEA-I lectin (0.2 mg/ml in 0.5M borae solution, pH 9.5) 
and Dynabeads (4x10^ beads/ml) (i.e. 0.5 ml of UEA-I lectin and 0.5 ml of 
Dynabeads) were incubated at room temperature for 24 hours with constant 
rotation. The beads were collected with a MPC and the supernatant was discarded. 
The beads were then washed four times with 0.01 M PBS containing 0.1% bovine 
serum albumin (BSA) (Sigma-Aldrich) for 10 min each for the first three times 
and for 30 min for the fourth time. Finally the beads were incubated in PBS/ 0.1% 
BSA overnight at 4 °C. The beads were collected with the MPC, resuspended in
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Hanks' balanced salt solution (HBSS) (Trace, NSW, Australia) to a final 
concentration of 4 x 10  ^ beads/ml and stored at 4 °C. All procedures were done 
under sterile conditions.
Isolation of human foetal and adult choroidal microvascular endothelial cells
Normal human foetal eyes (n=9), age ranging from 10 to 20 WG, were 
obtained within 60 min of surgery for the termination of pregnancy.
Normal adult eyes (n=12) with a post mortem delay of less than 24 hours 
and an age range of 17 to 83 years old were obtained through the Lions New 
South Wales Eye Bank (Sydney, NSW, Australia). All specimens with a known 
history of eye disease or other contraindications were excluded.
The eyes were washed with Hanks' balanced salt solution calcium and 
magnesium free (CMF HBSS). After anterior segment, vitreous and retina were 
removed, the RPE cells were removed with a spatula. The eye cup was washed 
carefully with CMF HBSS. The choroid was peeled off from the sclera, washed 
several times with CMF HBSS and cut into small pieces. These pieces were 
incubated in an enzyme mixture containing 1 mg/ml collagenase Type IA (Sigma- 
Aldrich), 1.2U/ml dispase II (Boehringer Mannheim, NSW, Australia) and 
400pg/ml DNase (Sigma-Aldrich) for 60 to 90 min at 37 °C. Collagenase and 
DNase were dissolved in Isocove’s DMEM (Trance) and dispase solution was 1:1 
diluted in Isocove’s DMEM. During the incubation, the choroid was gently 
agitated several times using a pipette to accelerate the digestion and to dissociate 
the cells. At the end of the digestion, 5ml of CMF HBSS containing 5% foetal 
bovine serum (FBS) was added to inactivate the enzymes. The suspension was 
then passed through an 80pm nylon mesh (Satake Australia, Robinson's Milling, 
NSW, Australia). Large vessel segments and collagen fibres of the choroid were 
trapped by the mesh. The filtered single cell suspension was centrifuged at 290 g 
for 8 min and resuspended in lOOpl CMF HBSS plus 5% FBS.
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Isolation of human adult retinal microvascular endothelial cells
Normal adult eyes (n= 13) with a post mortem delay of less than 24 hours 
and an age range of 17 to 83 years old were used in this part of the study.
The eyes were washed with CMF HBSS. After the anterior segment and 
vitreous were removed, the retina was carefully detached from the RPE and 
dissected away from the optic disc. The retinae were washed several times with 
CMF HBSS and cut into small pieces. These pieces were incubated in an enzyme 
mixture containing 500pg/ml collagenase (Sigma-Aldrich) and 1.2U/ml dispase II 
(Boehringer Manheim) for 15 mins at 37 °C, then 200|Lig/ml DNase (Sigma- 
Aldrich) was added and retinal cells were gently dissociated with a pipette. 
Digestion was allowed to continue for a total of 25 to 30 min. At the end of the 
digestion, 5ml of CMF HBSS plus 5% FBS was added to inactivate the enzymes. 
The digested cell suspension was passed through an 80 pm nylon mesh (Satake 
Australia, Robinson's Milling) to eliminate large vessel segments. Filtered cells 
were collected by centrifugation at 200 g for 10 min and once again, passed 
through a 40 pm nylon mesh (Satake Australia, Robinson's Milling) to trap the 
vessel fragments and cell clumps, then recentrifuged. The cell pellet was 
resuspended in lOOpl CMF HBSS plus 5% FBS.
Binding of beads to CMECs, RMECs, and primary culture of endothelial 
cells
The 100 pi solution of mixed choroidal cells or retinal cells were incubated 
with 3pl (for foetal) to 5 pi (for adult) of UEA I-coated beads for 10 min at room 
temperature with gentle agitation. After incubation, the cell-bead complex was 
washed five times with CMF HBSS plus 5% FBS; separation after each wash 
being achieved using a MPC.
After the last wash, the endothelial cell-bead complex was resuspended in 
100 pi Isocove’s DMEM with 25 mM N-2-hydroxyethylpiperazine-N'-ethane 
sulphonic acid (HEPES) (Trace) supplemented with 20% human serum, lOOpg/ml
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heparin (Trace), lOOpg/ml endothelial cell growth supplement (Collaborative 
Research, Itegrated Scienced, NSW, Australia), 2 mM/ml glutamine (Trace), 
50U/ml penicillin and 50pg/ml streptomycin (Trace) (EC culture medium). 
Primary culture was placed onto a 35 mm tissue culture dish coated with 40pg/ml 
fibronectin (Sigma-Aldrich). All cultures were maintained at 37 °C in a 
humidified atmosphere containing 5% C02.
After endothelial cells had attached to the bottom of the culture dish (2-5 
days), the debris and dead cells were washed off by rinsing twice with HBSS. 
Then 2 ml of fresh EC culture medium was added. During the attachment period, 
the culture dish was checked every day and a small amount of fresh EC culture 
medium was added when necessary.
CMECs and RMECs were passaged using 0.05% trypsin and 0.02% 
ethylenediamine-tetra-acetic-acid (EDTA) (Trace) after large confluent areas were 
seen. Cells were transferred into 35 mm tissue culture dishes coated with 0.5% 
gelatine (Sigma-Aldrich) for subsequent culture. Medium was changed twice a 
week. Any contaminating cells were removed by manually "weeding" using a 
heated needle followed by washing with CMF HBSS (Marks and Penny, 1986). 
This procedure was repeated until no contaminating cells were visible.
Binding control
To determine the ability of UEA-I beads to bind to endothelial cells, 
human adult fibroblasts from the capsule of Tenon (kindly donated by Dr M. 
Madigan) were used as a control. Cell suspension (1x10^ fibroblasts in 100 pi of 
CMF HBSS plus 5% FBS) was incubated with 5 pi of UEA-I-coated beads for 10 
min at room temperature with gentle agitation and followed by 5 washes with 
CMF HBSS plus 5% FBS, the beads being collected after each wash using MPC.
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Immunohistochemical characterisation of CMEC and RMEC
At passage 2 or 3, foetal and adult CMEC and RMEC were grown to confluence 
on 0.1 % gelatine coated chamber slides. The cultured cells were then rinsed with 
0.1 M TBS (pH 7.6) and fixed for 10 min at room temperature with 2% 
paraformaldehyde in 0.1M PBS (pH 7.4). Non-specific protein binding sites were 
blocked by 10% serum (from the species in which the secondary antibody was 
raised in 0.1 M TBS containing 0.4% saponin (TBS saponin, pH 7.6) for 20 min 
followed by incubation in H2O2 for 10 min. After washing three times with TBS 
saponin, cells were incubated with rabbit anti-human vWF (1:100, DAKO) for 1 
hour. Cells were also incubated with anti-SMA-a (1:50 DAKO) and GFAP 
(1:1000 DAKO) respectively to determine the extent of contamination with 
pericytes and retinal astrocytes. After the primary antibody reaction and several 
washes with TBS saponin, cultured cells were incubated in either biotinylated 
anti-mouse Ig whole antibody (Amersham, NSW, Australia), for SMA-a, or 
biotinylated anti-rabbit Ig whole antibody (Amersham) for anti-GFAP, vWF as 
secondary antibody (1:50, DAKO) for a further 45 min at room temperature, then 
washed twice in TBS saponin, 5 min each. Bound antibodies were detected using 
the avidin-biotin peroxidase labelling technique (Vectastain, Vector Laboratories, 
Burlingame, CA) then visualised using a nickel-enhanced, 3,3’-diaminobenzidine 
tetrahydrochloride solution. Labelled cultures were mounted in aqueous mounting 
medium and examined microscopically. As a negative control, primary antibody 
was omitted.
Results
Binding of UEA-I coated beads to CMEC and RMEC
UEA-I coated beads were successfully bound to CMEC and RMEC at an 
average ratio of about 10 to 20 beads per cell by counting after 10 min incubation, 
while pure populations of human adult fibroblasts incubated under the same
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experimental conditions failed to bind to the beads. It was found that a high 
concentration of beads impeded endothelial cell attachment.
Cells and cloning
Choroidal microvascular endothelial cells
Seven CMEC primary cultures from 9 foetal eyes and 10 CMEC primary 
cultures from 12 adult eyes, with >95% and >96% purity, were obtained (Table 7- 
1). After culture at 37 °C for less than 2 days (foetal CMEC) and 2 to 5 days 
(adult CMEC), cells with beads bound to them had attached to the bottom of the 
culture dish and started to form colonies. By 7 days (foetal CMEC) or 7 to 10 days 
(adult CMEC) of primary culture, large confluent areas could be seen (Figure 7- 
1). The cells formed a cobblestone-like monolayer. Overlapping of fibroblast-like 
cells (< 5%) was seen in peripheral areas of the colonies, especially in foetal 
CMEC culture (Figure 7-1). These cells were eliminated by "weeding". The cell 
growth rate accelerated after the first passage and they become confluent within 5- 
7 days with a typical cobblestone-like monolayer in subsequent passages (Figure 
7-2). No evidence of overgrowth by contaminating cells was found in passage 2 
(Figure 7-2). It was observed that beads were phagocytosed by CMECs after 2 
days culture.
Foetal and adult CMECs have been successfully subcultured for up to six 
passages. After the sixth passage, the cells stopped proliferating and senescent 
cells were seen in the culture, typified by enlarged cells and pleomorphism. These 
cultures were discarded.
Retinal microvascular endothelial cells
Eight human adult RMEC primary cultures were obtained from 13 eyes. 
The time taken for cell attachment in the primary culture and initial colony 
formation was 3 to 7 days, which was longer than the CMEC cultures. Cells 
reached confluence within 20 days. For later passages, the cells became confluent
Fig. 7.1. Phase-contrast photomicrographs of primary 
cultured CMECs. A. A foetal CMEC primary culture 7 days after 
UEA-I coated Dynabead isolation. Endothelial cell colonies merge to 
form a large confluent area. Overlapping of fibroblast-like cells is seen 
in a peripheral area of the colony (arrows). Granules are evident inside 
of cultured vascular endothelial cells (outline arrow heads). Dynabeads 
are also seen attached to cells (arrow heads). Scale bar = 25 pm. B. 
Adult primary culture of CMECs at day 10, showing pre-confluent 
spindle shape CMECs with Dynabeads (arrow heads) bound to them. 
Scale bar = 100 pm.

Fig. 7.2. Phase-contrast photomicrographs of sub-cultured
CMECs. A. Passage 2 of foetal CMECs isolated with UEA-I coated 
beads, at day 5. Cells form a cobblestone-like confluent monolayer and 
some beads have been phagocytosed by CMECs (arrow heads). No 
evidence of overgrowth by contaminating cells was found. B. Passage 
2 of adult CMECs isolated with UEA-I coated beads, at day 7. Cells are 
somewhat spindle shaped. Beads can be seen inside and outside of 
endothelial cells (arrow heads). Scale bars = 50 pm.
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Fig. 7.3. Phase-contrast photomicrographs of primary 
cultured RMECs. A. Early primary culture (day 5). The RMECs 
have started to grow. Beads bound to cells can be seen (arrow heads). 
B. Confluent monolayer of RMECs (day 19). Cell division has diluted 
concentration of beads such that very few beads can be seen (arrow 
heads). Scale bars = 50 pm.

Fig. 7.4. Light micrographs of peroxidase immunolabelled 
human foetal and adult CMEC in culture. A. A sample of anti- 
vWF labelled foetal CMECs in culture. More than 96% of cells show a 
positive reaction. The beads are also visible (arrow heads). Scale bar = 
50 pm. B. Adult CMEC labelled with anti-vWF, showing strong 
positive reaction. Some beads have been phagocytosed by endothelial 
cells (arrows). Scale bar = 10 pm.

Fig. 7.4. Light micrographs of peroxidase immunolabelled 
human foetal and adult CMEC in culture (continued). C.
Cultured adult CMECs labelled by anti-GFAP, showing weak 
immunoreactivity. Beads (arrow heads) are seen inside cells. Scale bar 
= 20 pm. D. No anti-SMA-a immunoreactivity is seen in this culture 
of adult CMEC. Beads are stained red (arrow heads). Scale bar = 50
pm.
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in 14 days (Table 7-1). Successfully isolated primary culture had high purity 
(>98%) and the morphology was similar to cultured CMEC, although they were a 
little more spindle-shaped (Figure 7-3). Adult RMECs have been subcultured for 
up to five passages and beads were also seen in cultured RMECs.
Immuno-characteristics of CMEC and RMEC
More than 95% of CMECs and more than 98% of RMECs showed a 
positive reaction with anti-vWF (Figure 7-4 A, B). The CMEC and RMEC were 
weakly immunoreactive with anti-GFAP but no immunoreactivity was detected 
using SMA-a antibody (Figure 7-4 C, D).
Failure of culture
The success rate was defined on the numbers of the eyes in which CMECs 
or RMECs were successfully isolated and cultured divided by the total number of 
eyes used expressing in a percentage (%) (Table 7-1). The most common cause of 
failure was contamination by non-endothelial cells in the primary culture (Table 7- 
2). Apart from contamination, cells failing to attach to the culture dish was the 
other major cause of non-growth. In one culture, cells failed to proliferate after the 
first passage and fungal infection was found once in a RMEC culture (Table 7-2).
Discussion
Vascular endothelial cells are organ-specific and are morphologically and 
functionally heterogeneous (Kumar et al., 1987; Fujimoto and Singer, 1988; 
Rymaszewski et al., 1992; Page et al, 1992; Lelkes 1993; Scott and Bicknell 
1993). Endothelial cells from different organs may vary in their production of 
certain cell growth factors, and in their response to external stimulation (Sakamoto 
et al, 1995). For example, glucose stimulates the secretion of plasminogen 
activator by human retinal endothelial cells, but not by human umbilical vein 
endothelial cells (Rymaszewski et al, 1992). Aortic endothelial cells express
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types III, IV and V collagen, but adrenal capillary endothelial cells express types 
I, III and V collagen (Jaffe, 1987). Capillary endothelial cells strongly express 
MHC-I and intercellular adhesion molecule (ICAM), which are variably weak to 
undetectable on large vessels (Page et al, 1992). The primary purpose of this 
experiment was to isolate and culture endothelial cells specifically from human 
choroid and retina; and to develop a cell culture model for the study of choroidal 
and/or retinal diseases.
A major problem in the isolation of human microvascular endothelium is 
the presence and rapid overgrowth of contaminating cells. Previous purification 
techniques, such as sorting by flow cytometry, rely on the endothelium 
undergoing a number of cell divisions. Use of UEA-I bound Dynabeads to isolate 
human CMEC and RMEC provides reliable cell viability and purity. However, 
analysis of failure culture indicated that the most common cause is still 
contamination. During isolation procedures, two circumstances were noted that 
may have resulted in contamination with non-endothelial cells. First, if the initial 
mixed population of cells contains more than approximately 50% non-endothelial 
cells, the physical limitations of the system may not allow complete purification. 
Minor contamination after purification (<1%) can be removed by mechanical 
weeding (Marks and Penny, 1986; Jackson et al, 1989). This must be done early 
before the contaminating cells start to spread. Second, inadequate washing of 
beads following incubation with mixed populations may cause slight 
contamination. This can be avoided by thoroughly mixing the cell suspension 
between washes and by reducing any agitation during MPC separation.
Apart from contamination, cells failing to attach to the culture dish was the 
other major reason for isolation and culture failure. Although the previous data 
suggested the beads did not interfere with the plating down of the endothelial cells 
onto gelatine-coated dishes (Jackson et al., 1990), it has been found, from the 
present experiment, that an overdose of Dynabeads usually results in a failure of 
cell attachment. The amount of UEA-I coated beads used to bind endothelial cells
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should depend on the amount of tissue. Foetal tissue contains less vascular 
endothelial cells and vessel segments than adult tissue, therefore, a smaller 
volume of coated beads (3 |il) was needed to complete the binding and isolation. 
The amount used for adult tissues (5 p.1) may be too high for foetal material and 
cause cell attachment failure.
Comparison of the characteristics of CMEC and RMEC culture indicated 
that RMECs were more difficult to isolate and culture. One RMEC culture failed 
to proliferate after the first passage; the reason for this was unknown. It may be 
due to low initial cell numbers, or perhaps over digestion by trypsin occurred 
during passage. Further technical improvement is needed to achieve a higher 
success rate.
There was no obvious alteration in the physical behaviour and function of 
endothelial cells bound to the beads compared to other types of isolation (Jackson 
et a l, 1990). The endothelial cells isolated by this method were viable, 
morphologically intact and grew to confluence as a cobblestone-like or spindle 
shaped monolayer. They continued to proliferate and reacted with anti-vWF. 
However, if it is intended to conduct functional studies after culture, it is better to 
dissociate the beads from the endothelial cells. This can be achieved by 
competitive inhibition with fucose immediately after isolation and before plating 
down on the primary culture dish (Jackson et al., 1990).
II. ISOLATION AND CULTURE OF HUMAN FOETAL AND ADULT
RETINAL PIGMENT EPITHELIUM
Introduction
The retinal pigment epithelium plays a critical role in a number of 
ophthalmic disorders, including ARMD and diabetic retinopathy. In addition, 
foetal RPE has been used for transplantation in the treatment of the some retinal 
or/and choroidal disorders (Ho and Del Prior, 1997). Reliable methods for the 
isolation and culture of RPE are essential for studies of RPE function and
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transplantation. Isolation and culture of human foetal RPE present problems 
associated with the limited size of the eye cup and greater adherence amongst RPE 
cells compared with adult eyes. The procedure presented here is based on 
mechanical dissection. The characteristics of the RPE were investigated using 
antibodies against cytokeratin, vimentin and CD31 immunolabelling.
Materials and methods 
Cell culture
Foetal eyes (n=7) from 13 to 20 WG were obtained within 60 minutes of 
pregnancy termination. Eyes were washed in cold CMF HBSS (Trance) then 
opened circumferentially 1-2 mm posterior to the ora serrata. After anterior 
segment detachment, the vitreous and neural retina were removed without 
touching the RPE surface. The whole RPE layer was carefully peeled off in 
several pieces from Bruch's membrane using curved forceps under the dissecting 
microscope. RPE pieces then were gently attached to the bottom of a 35mm 
culture dish with the apical surface downwards. DMEM (Trace) containing 25 
mM HEPES (Trace), 10% FBS (Trace), 2 mM/ml L-glutamine (Trace), 50 IU/ml 
penicillin and 50fig/ml streptomycin (Trace) (culture medium) was added to the 
culture dish to just cover the RPE pieces and maintained at 37°C in a humidified 
atmosphere containing 5% CO2. Initial explanted pieces were removed after 3-4 
days subsequent to the outgrowth of RPE cells from the edges of the explanted 
pieces, and an extra 2 ml of culture medium were added.
Seven adult eyes from donors aged 17-83 years (postmortem delay < 20 h) 
were used and the procedures for isolation and culture of the RPE were identical 
to those described for foetal material. Special attention was paid to peeling of the 
RPE layer in aged eyes since intercellular adhesion of the RPE is weaker than in 
foetal material. In addition to the mechanical peeling, RPE from 3 adult eyes was 
isolated using 0.25% trypsin digestion (Edwards et al., 1987), with cells being 
released from Bruch's membrane by gentle aspiration, then washed with HBSS
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plus 10% FBS. Cells were then spun at 243 g and the cell pellet was resuspended 
and cultured in culture medium.
Phenotype and cell viability
At the 3rd passage, foetal and adult RPE cells were grown in 8-well 
chamber slides. Peroxidase immunohistochemical methods were used to visualise 
bound monoclonal antibodies against cytokeratin (Becton Dickinson, Australia), 
vimentin and CD31 (DAKO). The immunoreaction procedures were similar to 
immunolabelling of endothelial cells (see above). In the negative control, primary 
antibody was omitted, the other steps were identical to the antibody reaction.
Cell viability was tested by trypan blue exclusion in primary culture for 
both foetal and adult RPE.
Results
All foetal RPE was successfully isolated and cultured by mechanical 
peeling without enzyme treatment. Within 3-4 days, cells grew out from the edges 
of the explant (Figure 7-5A) and within 7 days became confluent with an average 
yield of 1.4 x 1()6 cells in a 35mm dish (Figure 7-5B). Melanin granules were 
present in primary culture and up to the 7th passage (Figure 7-5B). The primary 
culture was passaged using 0.25% trypsin and up to 10 passages were obtained 
from a single primary culture. In later passages, the RPE proliferated at a faster 
rate with a spindle-shaped morphology. Mean cell viability was 95% in primary 
culture (Table 7-3).
Five primary cultures of RPE were obtained from 7 adult eyes using 
mechanical dissection with an average yield of 5.4 x 10^ cells in a 35mm dish 
(Figure 7-5C). Adult RPE cells exhibited a spindle-shape and the melanin was 
usually not present beyond the 5th passage (Figure 7-5D). The RPE isolated by 
trypsinisation grew well in primary culture (with average yield of 5.7 x 1()5) and
Fig. 7.5. Cultures of human foetal and adult RPE using a 
mechanical dissection technique. A. Phase-contrast micrograph 
of cultured human foetal RPE cells at day 5 after initial explant pieces 
have been removed. ** indicates the initial area occupied by the explant 
piece. Spindle shaped cells are shown in the culture, melanin granules 
are present in the cytoplasm (arrow heads). B. P h ase-co n tras t 
micrograph of a confluent primary culture of the human foetal RPE 
cells (day 10). Spindle and polygonal shaped cultured cells form a 
monolayer and cells are rich in pigment granules (arrow heads). C. A 
confluent primary culture of human adult RPE cells at day 9. Melanin 
granules are present in the cytoplasm of these spindle shaped cells 
(arrow heads). D. Phase-contrast micrograph of cultured human adult 
RPE at passage 5. Cells display a monolayer in culture. Some cells 
show active division (arrow). Melanin granules are not present in the 
cytoplasm. Scale bars = 50 jam.

Fig. 7.6. Light micrographs of peroxidase immunolabelled 
human foetal RPE cells in culture. A. Foetal RPE 
immunolabelled with anti-vimentin. Intermediate filaments are shown in 
the cytoplasm. B. Foetal RPE immunolabelled with anti-cytokeratin. 
Intermediate filaments appear in the cytoplasm, In some cells 
intermediate filaments are concentrated in the perinuclear region 
(arrows). C. Foetal RPE immunolabelled with anti-CD31. No 
immunoreactivity is found in the cells. D. Foetal RPE cells are used as 
a control in the immunolabelling. The primary antibody has been 
omitted. No immunoreactivity is observed. Scale bars = 20 pm.

Fig. 7.7. Light micrographs of peroxidase immunolabelled 
human adult RPE cells in culture. A. Anti-vimentin labelled 
adult RPE cells in culture. Intermediate filaments were positively 
labelled by anti-vimentin (arrows). B. Cytokeratin positive intermediate 
filaments are seen in the cytoplasm of cultured adult RPE cells. 
Filaments are concentrated in the perinuclear region in some cells 
(arrows), which is similar to the observation in cultured foetal REP. C. 
Adult RPE immunolabelled with anti-CD31. No immunoreactivity is 
found in the cells. D. Adult RPE cells are used as a control in the 
immunolabelling. The primary antibody has been omitted. No 
immunoreactivity is observed. Scale bars = 20 pm.
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subsequent passages, however, it took at least 10 to 14 days to initiate the primary 
proliferation. Contaminating fibroblast-like cells were sometimes found in the 
trypsinised primary culture. The mean viability of adult RPE was 89% in primary 
culture using the mechanical method, while using trypsinisation, 91% viability 
was obtained in primary culture (Table 7-3). The cell yield, viability, proliferation 
period of the primary culture and success rate of the isolation are summarised in 
Table 7-3.
Immunolabelling using antibodies against cytokeratin, vimentin and CD31 
indicated that both human foetal and adult RPE express vimentin and cytokeratin 
on intermediate filaments, while CD31 immunoreactivity was not seen (Figure 7-6 
and 7-7).
Discussion
Methods for the isolation and culture of human RPE can be classified into 
two groups - enzyme digestion (Mayerson et al., 1985; Pfeffer 1991; Castillo et 
al., 1995) and mechanical dissection (Aronson, 1983; Song and Lui 1990). Both 
these methods have been applied in different species (Timmers et al., 1984; Del 
Priore et al, 1988; Tezel et al., 1997). Most of these methods require considerable 
skill (Pfeffer 1991; Castillo et al., 1995) and sometimes result in contamination 
with other cell types or low cell yields (Aronson, 1983). A method using 45 min 
incubation with 2% Dispase II to detach the RPE from the retina described by 
Chang et al (1991) for the isolation of rat RPE was not applicable in the present 
experiment since human foetal and adult retinae were also digested by 2% Dispase 
II incubation at 37 °C for 45 min.
The present procedure is based on mechanical dissection but several 
technical modifications have been made to minimise contamination from 
choroidal cells, to reduce the time of initial cell growth and to increase primary 
cell yield. The initial separation of the RPE and choroid is the most difficult part 
of the procedure which should be carried out with the aid of a dissecting
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microscope in order to keep Bruch's membrane intact. The explant pieces should 
be attached to the bottom of the culture dish and the use of a small amount of 
culture medium helps to maintain attachment. Cells fail to grow if the explant 
piece is free floating. It was found that placing the apical side of the peeled RPE 
sheet downwards minimised contamination from the choroid which may result 
from occasional rupture of Bruch's membrane. Both foetal and adult RPE were 
cytokeratin and vimentin positive but CD31 negative, confirming that RPE has the 
characteristics of epithelium rather than endothelium.
Compared to other methods, the present technique provides a high yield of 
RPE cells, which show good viability and purity in subsequent culture, 
particularly RPE cells isolated from human foetal and young adult eyes (Zhu et 
al, 1998a).
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TABLE 7.1. Cell purities, days to confluence and rate of success in 
cultures of CMEC and RMEC
Cells CMEC RMEC
Eyes foetal adult adult
Purity >95% >96% >98%
Initial growth (days) <2 2-5 3-7
Primary confluence (days) 7 7-10 14-20
Passage confluence (days) 5-7 7 14
Passages 6 6 5
Rate of success (%) 78 83 61
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TABLE 7.2. Reasons for culture failure
Reason
CIVIEC RMEC
Total numberfoetal adult adult
Contamination 1 1 2 4
Attachment failure 1 1 1 3
Proliferation failure 0 0 1 1
Infection 0 0 1 1
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TABLE 7.3. Cell yield, viability and proliferation period of 
primary cultures of human RPE
Eyes Foetal Ac ult
Method mechanical mechanical enzyme
Yield 1.4xl06 5.2xl05 5.7xl05
Initial growth (days) 3-4 3-4 10-14
Confluence (days) 7-10 7-10 21
Viability (%) 95 89 91
Rate of success (%) 100 71 100
108
CHAPTER 8.
Effects of human ocular factors on vascular endothelial cell growth anddeath
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Introduction
Angiogenesis and vascular remodelling occur throughout normal growth and 
development. Ocular neovascularisation, described originally by Michaelson 
(1948) and Ashton et al. (1954), was thought to be influenced by the elaboration 
of angiogenic molecules. Subsequent studies on tumour angiogenesis have 
revealed a "tumour angiogenesis factor" which stimulates vascular growth in solid 
tumours (Folkman, et al, 1971; Folkman 1974). In general, the growth of the 
microvasculature is regulated by a balance between local stimulators and 
inhibitors (D'Amore 1994). Stimulating molecules include polypeptide growth 
regulators, such as VEGF, PDGF, acidic fibroblast growth factor (aFGF), basic 
fibroblast growth factor (bFGF), IL-8 and insulin-like growth factor. Potential 
growth inhibitors include not only soluble factors such as TGF-p, but also 
extracellular matrix constituents such as thrombospondin, which has been reported 
to have anti-angiogenic activity (Tolsma et al., 1993; D'Amore 1994). Although 
the factors involved in the control of angiogenesis are limited, there are numerous 
levels of control. For example, the synthesis of VEGF is regulated by the oxygen 
level in the micro environment of cells (Murata et al, 1994; Chan-Ling et al., 
1995; Stone and Maslim, 1997). On the other hand, the control of TGF-p appears 
to be not at the level of synthesis but, rather, through its activation (Antonelli- 
Orlidge et al., 1989).
Vitreous from adult humans and several animal species has been 
demonstrated to have inhibitory activities on vascular endothelial cell proliferation 
(Lutty et al., 1983; Raymond and Jacobson, 1982; Jacobson et al., 1984; Huang et 
al, 1996). It has also been demonstrated that vitreous contains molecule(s) which 
inhibited TGF-P2 activity and protected lenses from cataract formation (Lovicu et 
al, 1995; Schulz et al., 1996). Hyalocytes in the vitreous may play a role in 
effecting vascular regression in the developing eye and subsequently maintaining 
an avascular vitreous in the adult eye (Lang and Bishop, 1993; Evans and 
Ramanathan, 1996; Zhu et al, 1996b, 1998d). However, RPE cells have been
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suggested to produce several growth factors which stimulate endothelial cell 
proliferation (Wong et al., 1988; Morse et al., 1989; Yang et al, 1993; Sakamoto 
etal., 1995).
The studies from Chapter 3 to 6, using cresyl violet staining, 
immunohistochemical labelling, EM study and TUNEL technique, have provided 
clear evidence of hyaloid vascular regression during 10 to 20 WG and the 
processes of vascular regression are related to factors present in the local 
environment; with the hyalocytes in the hyaloid vasculature and vitreous playing 
an important role (Zhu et al. 1996b, 1997, 1998b). However, the factors derived 
from ocular tissues which influence vascular growth and/or regression remain to 
be identified. In the studies performed in this chapter, cultured HUVECs were 
used as a model to investigate the effects of different factors derived from ocular 
tissue on cell proliferation and inhibition.
Materials and methods
Cell culture and phenotype studies
HUVECs (ATCC CRL1730, USA) were cultured in F12K nutrient 
medium containing 0.29mg/ml L-glutamine (Sigma-Aldrich, NSW, Australia) and 
supplemented with 2.5mg/ml NaHCC>3, 10% FBS, 100fig/ml heparin (Trace), 
30|ig/ml endothelial cell growth supplement (Collaborative Research, Itegrated 
Scienced, NSW, Australia) and 50 IU/ml penicillin/50pg/ml streptomycin (Trace) 
(F12K growth medium) at 37°C in a humidified atmosphere containing 5% CO2. 
Medium was changed twice a week. Cell passages 5 to 7 were used in the 
experiments.
At passage 5, HUVECs were grown in 8-well chamber slides. Peroxidase 
immunohistochemical methods were used to visualise Polyclonal and monoclonal 
antibodies against vWF (DAKO, Australia), vimentin (DAKO,) and VEGF (Lab 
Supply Australia, NSW, Australia). The immunoreaction procedures were the 
same as immunolabelling of endothelial cells and RPE cells (see Chapter 7). In the
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negative controls, primary antibody was omitted, the other steps being identical to 
normal immunolabelling.
Vitreous extract and specific cell-conditioned medium preparation
1) Human adult and foetal vitreous extract and hyalocyte-conditioned medium 
preparation
Human adult eyes (n=21), age from 17 to 83 years old, with a postmortem 
delay of less than 14 hours, were used. After removal of the anterior segment, 
pooled vitreous was homogenised through a syringe, then centrifuged at 290 g for 
10 min at 4 °C. The supernatant was filtered through a 0.22pm filter and stored at 
-70 °C. The cell pellet (hyalocytes) was cultured in F12K growth medium for 7- 
10 days, the medium was collected, filter sterilised and stored at -20 °C.
Human foetal eyes (n=18), age from 16 to 20 WG, were obtained within 
60 min of pregnancy termination. The vitreous body, including hyalocytes and 
whole hyaloid vessels, was dissected from the eye cup and incubated in F12K 
growth medium for 5 days. Subsequently the vitreous body was further dissected 
from the hyaloid vessels and homogenised as for adult vitreous. The vitreal 
supernatant and the conditioned medium from the vitreous/hyaloid/hyalocyte 
cultures was combined, filter sterilised and stored at -20 °C.
2) Human foetal and adult RPE conditioned-media preparation
Human foetal and adult RPE were isolated mechanically and cultured in 
DMEM containing 25 mM HEPES (Trace, NSW, Australia) plus 10% FBS 
(Trace), 2mM/ml L-glutamine (Trace), 50 IU/ml of penicillin and 50pg/ml of 
streptomycin (Trance) (culture medium). The medium was changed twice a week. 
The second passages of RPE were cultured till confluent, culture medium was 
collected, then centrifuged at 290 g for 5 min at 4 °C. The supernatant was filtered 
through 0.22pm filter and stored at -20 °C.
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The methods for isolation, culture and characteristics of the RPE cells 
have been detailed in Chapter 7 and published recently (Zhu et ai, 1998a).
Normal HUVEC growth rate and viability
Normal HUVEC growth rate and cell viability were investigated as 
follows: HUVECs were seeded in quadruplicate at 2x10^ cells/well in 24-well 
plates and cultured in F12K growth medium. Medium was changed every 2 days 
and cell numbers were counted with a haemocytometer at days 1, 2, 3, 5 and 7. 
Trypan blue exclusion and haemocytometer counting were used to assess cell 
viability at 1, 2, 3, 5 and 7 days.
Cell proliferation assay
HUVECs were seeded in quadruplicate at 1.2xl()4 cells/well in 24-well 
plates, incubated for 24 hrs, then treated as follows: human adult vitreous diluted 
1:1, 1:4, 1:8 in F12K growth medium; adult hyalocyte-conditioned medium 
(AHC) diluted 1:1 in F12K growth medium; combined foetal vitreal supernatant 
and vitreous/hyaloid vessel/hyalocyte conditioned medium (FHC) diluted 1:1 in 
F12K growth medium; foetal and adult RPE-conditioned media (FRPEC and 
ARPEC) diluted 1:1 with F12K growth medium. Cells were also treated with 
VEGF 10 ng/ml (Sigma-Aldrich) in F12K growth medium as a positive control. 
For untreated negative control, cells were grown in F12K growth medium only.
Media were changed every 2 days and cell numbers were counted with a 
haemocytometer at days 1, 3, 5 and 7. All experiments were repeated 3 times.
Tétrazolium colorimetric (MTT) assay
Tétrazolium (MTT) colorimetric assay was used in addition to direct cell 
counting to determine the effect of the reagents. HUVECs were seeded on 96-well 
culture plates at an initial density of 4x10^ cells/well in F12K growth medium. 
After 24 hours, the medium and the unattached cells were removed and cultured
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cells were treated in triplicate with 1:1, 1:4, 1:8 diluted human adult vitreous, 1:1 
AHC, 1:1 FHC, 1:1 FRPEC, 1:1 ARPEC and lOng/ml VEGF for 1, 3, 5, 7 days 
respectively. Negative control was treated with F12K growth medium only. At 
end of the treatment, 10p.l of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyltetrazolium bromide) labelling reagent (Boehringer Mannheim, Australia) 
was added to each well at final concentration of 5mg/ml after removing the culture 
medium and treatment reagents. The plates containing MTT solution were placed 
back in the incubator for 4-5 hours then lOOfil of the solubilisation solution 
(Boehringer Mannheim) was added into each well and left in the incubator 
overnight. After checking for formation of the purple formazan crystals, the optic 
density was then measured with an enzyme-liked immunosorbent assay (ELISA) 
plate reader (Bio-Rad) at 550-665nm. All experiments were repeated three times.
Cell viability in treated groups
Trypan blue exclusion and haemocytometer counting were used to assess 
cell viability at days 1, 3, 5 and 7.
Examination of morphology
HUVECs were seeded at 1x10^ cells/well in chamber slides and treated 
with 1:1, 1:4 and 1:8 adult vitreous, AHC, FHC, ARPEC and FRPEC as above for 
5 days. Cells were rinsed in PBS, fixed in 2% paraformaldehyde and stained with 
0.5% cresyl violet, then examined and photographed using a light microscope.
TUNEL labelling
HUVECs were seeded at 1x104 cells/well in chamber slides. After 24 
hours, the medium and the unattached cells were removed and cells were treated 
with 1:1, 1:4, 1:8 diluted human adult vitreous, 1:1 AHC, 1:1 FHC, 1:1 FRPEC, 
1:1 ARPEC and lOng/ml VEGF for 5 days. At the end of the treatment, cells were 
rinsed in PBS, fixed in 2% paraformaldehyde for 10 min, then post-fixed in 100%
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acetone for 5 min at -20°C. After washing in distilled water at room temperature, 
cells were immersed in 70% ethanol for 10 min then transferred to 3% H2O2 for 
15 min. After several rinses in TBS saponin, cells were incubated in TBS saponin 
containing 10% sheep serum at room temperature for 20 min to block non-specific 
binding. Cells were then washed twice in TdT buffer for 3 min. Tissue was 
incubated in a reaction mixture containing 0.3 units/ml TdT (Boehringer- 
Mannheim, Australia) and 0.4nmol/ml biotinylated dUTP (Boehringer- 
Mannheim) in TdT buffer for 1 h in a humid chamber at 37°C. To stop the 
reaction, cells were incubated in a stop bath containing 300 mM/L NaCl, 30 
mM/L sodium citrate for 5 min, then blocked in 1% bovine serum albumin in PBS 
for 10 min followed by two washes in PBS.
For the peroxidase method, cells were incubated in Extra Avidin- 
conjugated peroxidase (Sigma-Aldrich) for 45 min, visualised using an ABC Kit 
(Vector Laboratories) and mounted with mounting medium.
For fluorescence microscopy, specimens were incubated in streptavidin- 
conjugated Cy-3 (Jackson Immuno Research Lab), diluted 1:1000 in PBS, for 45 
min at 37°C followed by a 5 min wash in PBS and mounted in PBS/glycerol 
gelatine (Sigma-Aldrich). As the positive control, cells were treated with mg/ml of 
exogenous DNase for 15 mins before processing in the TUNEL procedure. For the 
negative control, TdT incubation was omitted, the other steps being identical to 
normal TUNEL labelling.
DNA staining
After treatment in different agents for 5 days, cultured cells were also 
stained with AO/EB mixture and viewed by fluorescence microscopy (See 
Chapter 2).
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Statistics
One-way analysis of variance (ANOVA) and the Student-t test were used. 
All values were expressed as mean and standard deviation (Mean ± SD). P< 0.05 
was considered statistically significant.
Results
Characteristics and phenotypes of cultured HUVECs
Cultured HUVECs displayed a cobblestone or spindle-shaped monolayer 
when confluent, with a few cells overlapping on the monolayer (Figure 8-1). They 
were strongly immuno-reactive to anti-vWF and anti-vimentin, but only weakly to 
anti-VEGF (Figure 8-2). Some cell to cell connections (bridge connecting 
structures) were found using anti-vimentin immunolabelling (Figure 8-2B). In 
normal culture, cells took 5 to 7 days to double in number and cell viability 
remained over 92% (Figure 8-3).
Hyalocytes in the culture
Hyalocytes were difficult to isolate from foetal vitreous because of the limitation 
of small volume and high viscosity. Cell numbers from individual specimens were 
very low (Figure 8-4A). Hyalocytes isolated from each individual adult vitreous 
were also low in number but were greater than foetal hyalocytes (Figure 8-4B). 
Cells from both foetus and adult did not adhere to the culture dish firmly and did 
not proliferate in 5 day culture.
Effects of vitreous extract and hyalocyte-conditioned medium on HUVEC 
proliferation and cell viability
Human adult vitreous was observed to inhibit proliferation and reduce 
viability of HUVECs significantly (P< 0.05) (Figure 8-5, 8-6). The inhibitory 
effects were dose-dependent.
Fig. 8.1. Normal cultured HUVECs. Normal cultured HUVECs 
(passage 3) display a confluent spindle shape monolayer. A few 
fibroblast-like cells can be seen (arrows). Scale bar = 100 pm.
Fig. 8.2. Phenotype o f cultured H U V ECs (p e ro x id a s e  
immunolabelling). A. HUVECs were positively labelled by anti-vWF. 
B. Cells show intense immunoreactivity to anti-vimentin. Some bridge­
like connecting structure (arrows) can be seen in this sample. C. Anti- 
VEGF immunoreactivity was detected weakly in cultured HUVECs. D. 
No SMA-oc immunoreactivity is apparent in this culture. Scale bars = 
25 pm.

Fig. 8.3. Normal growth rate and viability of cultured 
HUVECs (Means+SD). Cells were seeded at 2xl()4 cells/well. 
During 3 to 5 days culture, cell number doubled. Cell viability is over 
92% during 7 days of culture.
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Fig. 8.4. Cultured human foetal and adult Hyalocytes.
Hyalocytes were cultured in F12K growth medium for 5 days. After 
conditioned medium was collected, cells were stained with cresyl 
violet. A. Hyalocytes isolated from a 16 WG foetal vitreous, showing 
very low cell number (arrow heads). B. Cultured hyalocytes isolated 
from a 65 year old human vitreous. Cells remain low in number, some 
contain granules (arrow heads). Scale bars = 25 fim.
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Human FHC inhibited HUVEC proliferation more effectively than adult 
vitreous extract from day 3 after (P< 0.05). This inhibitory effect was displayed as 
early as 24 to 48 hours after treatment (Figures 8-5, 8-6). At a higher 
concentration and after 5 days treatment, vitreous and FHC were observed to be 
cytotoxic, and HUVEC viabilities were approximately 50% reduced in FHC 
treated groups and 45% reduced in 1:1 vitreous treated group compared to 
controls (Figure 8-5, 8-6) (P< 0.05). The AHC treated group also showed 
inhibitory effects to HUVEC proliferation.
In contrast, ARPEC, FRPEC and VEGF (lOng/ml) stimulated HUVEC 
growth over time without reducing cell viability (Figure 8-5, 8-6). The effects 
were apparent after 24 to 48 hours treatment. After 7 days treatment, cell numbers 
were increased approximately 50% in ARPEC and FRPEC groups and 76% in 
VEGF treated group compared to the control groups (day 7 data) (Figure 8-5, 8- 
6).
The MTT assay also demonstrated the inhibitory effects of vitreous, AHC 
and FHC as well as the stimulatory effects of ARPEC, FRPEC and VEGF on 
endothelial cell proliferation. It was noticed that FHC exhibited a strong cytotoxic 
effect on HUVECs as detected by the MTT assay. The absorbance was reduced 
approximately 68% at day 1 and 82% after 7 days treatment compared to the 
control group (Figure 8-7). In the vitreous treatment groups, the inhibitory effect 
was dose-dependent but not time-dependent as determined by the MTT assay 
(Figure 8-7).
Fig. 8.5. Effect of human adult vitreous, AHC, FHC 
FRPEC, ARPEC and VEGF treatment on HUVEC 
proliferation (MeansiSD).  Cells were seeded at 1.2x10^ 
cells/well. Following exposure to adult vitreous, AHC and FHC, cell 
numbers are significantly decreased compared to controls. This effect 
was dose- and time-dependent for adult vitreous. In contrast, ARPEC, 
FRPEC and VEGF show a growth-stimulating effect. After 7 days 
treatment cell numbers were increased approx. 50% in ARPEC and 
FRPEC groups and 76% in VEGF treated group compared to the 
controls. There is no statistical difference between the ARPEC and 
FRPEC in all the culture period. * indicates p<0.()5 compared to the
control.
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Fig. 8.6. Effect of human adult vitreous, AHC, FHC 
FRPEC, ARPEC and VEGF treatment on HUVEC viability 
(Means+SD). Cell viability is significantly decreased compared to 
controls following exposure to adult vitreous, AHC and FHC. High 
concentrations of adult vitreous and FHC are cytotoxic, with approx. 
45-50% reduced viability at day 7 compared with the control group. 
ARPEC, FRPEC and VEGF slightly increases viability at day 7. * 
indicates p<0.()5 compared with the control.
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Fig. 8. 7. Inhibitory and stimulatory effects determined by
MTT assay (Means^SD). MTT assay confirms the results 
observed from cell haemocytometer counting and cell viability 
determined by trypan blue exclusion. FHC exhibited a strong cytotoxic 
effect on HUVECs. The absorbance was reduced approximate 68% at 
day 1 and 82% after 7 days treatment compared to the control group. In 
the vitreous treatment groups, the inhibitory effect was dose-dependent 
but not time-dependent. ARPEC, FRPEC and VEGF treatment groups 
show stimulatory effects (* indicates p<().()5).
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Morphological changes and cell death
Morphological studies using phase-contrast microscope and cresyl violet 
staining revealed cell degeneration and evidence of cell death following treatment 
with vitreous and hyalocyte-conditioned medium (Figure 8-8, 8-9). Many cells 
lost their normal spindle or cobblestone appearance and were vacuolated. Some 
cells showed loss of adhesion, especially in the FHC treated group (Figure 8-8). 
Condensed nuclear chromatin or fragmentation of the nuclei was seen in the 
cytoplasm (Figure 8-9). However, in ARPEC, FRPEC and VEGF treated groups, 
cell division was observed. No other morphological changes were found (Figure 
8-10 and 8-11).
Using in situ TUNEL labelling, a large number of TUNEL positive cells 
were found in the groups treated with the highest concentration (1:1) of human 
vitreous and FHC. Some were also present in 1:4 and 1:8 vitreous and AHC 
treated groups (Figure 8-12). As a positive control, all cell nuclei were positively 
labelled by the TUNEL technique after exogenous DNase was applied (Figure 8- 
12). No TUNEL positive cells were detected in the ARPEC, FRPEC, VEGF 
treated groups (Figure 8-13). DNA fragmentation and apoptotic bodies in cells 
treated with vitreous, AHC and FHC were also stained by AO/EB DNA staining 
(Figure 8-14, 8-15).
Discussion
Normal vascular growth and regression are controlled by a balance of 
angiogenic stimulators and inhibitors (D'Amore 1994). This is also true for ocular 
vasculopathies including diabetic retinopathy, ROP and ARMD. Understanding 
the mechanisms which mediate vascular growth and regression has potential 
significance for intervention in human ocular vasculopathies.
There are various model systems in which to study these angiogenic and/or 
regressive processes, among them, the proliferation assay is a well accepted and 
quantifiable procedure to evaluate vascular endothelial cell function in vitro. In
Fig. 8.8. Phase-contrast micrographs of HUVECs 5 days 
post-treatment with vitreous, AHC and FHC. A. In this 
control sample, HUVECs show a cobblestone-like monolayer after 
being treated with F12K growth medium. B. After being treated with 
1:1 vitreous, cells have lost their normal spindle or cobblestone-like 
appearance and are degenerating (arrows). C. Degenerated cells can be 
seen in this AHC treated culture (arrows). D. Cells are detached from 
the culture dish in this FHC treated culture and are showing signs of 
degeneration (arrows). Scale bars = 25 jam.

Fig. 8.9. Morphology of HUVECs 5 days post-treatment 
with vitreous, AHC and FHC (cresyl violet staining). A. In
1:1 adult vitreous treated culture, cells lose their normal spindle shape 
and become vacuolated (arrows). Some cells show evidence of 
apoptotic involution, with characteristic condensed nuclear chromatin 
and cytoplasmic pyknotic bodies (arrow heads). B. Degenerating 
HUVECs are seen at a higher magnification. Cells were treated with 1:1 
vitreous. A large vacuole (arrow) and the pyknotic nuclear fragments 
(arrow heads) are apparent inside the cell. One cell contains a large 
cytoplasmic pyknotic body (large arrow head). C. In this AHC treated 
culture, cell nuclei are broken up and pyknotic nuclear fragments are 
present in the cytoplasm (arrow heads). Two vacuolated cells (arrows) 
are apparent in this culture. D. Vacuolated cells can be seen in this 
FHC treated culture (arrows), cell number is decreased. Scale bars = 25
pm.
I
Fig. 8.10. Phase-contrast micrographs of HUVECs after 5 
days treatment with ARPEC, FRPEC and VEGF. In ARPEC, 
FRPEC and VEGF treated groups, cells display normal endothelial cell 
characteristics in culture. No cell degeneration was found. A: ARPEC 
treated group; B. FRPEC treated group; C. VEGF treated group. D. 
Control group. Scale bars = 25 pm.

Fig. 8.11. Morphology of HUVECs after 5 days treatment 
with ARPEC, FRPEC and VEGF (cresyl violet staining).
A. Control (F12K growth medium) culture displays a monolayer 
cobblestone-like morphology. B. ARPEC treated culture shows normal 
endothelial cell appearance, cell division can be observed (arrow). C. 
Cultured HUVECs treated with FRPEC show active division (arrow) 
and a normal cobblestone-like appearance. D. In VEGF-treated 
cultures, cell density appears increased and the morphology is similar to 
the controls. Scale bars = 25 pm.

Fig. 8. 12. TUNEL labelled HUVECs 5 days post­
treatm ent with vitreous, AHC and FHC (peroxidase  
method). A. F12K growth medium treated culture was used as a 
control. No TUNEL labelling is visible. Scale bar = 50 pm. B. In this 
1:1 vitreous treated group, cell numbers in culture are decreased. 
TUNEL positive cells (arrows) are observed, with condensed nuclear 
chromatin (arrow heads). Scale bar = 25 pm. C. This AHC treated 
culture shows similar TUNEL labelling to that seen in cultures treated 
with vitreous. TUNEL positive cells (arrows) are present. Scale bar = 
25 pm. D. This micrograph is from a culture treated with FHC. Cells 
lose their normal spindle-shaped morphology and are vacuolated (arrow 
heads). Many TUNEL positive cells (arrows) are seen. Scale bar = 50 
pm.

Fig. 8. 13. TUNEL labelled HUVECs 5 days post­
treatment with ARPEC, FRPEC and VEGF (peroxidase 
method). A. F12K growth medium cultured cells were incubated 
with exogenous DNase; all cell nuclei were positively labelled by the 
TUNEL technique. Cell division can be seen (arrow). Scale bar = 25 
pm. Cells from VEGF treated group (B) ARPEC treated group (C) 
and FRPEC treated group (D) are not TUNEL positive. Scale bars (B- 
D) = 50 pm.

Fig. 8. 14. AO/EB stained HUVECs 5 days post-treatment 
with normal F12K growth medium. No AO/EB positive staining 
is shown in both green (A) and red (B) field. Scale bars = 25 pm.

Fig. 8. 15. AO/EB stained HUVECs 5 days post-treatment 
with vitreous, AHC and FHC. A & B. 1:1 vitreous treated cells. 
Viable apoptotic cells were stained by AO (arrows in A); but EB 
staining is negative in the same field using green filter (arrows in B). 
Non-viable cells allowed EB to permeate the nuclear membrane and 
appear orange in colour (arrow heads in A and B). C. In this AHC 
treated culture, two damaged cell nuclei are stained by EB (arrow 
heads). D. FHC treated group, one apoptotic body is seen in the 
culture (arrow head). Three damaged cells were also stained orange by 
AO and EB (arrows). Scale bars = 25 fim.
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this study, in addition to haemocytometer cell counting in the proliferation assay, 
the MTT colorimetric assay was used to quantify the effects of human vitreous, 
hyalocyte conditioned medium and RPE conditioned medium on HUVECs. The 
colorimetric MTT assay is based on a shift of the absorption maximum of the 
tetrazolium salt MTT induced by the mitochondrial enzyme activity of living cells 
(Mosmann, 1983). It is designed for the spectrophotometric quantification of cell 
growth and viability and is used for the measurement of cell proliferation in 
response to growth factors, cytokines and nutrients and also for the measurement 
of cytotoxicity or growth inhibiting agents (Mosmann, 1983). From the current 
study, the MTT assay showed a clear relationship between the dose inhibitory 
effect of human vitreous and the live endothelial cell numbers or cell viability. In 
the FHC treated groups, result from the MTT assay showed a strong cytotoxic 
effect reflected by low optical density which indicated that the MTT assay is more 
sensitive than haemocytometer cell counting and trypan-blue exclusion.
RPE cells may have a mitogenic effect on various vascular cells including 
adrenal cortex capillary endothelial cells, bovine retinal capillary endothelial cells 
and bovine choriocapillary endothelium (Orlidge and D'Amore 1987; Wong et al, 
1988; Morse et al, 1989; Moisseiev et al, 1990). Previous studies have also 
suggested that RPE cells are capable of producing proteins immunologically 
similar to PDGF (Campochiaro et al, 1989, 1994, Vinores et al, 1995; Kliffen et 
al, 1997), VEGF (Adamis et al, 1993), bFGF (Schweigerer et al, 1987, Bost et 
al, 1992) and TGF-p (Connor et al, 1988; Matsumoto et al, 1994; Yoshimura et 
al, 1995).
PDGF is a cationic glycoprotein of approximately 30 kDa, composed of 
two subunits: A (18 kDa) and B (12-14 kDa). In vivo, it is synthesised by 
megakaryocytes and is transported in blood stored in the alpha granules of 
platelets (Antoniades, 1991). PDGF stimulates DNA synthesis and chemotaxis of 
endothelial cells in vitro and angiogenesis (Antoniades, 1991; Miyazono et al, 
1991). VEGF is an angiogenic growth factor which is heat and acid stable. It is a
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dimeric heparin-binding glycoprotein with a molecular weight of approximately 
46 kD (Ferrara et al, 1991, 1992). Four cDNA clones arising through alternative 
splicing and encoding of mature human monomeric VEGF with 121, 165, 189 and 
206 amino acids have been identified. Previous studies showed that VEGF 
promotes the growth of endothelial cells. The target cell specificity of VEGF is 
restricted to vascular endothelial cells (Ferrara 1992). bFGF, a prototypic member 
of a family of heparin-binding growth factors, was first purified from tumours on 
the basis of its ability to adhere to heparin and to stimulate the proliferation of 
endothelial cells (Klagsbrun and D'Am ore 1991). bFGF immunoreactivity was 
found in the endothelial cells of the hyaloid, lenticular and choroid vasculature, 
suggesting that bFGF plays an important role in neovascularisation (de Iongh and 
McAvoy, 1992; Zhang et al, 1993) and is synergistic with VEGF in the process 
of angiogenesis (Goto et al, 1993). The present study has found that human foetal 
and adult RPE-conditioned media promote HUVEC proliferation without 
influencing cell viability, suggesting that adult and foetal RPE release mitogenic 
factors into culture medium. The identity of the precise mitogenic factors from 
RPE cells has not been determined; however, the evidence from the present study 
suggests that this effect might be due to one or more of the above-mentioned 
factors because the stimulatory effect from ARPEC and FRPEC is similar to the 
effect produced by exogenous VEGF.
Vitreous has been demonstrated to have a vascular inhibitory effect on 
tumour-induced neovascularisation (Brem et al, 1977; Felton et al, 1979), retinal 
extract-induced neovascularisation (Lutty et al, 1983) and vascular endothelial 
cell proliferation in vitro (Raymond and Jacobson 1982, Jacobson et al, 1984; 
Huang et al, 1995, 1996; Evans et al, 1996). In the present study, human adult 
vitreous and FHC were used and the findings are consistent with previous studies. 
Hyalocytes were found to be difficult to isolate from foetal vitreous, cell numbers 
were very low from individual specimens, therefore, a combined FHC was used. 
Since hyalocytes isolated from adult vitreous were also low in number from each
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individual, pooled vitreous was used for the isolation and subsequent culture of 
hyalocytes. In contrast with Grabner and co-worker’s report (Grabner et al, 1980), 
the hyalocytes isolated from human vitreous in the current experiment did not 
show an ability to adhere to glass or plastic culture dishes. In normal culture 
conditions, hyalocytes did not proliferate, suggesting that hyalocytes have specific 
growth requirements which are different to endothelial cells.
The current study of HUVEC proliferation suggests that human vitreous 
and hyalocyte-conditioned medium contain anti-angiogenic factors which inhibit 
vascular endothelial cell growth in vitro. The inhibitory effect is dose-dependent. 
Vitreous at high concentration produced a cytotoxic pattern. Significantly, FHC 
had a stronger inhibitory effect on HUVEC growth than adult vitreous and AHC. 
This effect was cytotoxic, as evidenced by trypan blue staining and MTT assay. 
Morphological studies using cresyl violet staining revealed cell degeneration and 
evidence of cell death. Most damaged cells were TUNEL and AO/EB staining 
positive, suggesting that vitreous and hyalocyte-conditioned medium induced cell 
death, possibly via apoptosis at an early stage. At later stages, the dead cells were 
detached from the culture dish and many of them showed necrosis and cytolysis. 
Because cell loss was a gradual process and detached cells underwent cytolysis in 
a short period, the detached cell number in each supernatant was very low; for this 
reason, attempts to determine the nature of cell death in late stages have been 
unsuccessful.
The nature of the inhibitory factor(s) present in the vitreous and hyalocyte- 
conditioned medium has not been identified in the present study. It has been 
suggested that the factor(s) in the vitreous may be a product of the hyalocytes, 
with the effects correlated with the numbers and the locations of the hyalocytes in 
the vitreous (Raymond and Jacobson 1982, Lutty et al, 1993). Hyalocytes 
produce and process TGF-P (Lutty et al, 1993), a 25 kD peptide growth factor 
originally identified, purified, and named because it induces transformation of 
fibroblastic cells in monolayer culture and stimulates colony formation in soft
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agar (De Larco and Todaro, 1978; Roberts et al., 1981). TGF-ß modulates 
biological events as diverse as wound healing, angiogenesis and differentiation by 
stimulating or inhibiting cellular proliferation, Chemotaxis and extracellular matrix 
deposition and dissolution (McAvoy and Chamberlain, 1990; Barnard et al., 
1990). Because TGF-ß is a potent inhibitor of endothelial cell proliferation, and 
TGF-ß and vitreous inhibitor have similar cellular specificity, TGF-ß could be a 
candidate for a vitreous inhibitor of neovascularisation (Lutty et al., 1993). As the 
principal cellular component of normal vitreous, hyalocytes could control 
production and the rate of TGF-ß activation in vitreous since hyalocytes have a 
battery of acid hydrolases that could be responsible for activating latent TGF-ß 
(Lutty et al., 1993). Studies from previous chapters indicate that hyalocytes 
express leucocyte antigens (Chapter 4) and neuropeptides (Chapter 5, Zhu et al., 
1996a), and are involved in the involution of hyaloid vasculature during human 
eye development (Chapter 6). These observations combined with findings 
presented in this chapter, confirm the functional roles of the vitreous and 
hyalocytes in intraocular neovascularisation and vascular regression.
It is important to note that angiogenesis and vascular regression are 
complex processes. Angiogenesis involves a sequence of steps, including 
endothelial cell proliferation (sprout formation), degradation of the basement 
membrane, endothelial cell migration, vascular tube formation, connection of 
individual sprouts and anastomosis of newly formed capillaries (Folkman, 1984). 
Regulation of vascular growth and/or regression involve numerous levels of 
control and maybe multiple growth factors (D'Amore, 1994). Therefore, although 
the links between the in vitro activities of RPE cells, human vitreous, hyalocytes 
and HUVECs have been established, caution must be exercised in interpreting the 
biologic significance of these laboratory findings. Furthermore, it must also be 
noted that vascular endothelial cells display a broad functional and phenotypic 
heterogeneity as well as organ specificity (Kumar et al., 1987; Fujimoto and 
Singer, 1988; Fajardo, 1989, Rymaszewski et al, 1991, 1992; Page et al, 1992;
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Lelkes, 1993). The HUVECs used in the experiment have shown features in 
common with endothelial cells isolated from human choroid and retina, such as 
formation of a cobblestone or spindle-shape monolayer and expression of vWF 
antigen. A recent experiment from our laboratory has shown that HUVEC line in 
vitro model has the same functional reaction to the as (Dr. Philip Penfold personal 
communication). However, theses cells also have some specific features, such as 
rapid proliferation and strong expression of vimentin. The bridge structures 
detected with anti-vimentin may indicate that cultured HUVECs have some 
features in common with glial cells. Ideally, it would be better to repeat the same 
experiments (proliferation and MTT assays) using human choroidal, retinal and 
hyaloid microvascular endothelial cells. A major problem for using human ocular 
microvascular endothelial cells to test above factors is the limited supply of the 
human tissues. It is difficult, in such a short time, to produce such high number of 
human ocular microvascular endothelial cells to complete whole experiment. 
However, since the methods for insolation and culture of human choroidal and 
retinal vascular endothelial cells have been established and some of these 
endothelial cells have been successfully obtained from human foetal and adult 
choroid and adult retina (see Chapter 7), further experiments including the test of 
pan-specific TGF-ß neutralising antibody can be carried out in the near future.
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The development and regression of the hyaloid vasculature have been 
studied for more than a century, however, the cellular elements, antigenic profiles 
and factors which mediate vasculogenesis and regression of the hyaloid system 
remain to be fully described. This thesis has documented the development and 
early regression of the whole human hyaloid vascular system using 
morphological, functional and immunological techniques. The mechanisms of 
hyaloid vascular regression, including the involvement of the hyalocytes and the 
role of the constituents of the vitreous have been investigated. Particular areas of 
interest in this study of the human hyaloid system have been to examine its 
potential as a model for the study of intraocular neovascularisation and vascular 
regression; further, to explore the relationships of pathogenic changes associated 
with hyaloid vascular disease including ROP, PHTVL and PHPV to normal 
development of the hyaloid.
Morphology and antigenic phenotypes of the hyaloid vessels and hyalocytes
A major theme of this thesis has been to examine the relationship between 
morphological observations and their functional implications for development and 
regression of the hyaloid. Studies of the structural features and cellular elements 
of the normal human hyaloid vasculature were presented in Chapters 3 and 4. The 
results of these investigations are consistent with the descriptions provided by 
other researchers in different species. However, a number of additional 
observations concerning the human hyaloid have been made in the present 
studies:
The time course of hyaloid development and regression was observed to 
occur earlier than that documented previously. Existing studies suggest that 
vascular regression commences after 12 WG (Mann, 1950, Balazs et ai, 1980) 
and the development of the PM reaches its maximum at 24 WG, after which it 
begins to thin in the central portion (pupillary part) of the vessel (Ko et al, 1985). 
From the present study, the hyaloid system appeared well established by 10 WG;
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evidence of regress was detected as early as 11 WG and by 13 to 15 WG vessel 
regression was clearly apparent in the posterior portion of the hyaloid. The 
anterior portion of the hyaloid vasculature-PM vessels started to show thinning in 
vessel diameter at 14 WG, although during 14 to 16 WG PM vessels were much 
thicker in diameter than the vessels in 18 WG or after. There are significantly 
increased evidence in PM regression after 16 WG (Chapter 3).
The cellular elements and phenotypes of the human hyaloid vasculature 
were studied by immunohistochemistry and light and electron microscopy. A 
variety of distinct cellular constituents were identified: vascular endothelial cells, 
pericytes, hyalocytes and fibroblasts. Fibrillar and basement membrane collagens 
were also observed surrounding the vessels by TEM, consistent with previous EM 
findings. Additionally, specific immuno-markers for identifying these cellular 
elements were tested. The use of flat mounts in conjunction with specific antisera 
have provided novel immunohistochemical definitions of the cellular constituents 
of the human hyaloid. However, cross reactions between antibodies or target cells 
may lead to difficulty in interpreting results. Anti-SMA-a, for example, has been 
suggested to positively label vascular pericytes and smooth muscle cells of the 
vasculature and is commonly used as a marker to distinguish pericytes from 
endothelial cells or other cell types in vitro and in situ (Herman et al., 1985; Nehls 
and Drenckhahn, 1991). In large vessels of the hyaloid two forms of anti-SMA-a 
positive cells, circumferential and dendritiform, were found to co-exist, while in 
small vessels of the TVL or PM only dendritiform anti-SMA-a positive cells 
could be identified. SMA-a positive cells in the main HA and large branches of 
the VHP may include both pericytes and smooth muscle cells. However, 
dendritiform anti-SMA-a positive cells in small vessels of the TVL and PM 
would appear to represent true pericytes because of the absence of smooth muscle 
cells in these vessels shown by TEM. A similar situation has been found in human 
retina (Provis et al., 1997a). These findings provide evidence of heterogeneity of 
microvascular pericytes in the hyaloid and suggest that SMA-a is not a universal
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marker for pericytes. Some studies have suggested that monoclonal antibody 3G5 
is a specific marker for vascular pericytes (Powers et al, 1984; Nayak et al, 
1988). However, this monoclonal antibody has not been used in the present study 
as it has been reported to be lacking in specificity and limited expression during 
the mitotic cycle (Shepro and Morel, 1993). A more specific marker is still needed 
to distinguish true capillary pericytes from vascular smooth muscle cells.
In normal mature retinae, GFAP is recognised as a primary marker for 
astroglial intermediate filaments (Dreher et a l, 1992). However, GFAP 
immunoreactivity has not been found in the human hyaloid vascular system 
except in Bergmeister’s papilla (Chapter 4). The absence of macroglia-like cells or 
a glial limitans in the developing human hyaloid were also confirmed by 
ultrastructural studies. This finding suggests that the permeability characteristics 
of the hyaloid system may be induced and maintained by cellular elements other 
than macroglia.
In recent years, a variety of neuropeptides have been shown to play a role 
in regulating immune responses. CGRP and VIP immunoreactivity has been 
detected in immune cells, including monocytes, macrophages and lymphocytes 
(Calvo et al, 1994; Schraberger et al., 1997). Various neuropeptides have been 
detected in mast cells (Riederer et al., 1995; Cheng-Chew and Leung 1996). 
CGRP, SP and VIP containing nerve fibres have been reported to have a close 
relationship with mast cells and control the release of local mediators from mast 
cells (Ottosson and Edvinsson, 1997). At the EM level, CGRP labelled granules 
were present in some hyalocytes which morphologically resemble mast cells 
(Chapter 5). The possible relationships of CGRP, SP and VIP expression to the 
growth and regression of the hyaloid vasculature requires further investigation.
Finally, the presence of fenestrae in hyaloid vessels has been a long 
standing issue of debate. They have been observed by several authors in various 
species (Jack, 1972; El-Hifnawi 1994), whilst others have given contrasting 
reports (Braekevelt et al., 1970; De Schaepdrijver et al., 1989). One study
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conducted by Sellheyer and co-workers (1987) suggested that fenestrae were only 
observed before 9.9 WG in human embryos. In the present study, fenestrae were 
not found in normal hyaloid vessels during 10 to 20 WG.
Heterogeneity and classification of cellular elements in the human hyaloid
This thesis has identified heterogeneity in both hyalocyte and pericyte 
populations (see above) and has proposed a system of classification of these cells 
based on their relationship to the vasculature, their morphology, phenotype and 
distribution within the vitreous (Chapters 3, 4 and 5). The term hyalocyte was 
introduced by Balazs, Toth and Eckl (1964) to describe a homogenous population 
of cells in the vitreous. Subsequently, hyalocytes were noted to display 
characteristics in common with macrophages (Schneider et al, 1995). The results 
of the present study suggest that hyalocytes are a heterogeneous population of 
leucocyte-lineage cells including possible subpopulations of macrophages, large 
granule lymphocytes and mast cells. The expression of MHC-I, MHC-II and 
CD45 antigens, the presence of neuropeptides and the morphological features 
revealed by light and electron microscopy has provided further evidence that 
hyalocytes in the hyaloid vascular system and vitreous are a heterogeneous 
population of leucocyte-lineage cells which may play an important role related to 
regression of the hyaloid vasculature and the immunological status of the vitreous.
According to their relationship to the vasculature, hyalocytes were 
classified as vessel- and non vessel-associated types. Non-vessel associated 
hyalocytes were located in the foetal vitreous, with a tendency to distribute in 
different layers; small rounded cells occurred close to the vessels, dendritiform 
cells in the cortical layer and short-process cells between the vessels and the 
cortical layer. It remains uncertain whether these three layers of cells represent 
different developmental stages of hyalocytes which are undergoing migration 
from the vessels to cortical vitreous. Vessel-associated hyalocytes were present 
throughout the whole vessel system as three morphologically distinct types
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(Chapters 3, 4, 5; Zhu et al, 1998c). Ultrastructural studies revealed a subgroup 
of small juxtavascular hyalocytes, morphologically distinct from the large 
intervascular macrophage-like type.
Hyalocyte heterogeneity, their relationship with the vasculature and their 
distributions in the vitreous have implications for their different roles in the 
hyaloid vascular system and vitreous. Hyalocytes may function not only as 
phagocytes of the hyaloid vasculature and vitreous, but also as a network of 
immune accessory cells. They may also include populations of natural killer cells 
and mast cells capable of producing cytokines and other cytolytic mediators.
Mechanisms of hyaloid vascular regression
The mechanisms of hyaloid vascular regression have been studied using a 
combination of morphological and in situ labelling techniques (Chapters 3 and 6) 
and in vitro functional studies of ocular factors (Chapter 8). Angiogenesis and 
vascular regression are regulated by a balance between local stimulators and 
inhibitors (Folkman et al, 1983; D'Amore 1994). In situ studies have shown that 
cell death occurs in scattered individual vascular cells and subsequently segmental 
involution. Segmental involution can be induced from junction to junction without 
influencing neighbouring normal vasculature and hyalocytes are often apposed to 
both segments and individual dying cells, suggesting the involvement of specific 
signals for regression.
The features of cell death in the hyaloid vasculature are consistent with 
some aspects of apoptosis detected at the light microscope level. However, at the 
electron microscopic level, both apoptotic and cytolytic cell death were found and 
apoptotic bodies were not often observed in involuting vascular cells and 
vasculature. This finding challenges the concept that hyaloid regression is solely 
mediated by apoptotic mechanisms. It also indicates that the determination of 
apoptosis is a complex procedure and caution should be exercised in the
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interpretation of in situ detection of DNA fragmentation. Morphological studies, 
especially EM, are critical to the definition of apoptosis (Verhaegen, 1998).
The mediators of cell death and involution of the hyaloid vasculature are 
still unknown. In addition to internal factors, a variety of extracellular stimuli 
such as hormones, cytokines and killer cells have also been considered (Majno 
and Joris, 1995). Hyalocytes produce and process TGF-p which has been 
demonstrated to trigger apoptosis and inhibit vascular endothelial cell 
proliferation. Other factors such as TNF and GM-CSF, reported to be released by 
natural killer cells and macrophages, may also mediate the induction of apoptosis 
and cell death. Partial vessel blockage, due to death of individual endothelial cells, 
may result in deprivation of cell survival factors such as FGF, VEGF and serum 
albumin leading to whole vessel regression. The effects of inhibitory factors 
derived from the vitreous and hyalocytes and stimulatory factors derived from the 
RPE on vascular endothelial cell proliferation have been demonstrated in Chapter 
8. It was revealed that high concentrations of inhibitory factors can induce cell 
death by both apoptosis and cytolysis. This finding is consistent with the results of 
in situ studies of cell death and vascular regression (Chapter 6) and suggests that 
some local inhibitory factors from the vitreous and hyalocytes may also play a 
pivotal role in inducing cell death and consequently hyaloid vascular regression. 
Hyaloid vascular regression may involve both hyalocyte-mediated apoptosis and 
cytolysis; hyalocytes appear also to play an important role in the uptake of 
apoptotic bodies and cell debris.
Clinical implications
A number of retinal and choroidal diseases, including proliferating diabetic 
retinopathy, ROP, ARMD and persistent hyaloid system have common 
pathological features in abnormal vascular proliferation and neovascularisation.
Persistent hyaloid system especially PHPV/PHTVL, for example, is one of 
the major causes of leukocoria in newborns, resulting in complications such as
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cataract, secondary glaucoma and consequently vision loss in most of cases. 
However, it remains critical to distinguish between leukocoria due to 
developmental abnormalities of the hyaloid and other more serious conditions 
such as retinoblastoma. Previous studies have shown a close relationship between 
the hyaloid and retinal vasculature, abnormalities in the development of retinal 
vessels, such as in ROP, are often reflected in the hyaloid system (Eller et al, 
1987). Although persistent hyaloid is not the direct cause of ROP, it may 
contribute to its pathogenesis (Eller et al, 1987; Akeo et al., 1992). During ROP 
the retina is maldeveloped and the hyaloid system may serve as a extra supply to 
the ischaemic retina (Eller et al, 1987). It has been suggested that both persistent 
hyaloid and proliferation of the retinal vasculature are a reaction to angiogenic 
factors such as oxygen tension and VEGF (Patz 1982; Larrazabal and Penn, 1990; 
Alon et al, 1995; Aiello et al, 1995). Destruction of the balance of vasogenic 
stimuli and inhibitors may be the basis of pathological change in the ocular 
vasculatures. This study has also demonstrated the involvement of various forms 
of leucocytes in both the formation and elimination of the hyaloid, further 
illustrating the common relationship between immune cells and vasculogenesis 
previously documented, for example, in ARMD (Penfold et al, 1987).
Understanding of the mechanisms which mediate vascular development 
and regression has great potential significance for the development of treatments 
and prevention of ocular disorders. Further studies are needed, directed towards 
the identification and characterisation of vitreous and hyalocyte derived molecules 
and exploring their relevance to the pathogenesis of proliferative retinal diseases.
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